data_2d9o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d9o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.459 ' CD2' HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 28.0 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 242' ' ' LEU . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 199' ' ' GLN . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.0 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 244' ' ' ILE . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 235' ' ' VAL . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.462 HG22 ' CG2' ' A' ' 231' ' ' VAL . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.437 ' CD2' HD23 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.5 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.474 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.41 HD21 ' NE2' ' A' ' 199' ' ' GLN . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.469 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.1 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 176' ' ' LYS . 9.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.455 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.439 ' CG2' HG21 ' A' ' 244' ' ' ILE . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.474 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 175' ' ' LEU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.521 HD11 ' CE1' ' A' ' 221' ' ' PHE . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 48.3 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.453 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 199' ' ' GLN . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.513 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.471 HG12 ' CD2' ' A' ' 175' ' ' LEU . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.462 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 231' ' ' VAL . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 48.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.443 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.2 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 190' ' ' SER . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 242' ' ' LEU . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 199' ' ' GLN . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.568 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.568 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.462 ' CA ' ' HB2' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 225' ' ' LYS . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB2' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 173' ' ' LEU . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 240' ' ' ASN . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' PRO . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.467 HG12 ' CD2' ' A' ' 175' ' ' LEU . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.548 HD23 ' CE3' ' A' ' 246' ' ' TRP . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 38.6 p90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.498 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.447 ' CD2' ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 205' ' ' LEU . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.408 ' N ' HG12 ' A' ' 204' ' ' VAL . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 8.8 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 246' ' ' TRP . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.434 ' CG2' HD13 ' A' ' 173' ' ' LEU . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.447 ' OE1' ' CD2' ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.548 ' CE3' HD23 ' A' ' 173' ' ' LEU . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 242' ' ' LEU . 85.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.433 ' CD1' HG21 ' A' ' 219' ' ' VAL . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.491 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.6 mp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.47 ' HB3' ' CA ' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.404 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' PRO . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.453 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.453 ' N ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.414 ' CD2' HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 33.0 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 242' ' ' LEU . 57.2 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.434 ' N ' HD11 ' A' ' 209' ' ' LEU . 8.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.537 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.448 ' CG2' HD13 ' A' ' 173' ' ' LEU . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 189' ' ' TYR . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 175' ' ' LEU . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.581 ' CZ ' ' CD2' ' A' ' 242' ' ' LEU . 99.3 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.404 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 199' ' ' GLN . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.468 HG21 ' N ' ' A' ' 220' ' ' GLU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.468 ' N ' HG21 ' A' ' 219' ' ' VAL . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.527 ' HB3' ' CH2' ' A' ' 246' ' ' TRP . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.581 ' CD2' ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 227' ' ' ALA . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.405 ' CZ ' ' CD2' ' A' ' 242' ' ' LEU . 96.3 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.445 ' CD1' ' HB ' ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' GLN . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.462 HG12 ' CG2' ' A' ' 219' ' ' VAL . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.462 ' CG2' HG12 ' A' ' 204' ' ' VAL . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 50.8 m-80 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 240' ' ' ASN . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' PRO . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' A' ' 231' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 177' ' ' TRP . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 40.7 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.507 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 74.5 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 204' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 225' ' ' LYS . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 173' ' ' LEU . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.556 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.402 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.507 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.46 HD13 ' CG2' ' A' ' 231' ' ' VAL . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.44 ' CD2' HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.458 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 43.0 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.42 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.462 HD11 ' CG2' ' A' ' 219' ' ' VAL . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.458 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 207' ' ' LEU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.46 ' CG2' HD13 ' A' ' 173' ' ' LEU . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 242' ' ' LEU . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.402 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.516 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.495 HD23 ' CE3' ' A' ' 246' ' ' TRP . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.403 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.1 p90 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 219' ' ' VAL . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 8.9 mp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' THR . . . . . 0.447 ' CG2' ' HD3' ' A' ' 176' ' ' LYS . 71.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.406 ' CG2' HD12 ' A' ' 173' ' ' LEU . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 54.4 m-80 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.495 ' CE3' HD23 ' A' ' 173' ' ' LEU . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 244' ' ' ILE . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.462 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 190' ' ' SER . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 199' ' ' GLN . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.524 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.458 HG21 ' N ' ' A' ' 220' ' ' GLU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.552 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.466 HG22 ' CG2' ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.566 HD22 ' CE3' ' A' ' 246' ' ' TRP . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.458 ' CZ ' ' CD2' ' A' ' 242' ' ' LEU . 80.2 m-85 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 190' ' ' SER . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.449 ' CD2' HD12 ' A' ' 242' ' ' LEU . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.405 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' TYR . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.422 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD11 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.403 HD11 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.466 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 246' ' ' TRP . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.457 ' CG2' HG22 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.448 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.543 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 235' ' ' VAL . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.457 HG22 ' CG2' ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.566 ' CE3' HD22 ' A' ' 173' ' ' LEU . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.481 HD22 ' CZ3' ' A' ' 246' ' ' TRP . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . 0.468 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.52 ' CE1' HD12 ' A' ' 237' ' ' LEU . 58.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 199' ' ' GLN . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 9.6 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 209' ' ' LEU . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.459 ' N ' HG11 ' A' ' 208' ' ' VAL . 7.2 mp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 219' ' ' VAL . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.418 ' CG2' HD13 ' A' ' 173' ' ' LEU . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 229' ' ' LEU . 9.2 m-80 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 236' ' ' GLY . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . 0.467 ' N ' HG22 ' A' ' 235' ' ' VAL . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.52 HD12 ' CE1' ' A' ' 189' ' ' TYR . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.52 HD23 ' CE2' ' A' ' 189' ' ' TYR . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.481 ' CZ3' HD22 ' A' ' 173' ' ' LEU . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.57 HD13 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 244' ' ' ILE . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 44.2 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 242' ' ' LEU . 37.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.438 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 221' ' ' PHE . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.43 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.57 ' CE1' HD13 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.431 ' HB3' ' CA ' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.498 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.468 ' CG2' HG23 ' A' ' 244' ' ' ILE . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.527 HD13 ' CE1' ' A' ' 189' ' ' TYR . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 173' ' ' LEU . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.415 HD13 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.7 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.464 ' CD2' HD13 ' A' ' 242' ' ' LEU . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.464 ' CG1' HD13 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 208' ' ' VAL . 6.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.415 ' CE1' HD13 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.45 HG23 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 15.5 m-80 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.45 ' NE1' HG23 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 231' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.446 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.407 ' C ' HG23 ' A' ' 218' ' ' VAL . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 217' ' ' ALA . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 220' ' ' GLU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.434 ' HB1' ' CH2' ' A' ' 246' ' ' TRP . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . 0.464 ' CG2' HD21 ' A' ' 173' ' ' LEU . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.556 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.503 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 230' ' ' ALA . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.434 ' CH2' ' HB1' ' A' ' 227' ' ' ALA . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.506 ' CZ ' HD13 ' A' ' 237' ' ' LEU . 82.6 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.413 ' CG ' HD21 ' A' ' 207' ' ' LEU . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.424 ' HG ' ' CD ' ' A' ' 199' ' ' GLN . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.456 ' O ' ' C ' ' A' ' 199' ' ' GLN . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.574 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.566 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 246' ' ' TRP . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 46.2 p90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.402 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 199' ' ' GLN . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.401 HG12 ' CG2' ' A' ' 219' ' ' VAL . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 219' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 62.2 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.425 ' CG2' HD13 ' A' ' 207' ' ' LEU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.404 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . 0.475 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 173' ' ' LEU . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.8 t -142.25 111.19 6.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.9 p -140.1 154.13 46.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.75 70.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.5 p -116.92 122.52 44.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.2 m -72.91 -50.45 23.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 43.02 71.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -94.94 -50.4 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.86 -177.66 3.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -48.36 144.1 6.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.551 HD11 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.459 ' CD2' HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.467 ' NE1' ' HA2' ' A' ' 215' ' ' GLY . 28.0 p90 -137.24 161.85 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -70.92 119.1 14.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 37.1 t -133.84 147.09 51.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -70.49 166.63 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 183' ' ' ASP . 7.5 mptt -53.9 166.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 6.9 pt-20 -35.09 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 181' ' ' LYS . 27.4 t70 -135.57 163.99 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.95 -13.73 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 14.0 t -91.36 129.48 37.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -71.88 -54.28 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.66 -58.85 0.56 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.77 30.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -156.7 177.4 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.446 ' CD2' HD11 ' A' ' 242' ' ' LEU . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 199' ' ' GLN . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.45 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.417 ' N ' HG11 ' A' ' 208' ' ' VAL . 8.3 mp -119.95 149.41 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -92.23 122.22 34.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 p -90.01 -36.06 15.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -40.76 -57.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -116.57 142.14 29.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.77 46.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.467 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 69.98 45.11 58.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.0 p -145.63 139.25 26.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.551 ' CE1' HD11 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.4 ' CB ' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 244' ' ' ILE . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 235' ' ' VAL . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.462 HG22 ' CG2' ' A' ' 231' ' ' VAL . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.437 ' CD2' HD23 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -160.45 144.66 14.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 77.5 65.74 1.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -97.0 137.27 21.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.02 34.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.26 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -142.79 117.66 9.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -158.83 140.53 13.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.36 161.7 16.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.7 t -106.12 41.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.98 39.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.11 3.93 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.735 2.29 . . . . 0.0 112.357 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.9 p -79.36 165.64 22.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 p -169.48 176.16 5.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -80.81 105.76 12.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 p -166.61 145.2 5.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.822 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 138.22 75.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.6 p -87.43 170.07 11.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.1 m -158.09 134.23 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.03 154.98 18.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -87.95 150.66 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.85 -149.03 42.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -111.64 151.7 43.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.45 ' CD2' HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.5 p90 -163.92 143.58 8.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -55.68 161.04 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.95 165.11 31.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -79.03 -175.61 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -117.48 -43.62 2.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -116.85 -54.19 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.85 140.39 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.76 -50.6 69.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 60.7 m -42.48 130.71 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 24.58 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 118.29 -81.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.86 43.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.474 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 -153.16 157.91 41.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.41 HD21 ' NE2' ' A' ' 199' ' ' GLN . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.511 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.469 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.469 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.1 mp -144.47 146.15 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -76.24 106.61 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 36.5 m -72.17 -62.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -47.3 -52.89 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -105.38 95.93 10.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.589 0.709 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 129.82 18.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 132.27 -28.63 3.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.471 ' CG2' ' HD2' ' A' ' 176' ' ' LYS . 9.4 p -114.4 169.46 9.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.455 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.439 ' CG2' HG21 ' A' ' 244' ' ' ILE . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.404 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.474 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.45 HG12 ' CD2' ' A' ' 175' ' ' LEU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.91 153.49 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.88 50.07 4.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.441 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 18.9 tt0 -72.58 140.62 81.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.441 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.8 Cg_endo -69.77 172.7 12.18 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -91.12 150.14 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.79 -64.03 1.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.64 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.8 m -78.04 92.25 4.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -131.17 79.51 0.36 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 152.05 68.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.331 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.4 m -111.72 140.15 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.3 t -112.02 114.52 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 161' ' ' GLY . 66.7 m -36.33 127.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.5 m -164.29 177.23 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.29 -177.17 22.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 74.2 m -106.61 125.63 51.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.6 p -77.04 160.64 28.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.59 -134.03 3.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.35 120.28 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 158.26 165.1 15.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p -110.76 143.54 28.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.521 HD11 ' CE1' ' A' ' 221' ' ' PHE . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 48.3 p90 -139.75 151.83 46.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -65.66 151.71 45.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 4.5 m -156.01 153.73 29.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -78.9 177.69 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -52.01 173.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.852 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.26 88.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' GLU . 9.3 m-20 -129.27 159.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' ASP . 10.1 mm-40 -37.44 -54.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 p -70.9 143.16 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 43.32 2.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.62 175.5 48.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -85.71 46.91 3.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 -149.7 163.92 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.453 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.453 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 199' ' ' GLN . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.559 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.559 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -126.96 134.28 50.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.8 t -65.21 102.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.9 t -70.28 -58.2 4.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.93 -55.88 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 8.8 mmmm -101.67 97.68 8.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.5 Cg_endo -69.74 130.95 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.83 -34.55 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p -107.44 145.5 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.47 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.521 ' CE1' HD11 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.513 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.471 HG12 ' CD2' ' A' ' 175' ' ' LEU . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.462 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.44 176.49 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.2 53.57 39.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -74.21 137.23 75.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.32 3.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 0.0 112.304 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.6 141.46 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.95 110.02 21.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -168.07 168.86 11.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -134.81 149.4 50.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 109.54 -158.08 14.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -28.45 25.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.386 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 46.53 46.65 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 56.3 m -133.17 163.16 29.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.1 t -120.28 95.08 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -116.38 142.1 47.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.76 -142.69 0.84 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.2 m -88.57 96.42 10.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.7 m -87.19 -51.78 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.36 157.88 9.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.36 143.13 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.1 160.51 10.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p -99.63 145.08 29.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.466 HD12 ' CG2' ' A' ' 231' ' ' VAL . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.467 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -149.59 144.01 25.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -49.96 152.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.9 p -156.69 145.85 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -78.77 179.73 7.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -89.8 75.34 7.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 181' ' ' LYS . 24.1 mt-10 36.7 48.23 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -95.13 -61.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -118.78 -45.6 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.6 p -150.18 -177.07 5.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -116.35 40.14 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.41 146.14 11.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -76.65 65.41 2.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 96.2 m-85 -162.32 169.33 20.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 190' ' ' SER . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.406 ' CD2' HD13 ' A' ' 242' ' ' LEU . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.464 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 199' ' ' GLN . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.568 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.568 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.462 ' CA ' ' HB2' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.13 122.83 47.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -56.8 147.62 22.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.1 t -111.5 -47.54 3.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -38.98 -49.47 1.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -129.38 126.9 23.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 137.34 35.22 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.31 22.52 11.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p -140.36 140.64 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.417 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 225' ' ' LYS . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.462 ' HB2' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.466 ' CG2' HD12 ' A' ' 173' ' ' LEU . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 240' ' ' ASN . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' PRO . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.467 HG12 ' CD2' ' A' ' 175' ' ' LEU . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.84 173.12 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.1 26.96 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.468 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 33.4 tt0 -90.11 139.83 27.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.611 0.72 . . . . 0.0 110.901 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.75 176.79 6.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.359 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -66.97 130.57 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.94 -64.06 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -90.78 142.82 27.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.8 p -112.83 114.83 27.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -160.6 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 138.48 38.21 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.1 p -172.66 151.32 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 m 54.08 41.66 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.5 t -110.64 -46.61 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t 53.0 37.97 26.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.1 125.6 2.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 42.1 t -70.21 106.49 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 p -66.6 126.0 27.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 168' ' ' GLN . . . 123.62 157.1 9.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.476 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 167' ' ' GLY . 1.7 mp0 -113.89 149.13 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 153.62 171.05 20.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p -71.19 142.08 86.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.548 HD23 ' CE3' ' A' ' 246' ' ' TRP . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 38.6 p90 -152.58 141.65 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.82 98.62 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.8 p -82.21 -51.11 8.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.4 ' CG ' ' OG ' ' A' ' 185' ' ' SER . 3.4 mmtp -151.48 -179.07 7.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -101.1 87.5 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 63.42 35.89 11.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -134.11 176.2 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.03 114.33 28.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' A' ' 180' ' ' LYS . 10.7 p -167.09 158.95 12.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -85.19 -56.25 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 111.9 -130.31 9.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.92 53.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.498 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 -153.75 158.75 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.447 ' CD2' ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.538 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 205' ' ' LEU . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.408 ' N ' HG12 ' A' ' 204' ' ' VAL . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 8.8 mp -130.75 177.49 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 p -47.92 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.3 t -127.06 -32.01 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -126.85 -60.37 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -92.06 117.16 67.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.598 0.713 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 142.54 48.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.338 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 124.79 -13.95 7.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p -120.6 158.5 27.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.471 ' HB1' ' CH2' ' A' ' 246' ' ' TRP . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.434 ' CG2' HD13 ' A' ' 173' ' ' LEU . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' OE1' ' CD2' ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.498 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.548 ' CE3' HD23 ' A' ' 173' ' ' LEU . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.98 140.79 29.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.08 49.74 1.85 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.442 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 11.2 tp60 -70.76 138.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.588 0.708 . . . . 0.0 110.879 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.415 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.76 162.56 41.6 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.86 117.09 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -126.61 151.34 48.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.03 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.1 t -97.09 135.43 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -100.55 146.11 17.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 258' ' ' SER . 54.2 Cg_endo -69.74 -13.71 35.11 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' PRO . 2.6 p -36.81 -73.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.8 t -100.98 141.6 33.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.1 p -115.39 167.76 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -74.09 159.77 32.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -160.89 35.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.5 p -153.14 113.74 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 t -106.79 158.11 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.43 -138.84 15.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -45.58 154.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.75 -157.41 30.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -93.02 140.92 23.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.63 141.53 18.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -56.62 122.08 11.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 34.9 t -127.45 143.31 51.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.66 163.0 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.63 130.51 35.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.77 43.46 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.07 132.76 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -72.65 -53.9 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.2 t -49.61 -41.63 42.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 59.06 25.77 14.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 105.03 -98.99 1.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -173.82 41.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.433 ' CE2' HD21 ' A' ' 242' ' ' LEU . 85.4 m-85 -132.64 167.37 20.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 199' ' ' GLN . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.47 ' CA ' ' HB3' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.491 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.6 mp -139.52 153.59 47.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.5 t -91.87 116.9 29.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.2 m -88.83 -39.23 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -52.05 -58.85 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -102.94 122.28 46.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 127.6 14.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 94.85 38.84 4.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.444 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.7 p -155.64 145.77 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.433 HG21 ' CD1' ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.47 ' HB3' ' CA ' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.404 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 241' ' ' PRO . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.453 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.453 ' N ' ' HE3' ' A' ' 243' ' ' LYS . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -159.45 146.04 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 55.12 5.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -92.37 136.3 25.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.924 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 142.98 49.52 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.688 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.473 ' O ' ' NE2' ' A' ' 252' ' ' GLN . 1.4 tm0? -84.31 86.63 7.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.91 134.3 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -127.32 114.08 17.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.0 t -112.44 104.36 12.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 86.28 76.48 1.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 102.27 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.706 2.271 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.8 t -153.45 139.27 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 65.0 m -141.7 173.0 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.463 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 161' ' ' GLY . 60.7 p 37.12 42.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.818 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -80.6 106.79 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -114.57 133.86 11.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.0 t -119.67 174.24 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 95.5 p -113.18 143.62 44.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -133.1 157.03 22.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.455 ' C ' ' CD ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -121.07 165.74 14.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.26 176.44 22.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -68.65 146.31 97.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.537 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.414 ' CD2' HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 33.0 p90 -127.92 137.06 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -58.13 140.51 52.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 21.8 t -174.85 148.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -54.79 141.23 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -73.04 -50.95 20.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -80.44 44.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.06 149.85 43.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -86.62 -46.09 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.2 t -59.09 162.14 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -54.7 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 145.49 33.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 86.87 39.19 7.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 242' ' ' LEU . 57.2 m-85 -160.99 135.56 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.469 ' CD2' HD12 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.563 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.419 ' CG1' HD11 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 209' ' ' LEU . 8.2 mp -121.14 136.41 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -77.94 129.87 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.0 t -90.49 -64.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -38.24 -55.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.27 106.98 20.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 116.68 4.68 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 103.44 28.7 5.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.86 150.27 39.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.537 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.448 ' CG2' HD13 ' A' ' 173' ' ' LEU . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 189' ' ' TYR . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 175' ' ' LEU . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -140.98 175.21 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 46.97 82.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.82 144.82 29.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 141.55 45.56 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -171.85 132.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.87 84.21 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.93 42.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.9 t -70.78 156.9 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 132.0 -95.85 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 114.0 3.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.2 t -72.9 164.43 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.0 t -107.01 -47.83 3.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.522 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.2 m 44.15 47.97 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.4 t -131.7 121.04 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.65 91.79 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.5 p -132.05 176.71 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -142.72 137.88 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.03 59.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -124.04 176.96 6.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.15 175.46 25.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p -56.04 143.43 62.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.469 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 -140.77 144.46 35.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -49.87 136.9 17.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.08 138.26 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.93 146.18 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -46.1 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.12 46.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.84 175.32 7.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -119.05 84.47 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 18.9 m -159.32 145.05 16.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -112.26 21.71 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.58 -60.88 2.43 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.34 60.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.581 ' CZ ' ' CD2' ' A' ' 242' ' ' LEU . 99.3 m-85 -147.98 140.59 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.404 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 199' ' ' GLN . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.454 ' N ' HG13 ' A' ' 208' ' ' VAL . 7.0 mp -127.13 142.33 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.0 t -76.12 122.76 24.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.4 m -88.57 -44.41 10.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.88 -42.93 89.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 34.0 mmtt -99.32 105.38 32.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.1 Cg_endo -69.8 128.74 16.42 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 89.11 32.04 11.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p -152.65 145.93 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.468 HG21 ' N ' ' A' ' 220' ' ' GLU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.468 ' N ' HG21 ' A' ' 219' ' ' VAL . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.527 ' HB3' ' CH2' ' A' ' 246' ' ' TRP . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.532 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.581 ' CD2' ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.465 HG12 ' CD2' ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.527 ' CH2' ' HB3' ' A' ' 227' ' ' ALA . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -154.03 177.24 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 48.56 57.21 8.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.424 ' CD ' ' HD2' ' A' ' 251' ' ' PRO . 12.4 tm0? -83.48 137.23 42.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.0 110.879 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.424 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 54.1 Cg_endo -69.69 107.5 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.679 2.253 . . . . 0.0 112.365 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -126.3 37.33 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -78.52 167.65 20.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -154.43 162.85 40.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.2 m -82.37 98.9 9.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.3 -165.11 33.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.454 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -48.99 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.647 2.231 . . . . 0.0 112.337 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.8 t -170.42 119.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.1 p -78.87 -22.13 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 p -122.54 126.58 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t 47.26 42.14 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.91 -76.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.5 m -69.12 106.01 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 30.1 p -94.88 -45.89 7.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -116.78 -175.78 17.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -108.18 129.29 55.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.15 31.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -59.31 144.06 84.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -151.71 155.69 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -50.78 172.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.1 p -172.92 138.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -72.97 114.77 11.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.33 -52.26 10.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -49.6 -40.06 37.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.86 115.21 27.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -61.55 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 10.3 t -142.22 160.72 39.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -69.29 -52.36 28.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 135.05 -112.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' CD1' ' A' ' 189' ' ' TYR . . . -147.26 51.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.566 ' CD1' ' O ' ' A' ' 188' ' ' GLY . 96.3 m-85 -162.07 161.2 28.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.445 ' CD1' ' HB ' ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 199' ' ' GLN . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.462 HG12 ' CG2' ' A' ' 219' ' ' VAL . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -134.0 143.15 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -74.03 108.38 6.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 43.7 t -75.53 -66.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -43.68 -43.21 5.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -119.51 93.46 47.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.606 0.717 . . . . 0.0 110.887 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 123.04 9.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 146.97 -33.25 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 20.9 p -113.5 164.0 14.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.462 ' CG2' HG12 ' A' ' 204' ' ' VAL . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.465 ' CG2' HD11 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 50.8 m-80 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.567 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.44 ' O ' ' C ' ' A' ' 240' ' ' ASN . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 241' ' ' PRO . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -173.32 156.18 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.58 41.53 7.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -56.62 130.44 77.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 2.38 3.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.378 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.35 59.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -161.29 144.85 12.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.31 120.73 40.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 59.0 m -90.78 -48.39 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.82 -170.26 26.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 93.89 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.5 m -101.57 -43.84 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 58.0 m -115.29 157.66 23.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 p -91.78 149.82 21.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 95.5 p -114.39 142.34 46.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.33 174.27 29.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.1 p -109.7 -64.39 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -169.29 163.01 10.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 168' ' ' GLN . . . 70.62 71.13 1.06 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.506 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 167' ' ' GLY . 11.2 pt20 -34.92 119.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -136.97 -175.92 14.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p -115.24 143.29 30.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.438 HD11 ' CG2' ' A' ' 231' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.452 ' HG3' ' N ' ' A' ' 177' ' ' TRP . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 40.7 p90 -162.72 146.53 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -60.25 152.89 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.65 134.89 22.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.51 154.82 23.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -98.57 -41.0 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -66.58 -27.78 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.99 145.99 25.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.5 -11.95 44.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.9 p -72.89 162.18 29.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . 0.442 ' N ' ' HE2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -69.02 -48.42 63.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 146.81 -119.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -115.88 53.98 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.504 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.508 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 74.5 m-85 -162.87 121.48 2.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 204' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.556 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.1 155.49 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.1 t -73.12 131.07 41.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.0 m -95.58 -60.84 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -50.21 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -98.86 101.39 12.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 141.34 44.74 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.263 . . . . 0.0 112.316 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.87 -13.77 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.3 p -124.78 173.53 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' HG3' ' N ' ' A' ' 226' ' ' ALA . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 225' ' ' LYS . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.438 ' CG2' HD11 ' A' ' 173' ' ' LEU . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.556 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.402 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.507 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -174.09 171.22 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.88 38.91 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.428 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 35.5 tt0 -62.21 138.23 96.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 110.926 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.7 Cg_endo -69.75 110.56 2.58 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.721 2.281 . . . . 0.0 112.372 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -89.95 93.56 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.84 109.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -151.54 119.62 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -80.14 85.1 5.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.08 -93.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.447 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -11.95 31.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.67 2.247 . . . . 0.0 112.321 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t -73.42 84.57 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.7 t -43.57 109.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -165.48 128.2 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -79.54 -50.82 10.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 133.88 138.07 3.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.1 m -86.93 104.53 16.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -93.4 150.05 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -130.86 97.39 0.37 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -139.6 122.87 17.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 118.09 -156.74 15.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p -79.8 143.5 58.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.46 HD13 ' CG2' ' A' ' 231' ' ' VAL . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.44 ' CD2' HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.458 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 -159.27 177.76 10.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -109.79 107.19 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.37 121.12 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -61.95 164.01 7.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -49.7 156.52 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.869 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -45.76 97.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 184' ' ' GLU . 31.7 t70 -134.11 166.9 21.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASP . 13.9 tt0 -35.92 -60.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.2 m -79.63 175.56 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -79.83 -64.82 1.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -157.72 42.5 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.09 11.94 47.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 43.0 m-85 -142.23 130.23 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.42 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.462 HD11 ' CG2' ' A' ' 219' ' ' VAL . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.89 140.45 51.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.7 p -38.73 145.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -121.75 -16.59 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 -47.88 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -133.13 123.32 17.83 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.543 0.687 . . . . 0.0 110.869 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.64 2.227 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.458 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p -120.06 168.15 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.462 ' CG2' HD11 ' A' ' 207' ' ' LEU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.412 ' CG2' ' C ' ' A' ' 260' ' ' GLY . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.46 ' CG2' HD13 ' A' ' 173' ' ' LEU . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.477 ' O ' ' N ' ' A' ' 242' ' ' LEU . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.402 ' H ' ' CG1' ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.516 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.44 HG12 ' CD2' ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.496 ' CG ' ' OE1' ' A' ' 250' ' ' GLN . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -126.47 -11.54 6.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.448 ' O ' ' CE3' ' A' ' 246' ' ' TRP . . . -95.08 55.46 1.82 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.496 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 2.4 tp60 -80.39 129.07 70.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.581 0.705 . . . . 0.0 110.921 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.18 15.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -40.95 -50.59 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.3 -57.79 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 256' ' ' GLY . . . -159.06 145.6 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.0 t -38.27 -31.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 254' ' ' ALA . . . 129.76 -161.09 22.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.2 m -101.37 137.91 39.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 4.6 t 40.05 45.73 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.412 ' C ' ' CG2' ' A' ' 223' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 p -81.62 114.87 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -127.22 123.0 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.95 148.51 17.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.6 t -101.87 -55.79 2.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.3 t -50.53 -54.65 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.24 -100.11 2.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -96.29 101.8 13.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 128.78 -174.96 18.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p -118.06 138.58 25.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.495 HD23 ' CE3' ' A' ' 246' ' ' TRP . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.447 ' HD3' ' CG2' ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.436 ' NE1' ' HA2' ' A' ' 215' ' ' GLY . 49.1 p90 -149.43 140.94 23.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -62.97 134.9 56.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 27.3 p -117.41 132.64 56.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -53.2 169.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 182' ' ' GLU . 33.8 tptt -93.01 105.1 17.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' LYS . 15.8 mm-40 37.9 50.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 183' ' ' ASP . 27.6 t70 -88.61 41.93 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 41.47 40.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.3 p -172.47 167.64 5.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -96.25 -39.45 9.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.03 -166.38 32.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.94 29.75 10.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -137.69 165.16 27.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 219' ' ' VAL . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 217' ' ' ALA . 8.9 mp -121.82 157.6 30.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 t -91.75 163.33 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.815 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 69.2 m -120.18 -55.52 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -53.7 -54.86 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -91.04 108.53 28.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.0 110.877 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.81 131.88 22.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.65 2.234 . . . . 0.0 112.324 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.436 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 87.64 26.86 28.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' THR . . . . . 0.447 ' CG2' ' HD3' ' A' ' 176' ' ' LYS . 71.7 p -136.63 150.87 48.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.424 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.424 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.406 ' CG2' HD12 ' A' ' 173' ' ' LEU . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 54.4 m-80 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.402 ' CD1' ' HA ' ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.538 ' CD1' ' OE1' ' A' ' 250' ' ' GLN . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 -161.28 108.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.54 55.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.538 ' OE1' ' CD1' ' A' ' 246' ' ' TRP . 22.0 tt0 -102.79 137.49 19.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.648 0.737 . . . . 0.0 110.865 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 144.55 53.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -119.13 -68.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.67 40.92 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.7 38.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.8 t -168.49 174.12 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.5 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 142.25 47.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.8 m -124.18 119.89 30.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 35.3 t -167.42 140.83 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.2 m -124.09 177.53 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.8 p -101.63 -45.67 5.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.35 -95.79 0.79 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.8 t -71.56 121.96 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.2 p -74.84 -51.59 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.85 -170.03 27.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -56.73 159.23 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.39 179.33 47.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p -103.15 152.27 38.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.432 ' CD2' HG12 ' A' ' 244' ' ' ILE . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.462 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 -134.75 166.91 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -82.83 116.76 22.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 41.0 t -93.7 116.77 29.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.46 ' N ' ' HE2' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -67.97 171.44 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -87.57 -47.8 8.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 2.7 pp20? -88.17 41.83 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -73.51 173.64 9.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -117.15 -55.0 2.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.0 t -113.51 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -134.1 -50.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.02 -53.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.465 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -170.69 37.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 82.8 m-85 -164.01 171.08 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 190' ' ' SER . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 199' ' ' GLN . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.524 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.524 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp -126.67 135.25 50.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.3 t -57.58 108.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.7 t -76.22 -49.13 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 212' ' ' LYS . 2.8 mppt? -62.91 -57.88 9.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -99.65 100.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 129.55 17.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.628 2.219 . . . . 0.0 112.321 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 129.47 -36.17 2.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p -106.33 148.66 27.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.458 HG21 ' N ' ' A' ' 220' ' ' GLU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.552 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.466 HG22 ' CG2' ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -160.18 122.49 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 114.57 57.7 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.09 139.9 34.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.599 0.714 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 144.7 55.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -109.56 83.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -98.56 42.6 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -56.64 96.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.4 p -117.26 120.25 37.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -106.39 -176.13 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 1.71 4.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 66.7 m -79.39 157.15 27.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.2 m -77.33 164.38 25.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.517 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.8 t -161.38 149.76 15.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.0 t -96.74 -51.84 4.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.63 -100.03 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -145.05 171.04 15.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 m -124.17 148.9 46.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -159.65 55.13 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -42.01 142.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.46 163.26 10.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.89 147.15 35.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.566 HD22 ' CE3' ' A' ' 246' ' ' TRP . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -135.31 141.79 45.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -53.14 141.99 21.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 8.1 t -158.14 144.35 17.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -77.11 159.6 29.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -81.11 -70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 183' ' ' ASP . 28.5 mm-40 -46.35 -44.27 16.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' GLU . 0.9 OUTLIER -37.23 -47.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 54.66 32.83 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.6 m -115.43 176.91 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -82.58 -46.67 13.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 119.45 -161.74 13.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.03 47.49 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.475 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.458 ' CZ ' ' CD2' ' A' ' 242' ' ' LEU . 80.2 m-85 -148.15 127.59 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' A' ' 190' ' ' SER . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.405 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.449 ' CD2' HD12 ' A' ' 242' ' ' LEU . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.405 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 201' ' ' TYR . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.549 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.549 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.422 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD11 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.403 HD11 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp -127.44 146.39 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -79.4 136.79 37.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 80.8 p -100.92 -23.87 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.435 ' C ' ' HE3' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -74.17 -75.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.468 ' HE3' ' N ' ' A' ' 213' ' ' LYS . 0.1 OUTLIER -74.86 122.02 86.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.932 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 127.01 13.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.672 2.248 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 85.73 39.33 8.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p -145.22 145.99 31.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.466 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.422 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.536 ' HB2' ' CH2' ' A' ' 246' ' ' TRP . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.415 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.457 ' CG2' HG22 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.448 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.543 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 237' ' ' LEU . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 235' ' ' VAL . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.457 HG22 ' CG2' ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.566 ' CE3' HD22 ' A' ' 173' ' ' LEU . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.32 121.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 112.6 59.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.468 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 23.2 tt0 -99.34 139.36 20.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.3 Cg_endo -69.76 135.97 31.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 0.0 112.297 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -111.75 26.12 10.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.51 124.38 52.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.47 45.23 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -148.8 -175.83 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -126.81 -80.5 0.34 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.451 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -26.67 27.36 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.234 . . . . 0.0 112.341 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.2 m -63.69 148.3 49.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 80.7 p -62.14 157.76 18.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.4 t -133.64 174.42 10.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 t -73.87 90.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 69.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -42.31 -53.75 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.8 m -97.85 113.7 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.93 171.41 38.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.33 108.86 20.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.0 178.02 51.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p -50.94 142.9 16.33 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.481 HD22 ' CZ3' ' A' ' 246' ' ' TRP . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.468 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 -144.6 153.9 42.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -59.78 110.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.6 p -102.7 146.57 28.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 -177.96 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -81.67 43.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.59 43.5 9.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.98 -49.95 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.79 -54.19 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.0 p -132.67 173.39 11.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -72.12 -48.01 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.7 31.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.28 35.27 84.02 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.52 ' CE1' HD12 ' A' ' 237' ' ' LEU . 58.8 m-85 -158.72 152.48 23.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.459 ' O ' ' C ' ' A' ' 199' ' ' GLN . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 9.6 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 209' ' ' LEU . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.459 ' N ' HG11 ' A' ' 208' ' ' VAL . 7.2 mp -122.03 137.98 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -67.13 110.58 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.7 t -75.45 -69.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -47.17 -44.25 21.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -104.53 92.75 5.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 127.03 14.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.342 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 126.49 -34.4 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p -107.93 153.42 23.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.439 ' CG2' HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 219' ' ' VAL . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.418 ' CG2' HD13 ' A' ' 173' ' ' LEU . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 229' ' ' LEU . 9.2 m-80 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.441 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 236' ' ' GLY . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.467 ' N ' HG22 ' A' ' 235' ' ' VAL . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.52 HD12 ' CE1' ' A' ' 189' ' ' TYR . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.52 HD23 ' CE2' ' A' ' 189' ' ' TYR . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.481 ' CZ3' HD22 ' A' ' 173' ' ' LEU . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -160.44 146.63 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.92 44.4 6.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.17 130.22 50.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.559 0.695 . . . . 0.0 110.933 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 133.48 25.69 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 0.0 112.357 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -100.1 -43.96 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.77 156.14 23.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.52 127.58 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -131.51 -52.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.28 157.54 32.95 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -22.48 32.14 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 70.9 m -105.98 94.5 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.2 m -78.84 109.37 13.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.2 p 39.48 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 110.913 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.3 t -54.52 132.93 45.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 165' ' ' SER . . . 61.06 -115.05 7.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 164' ' ' GLY . 1.9 m 36.95 51.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.369 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.4 p -108.11 122.6 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.24 -58.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -53.78 156.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.33 -164.36 33.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p -45.57 144.6 2.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.57 HD13 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 244' ' ' ILE . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.535 ' CE2' ' O ' ' A' ' 215' ' ' GLY . 44.2 p90 -147.72 146.98 29.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -81.56 109.73 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.42 -74.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -156.15 165.87 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -84.69 -54.54 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -122.96 80.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -174.6 120.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -80.33 80.01 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.9 t -140.78 158.81 43.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -82.41 -52.15 7.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 115.87 -148.97 18.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.0 23.52 13.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.527 ' CE1' HD13 ' A' ' 242' ' ' LEU . 37.6 m-85 -128.42 139.16 52.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.438 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 221' ' ' PHE . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.514 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.431 ' CA ' ' HB3' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.43 ' N ' ' CG1' ' A' ' 208' ' ' VAL . 7.0 mp -131.25 -177.38 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.8 p -53.4 179.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.7 t -123.85 -43.32 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -116.99 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -81.96 116.45 63.4 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.71 2.273 . . . . 0.0 112.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 129.21 -33.25 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p -101.97 159.59 15.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.57 ' CE1' HD13 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.431 ' HB3' ' CA ' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.498 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.468 ' CG2' HG23 ' A' ' 244' ' ' ILE . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.514 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.527 HD13 ' CE1' ' A' ' 189' ' ' TYR . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.498 ' CD1' ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 173' ' ' LEU . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -173.06 164.66 4.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 69.61 50.23 32.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.459 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 9.7 tt0 -77.37 142.86 67.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.934 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.77 119.83 6.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.351 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.489 ' CD ' ' C ' ' A' ' 252' ' ' GLN . 1.7 pp0? -131.32 165.91 22.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.17 104.43 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -107.79 128.53 54.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.8 m -112.75 87.98 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -145.6 -88.88 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 1.08 4.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 m 41.58 45.22 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 27.0 t -116.18 -42.67 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -94.85 -49.86 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.823 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.6 p -102.67 114.8 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.22 -102.37 0.87 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.7 t -152.37 141.13 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.822 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 35.8 p -125.41 173.29 8.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.58 -137.09 13.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -135.18 158.74 43.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.08 155.83 25.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p -82.62 142.56 46.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.415 HD13 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -137.4 153.08 50.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -62.62 147.18 50.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.2 p -159.54 166.02 31.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 182' ' ' GLU . 17.7 mttp -104.22 111.17 23.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -43.04 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 180' ' ' LYS . 11.6 pt-20 -127.4 -174.1 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 184' ' ' GLU . 0.6 OUTLIER 68.26 34.33 3.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 183' ' ' ASP . 28.5 tt0 34.5 41.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 43.7 t -97.3 104.96 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -67.79 -44.46 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.04 -50.98 0.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 126.41 47.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 96.7 m-85 -162.53 159.65 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.464 ' CD2' HD13 ' A' ' 242' ' ' LEU . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.464 HD13 ' CG1' ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.464 ' CG1' HD13 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.422 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 208' ' ' VAL . 6.9 mp -124.0 139.55 53.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -82.95 94.99 7.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 62.5 p -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -55.97 -48.87 75.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -104.66 116.15 61.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 129.69 18.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 86.86 33.11 13.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p -150.24 145.51 26.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.473 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.415 ' CE1' HD13 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.434 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.45 HG23 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 15.5 m-80 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.462 HG12 ' CD2' ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.45 ' NE1' HG23 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -169.83 141.5 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.47 40.34 3.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.439 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 41.0 tt0 -78.12 138.57 60.64 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.6 Cg_endo -69.8 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -128.13 84.58 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -159.43 176.71 11.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 44.0 39.67 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 157.14 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 125.73 -171.06 17.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 97.69 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.352 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.8 p -121.78 177.44 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.9 p -144.92 148.22 33.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 83.8 p -81.84 85.78 6.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.2 t -38.87 -60.72 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.46 103.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -72.38 157.85 36.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.402 . . . . 0.0 110.813 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -88.04 145.39 26.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.4 118.99 4.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -144.4 140.6 29.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.904 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.77 178.8 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p -60.91 146.69 86.81 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.464 HD21 ' CG2' ' A' ' 231' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -143.8 145.54 32.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -52.58 162.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 18.8 p -158.7 151.96 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 182' ' ' GLU . 16.2 ttmm -52.99 166.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 182' ' ' GLU . 5.3 tmtm? -50.99 90.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 67.1 mm-40 34.22 54.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.414 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 23.5 p-10 -79.25 164.51 24.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.29 46.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.1 m -157.26 170.0 23.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -51.95 9.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 138.96 -118.48 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -113.63 40.39 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 -151.37 154.18 36.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.446 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.413 HD13 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp -135.3 135.91 41.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -65.25 115.76 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 33.6 t -80.11 -54.32 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -53.25 -58.3 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -100.93 98.91 9.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.8 Cg_endo -69.78 131.45 21.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.14 -27.41 4.81 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 61.8 p -110.64 150.46 28.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.407 ' C ' HG23 ' A' ' 218' ' ' VAL . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . 0.407 HG23 ' C ' ' A' ' 217' ' ' ALA . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 220' ' ' GLU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.45 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.434 ' HB1' ' CH2' ' A' ' 246' ' ' TRP . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . 0.464 ' CG2' HD21 ' A' ' 173' ' ' LEU . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.556 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.503 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 230' ' ' ALA . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.434 ' CH2' ' HB1' ' A' ' 227' ' ' ALA . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -174.14 157.05 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.72 66.08 1.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -95.57 152.82 39.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 121.05 7.75 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -107.53 157.91 17.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.86 82.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.33 114.55 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.0 t -72.67 -50.83 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.43 -157.36 15.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 121.87 8.55 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.721 2.281 . . . . 0.0 112.351 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 67.1 p -99.44 135.67 40.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 93.6 p -152.46 171.03 18.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 p -50.93 160.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p 41.04 42.1 1.46 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -83.15 138.38 17.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 47.7 t -51.63 148.93 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -126.58 133.8 50.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.15 -167.56 39.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -125.7 113.34 17.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.864 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.1 -173.51 28.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p -80.61 143.8 55.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.493 ' CE2' ' O ' ' A' ' 215' ' ' GLY . 43.9 p90 -139.33 146.06 39.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 140.82 57.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.8 t -145.83 111.7 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -50.76 168.44 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -104.32 -45.39 4.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 181' ' ' LYS . 9.3 pt-20 -76.48 -37.05 57.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.06 95.42 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.5 93.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.1 m -169.28 164.39 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -71.01 -56.01 7.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.73 36.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.4 36.47 77.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.529 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.506 ' CZ ' HD13 ' A' ' 237' ' ' LEU . 82.6 m-85 -157.31 162.79 39.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.413 ' CG ' HD21 ' A' ' 207' ' ' LEU . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.424 ' HG ' ' CD ' ' A' ' 199' ' ' GLN . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.456 ' O ' ' C ' ' A' ' 199' ' ' GLN . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.574 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . 0.469 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.419 ' CD1' ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.418 ' CD1' HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.9 mp -129.15 137.3 51.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.7 t -60.62 123.72 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 m -87.35 -52.34 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -64.63 -55.49 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 98.75 9.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.582 0.706 . . . . 0.0 110.876 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 142.6 48.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.318 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 115.82 -36.74 3.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.513 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 78.0 p -101.76 146.58 27.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.439 HG13 ' CD1' ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.469 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.566 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.506 HD13 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.21 176.75 9.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.43 58.14 16.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.13 134.79 85.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 252' ' ' GLN . 53.3 Cg_endo -69.76 2.7 3.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.33 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 251' ' ' PRO . 3.1 tp60 -34.47 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.25 176.25 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -135.87 -179.56 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.3 m -39.85 -54.86 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 65.05 161.19 0.59 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 0.53 5.52 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.348 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.9 m -69.98 169.18 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.4 t -69.09 147.42 51.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 -179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.4 m -90.83 172.59 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 27.5 p -123.28 146.51 47.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.93 -117.94 0.83 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 80.1 p -56.4 104.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.9 m -49.33 176.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.835 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -121.32 -63.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.3 149.55 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.61 147.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p -115.04 144.14 31.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 246' ' ' TRP . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.421 ' CD2' HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TRP . . . . . 0.44 ' CE2' ' O ' ' A' ' 215' ' ' GLY . 46.2 p90 -146.53 137.89 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -51.15 101.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 44.1 t -96.8 117.74 31.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -53.85 -28.83 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 180' ' ' LYS . 30.9 ttpt 33.08 35.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 180' ' ' LYS . 34.4 mm-40 -133.98 -50.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.93 178.56 2.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.58 42.67 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 7.8 t -153.7 177.27 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -100.68 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.73 -177.76 43.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.47 40.9 2.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.475 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 -149.81 167.92 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.402 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 199' ' ' GLN . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.566 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.401 HG12 ' CG2' ' A' ' 219' ' ' VAL . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 219' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.6 mp -137.88 134.91 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.0 t -55.57 138.14 47.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 38.3 p -100.54 -62.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.413 ' NZ ' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -58.24 -53.01 63.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 213' ' ' LYS . 6.5 mptt -101.7 97.94 8.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.578 0.704 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 141.94 46.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.361 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.44 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 120.5 -41.29 1.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.478 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 62.2 p -97.65 151.02 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.425 ' CG2' HD13 ' A' ' 207' ' ' LEU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.404 ' N ' ' CG2' ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' PHE . . . . . 0.56 ' CE1' HD13 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.4 ' CD ' ' HG3' ' A' ' 251' ' ' PRO . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.566 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . 0.475 ' HG ' ' CZ ' ' A' ' 189' ' ' TYR . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.421 HG12 ' CD2' ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' TRP . . . . . 0.568 ' CE3' HD21 ' A' ' 173' ' ' LEU . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.88 112.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.51 65.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -107.24 133.08 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 110.931 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.4 ' HG3' ' CD ' ' A' ' 228' ' ' GLU . 54.1 Cg_endo -69.75 119.73 6.63 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.371 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -145.78 173.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -121.07 -48.56 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -62.92 84.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.7 m -86.69 172.77 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.57 166.48 29.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 174.75 9.03 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 20.0 m -79.94 150.45 30.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 3.0 t -60.63 -48.48 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 216' ' ' THR . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.631 ' HB3' HD23 ' A' ' 242' ' ' LEU . 28.0 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.871 HD12 HG21 ' A' ' 219' ' ' VAL . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.424 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 207' ' ' LEU . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 222' ' ' ALA . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.728 HD13 HG23 ' A' ' 219' ' ' VAL . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.42 HG22 ' HD3' ' A' ' 176' ' ' LYS . 77.0 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 198' ' ' LEU . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.424 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 173' ' ' LEU . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.441 ' H ' HG13 ' A' ' 238' ' ' VAL . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 177' ' ' TRP . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 230' ' ' ALA . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.432 ' CD2' HD21 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.706 HD23 HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.996 ' HD2' HG22 ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.749 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 219' ' ' VAL . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 219' ' ' VAL . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.996 HG22 ' HD2' ' A' ' 176' ' ' LYS . 9.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 173' ' ' LEU . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 198' ' ' LEU . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 219' ' ' VAL . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 244' ' ' ILE . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 227' ' ' ALA . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.839 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 177' ' ' TRP . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.839 HD11 ' OE2' ' A' ' 234' ' ' GLU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 227' ' ' ALA . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.734 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.3 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.461 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 219' ' ' VAL . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 222' ' ' ALA . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.622 ' N ' HG22 ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 222' ' ' ALA . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 244' ' ' ILE . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.455 ' H ' HG13 ' A' ' 238' ' ' VAL . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 177' ' ' TRP . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.592 HG21 HG22 ' A' ' 231' ' ' VAL . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.473 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 246' ' ' TRP . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.663 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.2 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.489 ' CG ' HD23 ' A' ' 207' ' ' LEU . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 204' ' ' VAL . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 219' ' ' VAL . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 195' ' ' LEU . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 191' ' ' LYS . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.601 ' N ' HG22 ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 227' ' ' ALA . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 244' ' ' ILE . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.716 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.716 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 177' ' ' TRP . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.697 HG21 HG22 ' A' ' 231' ' ' VAL . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.518 ' CE2' HD21 ' A' ' 173' ' ' LEU . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 221' ' ' PHE . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 198' ' ' LEU . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.778 ' HB3' HD23 ' A' ' 242' ' ' LEU . 38.6 p90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.497 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 175' ' ' LEU . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.816 HD23 ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.556 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.8 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 173' ' ' LEU . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 198' ' ' LEU . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 219' ' ' VAL . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.606 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 235' ' ' VAL . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.816 ' OE1' HD23 ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 233' ' ' ASN . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.45 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.778 HD23 ' HB3' ' A' ' 177' ' ' TRP . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 231' ' ' VAL . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.552 HD11 ' HB1' ' A' ' 227' ' ' ALA . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 244' ' ' ILE . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 242' ' ' LEU . 85.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HZ3' HD23 ' A' ' 207' ' ' LEU . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.51 HD12 HG11 ' A' ' 204' ' ' VAL . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 219' ' ' VAL . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.562 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 195' ' ' LEU . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.526 HD23 ' HZ3' ' A' ' 191' ' ' LYS . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.757 ' C ' HD12 ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.757 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 173' ' ' LEU . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.562 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 244' ' ' ILE . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 235' ' ' VAL . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.725 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.725 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 189' ' ' TYR . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 231' ' ' VAL . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.635 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.678 ' HB3' HD23 ' A' ' 242' ' ' LEU . 33.0 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.438 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 57.2 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 175' ' ' LEU . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.465 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.571 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 219' ' ' VAL . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.465 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.41 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 227' ' ' ALA . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.421 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 231' ' ' VAL . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.498 ' CE2' HD21 ' A' ' 173' ' ' LEU . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.947 HD12 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 99.3 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.595 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 219' ' ' VAL . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' C ' HD12 ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.419 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 198' ' ' LEU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.947 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 227' ' ' ALA . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.595 ' CD ' HD22 ' A' ' 197' ' ' LEU . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.699 HG12 HD23 ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.587 HD12 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 216' ' ' THR . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.569 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.3 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HG3' HD23 ' A' ' 207' ' ' LEU . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 197' ' ' LEU . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.73 ' CD1' HG21 ' A' ' 219' ' ' VAL . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 195' ' ' LEU . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.748 HD23 ' HG3' ' A' ' 191' ' ' LYS . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 209' ' ' LEU . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.2 mp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 176' ' ' LYS . 20.9 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 198' ' ' LEU . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 223' ' ' THR . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 222' ' ' ALA . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 19.0 m120 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 236' ' ' GLY . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.569 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 238' ' ' VAL . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.491 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.659 ' O ' HG13 ' A' ' 218' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 244' ' ' ILE . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.633 ' HD2' HG22 ' A' ' 216' ' ' THR . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.642 ' HB3' HD23 ' A' ' 242' ' ' LEU . 40.7 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.502 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 74.5 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.513 HD12 HG11 ' A' ' 204' ' ' VAL . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 219' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 195' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 222' ' ' ALA . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.633 HG22 ' HD2' ' A' ' 176' ' ' LYS . 3.3 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 173' ' ' LEU . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 198' ' ' LEU . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.546 ' N ' HG22 ' A' ' 219' ' ' VAL . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.419 ' HE1' HG11 ' A' ' 219' ' ' VAL . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.513 ' HD2' HD11 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 225' ' ' LYS . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 227' ' ' ALA . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 177' ' ' TRP . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 175' ' ' LEU . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 247' ' ' LEU . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 248' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.763 HD12 ' CE1' ' A' ' 221' ' ' PHE . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.514 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HD21 ' A' ' 242' ' ' LEU . 43.0 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.446 HD13 ' OE2' ' A' ' 234' ' ' GLU . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.557 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 209' ' ' LEU . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.514 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 220' ' ' GLU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.763 ' CE1' HD12 ' A' ' 173' ' ' LEU . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 235' ' ' VAL . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 233' ' ' ASN . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.688 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.544 HG12 HD23 ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 221' ' ' PHE . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.927 ' HD3' HG22 ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.552 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.1 p90 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 204' ' ' VAL . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.543 HD22 ' HZ ' ' A' ' 221' ' ' PHE . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 195' ' ' LEU . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 209' ' ' LEU . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.9 mp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.927 HG22 ' HD3' ' A' ' 176' ' ' LYS . 71.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.614 ' N ' HG22 ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 244' ' ' ILE . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 16.8 m120 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.862 HG21 HG22 ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 221' ' ' PHE . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 194' ' ' LEU . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.483 ' CG ' HD23 ' A' ' 207' ' ' LEU . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 175' ' ' LEU . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.407 HD12 HG11 ' A' ' 204' ' ' VAL . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 219' ' ' VAL . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.593 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 195' ' ' LEU . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.483 HD23 ' CG ' ' A' ' 191' ' ' LYS . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 198' ' ' LEU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.593 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 201' ' ' TYR . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.568 HG22 HG21 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 233' ' ' ASN . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.568 HG21 HG22 ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 227' ' ' ALA . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 244' ' ' ILE . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.533 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 80.2 m-85 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.481 ' CG ' HD23 ' A' ' 207' ' ' LEU . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.413 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 219' ' ' VAL . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.42 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 222' ' ' ALA . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 191' ' ' LYS . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 198' ' ' LEU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 222' ' ' ALA . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.554 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.718 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.718 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.857 HD12 ' CE1' ' A' ' 221' ' ' PHE . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 198' ' ' LEU . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 242' ' ' LEU . 58.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 219' ' ' VAL . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 39.1 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.582 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.471 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 207' ' ' LEU . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 222' ' ' ALA . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.425 ' HB2' HG11 ' A' ' 204' ' ' VAL . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.857 ' CE1' HD12 ' A' ' 173' ' ' LEU . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.471 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 244' ' ' ILE . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 229' ' ' LEU . 5.6 m120 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 231' ' ' VAL . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.787 HD12 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 198' ' ' LEU . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 242' ' ' LEU . 44.2 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.495 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 37.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.501 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.663 HD13 HG11 ' A' ' 219' ' ' VAL . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.567 ' N ' HG12 ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 198' ' ' LEU . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.787 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 223' ' ' THR . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 222' ' ' ALA . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.418 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 227' ' ' ALA . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.745 HD12 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.837 HD23 HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.6 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.7 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.602 HD12 HG11 ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 222' ' ' ALA . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 208' ' ' VAL . 6.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.602 HG22 ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.745 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.513 HG21 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 12.7 m120 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.79 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.686 ' H ' HG13 ' A' ' 238' ' ' VAL . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.6 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.837 HG12 HD23 ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.513 ' NE1' HG21 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.413 ' HZ2' HD23 ' A' ' 247' ' ' LEU . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 218' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 218' ' ' VAL . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 198' ' ' LEU . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 216' ' ' THR . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.501 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.603 HD23 ' HZ1' ' A' ' 200' ' ' LYS . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 219' ' ' VAL . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.603 ' HZ1' HD23 ' A' ' 197' ' ' LEU . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.531 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 207' ' ' LEU . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 222' ' ' ALA . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 204' ' ' VAL . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.579 ' C ' HD12 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 176' ' ' LYS . 61.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 173' ' ' LEU . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.531 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.565 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 246' ' ' TRP . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 231' ' ' VAL . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' TRP . . . . . 0.666 ' HE1' HG11 ' A' ' 231' ' ' VAL . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.413 HD23 ' HZ2' ' A' ' 172' ' ' LYS . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.72 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HG3' HG22 ' A' ' 218' ' ' VAL . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 198' ' ' LEU . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 216' ' ' THR . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.451 ' CZ3' HD11 ' A' ' 194' ' ' LEU . 43.9 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.695 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 82.6 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.451 HD11 ' CZ3' ' A' ' 177' ' ' TRP . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.692 HD12 HG11 ' A' ' 204' ' ' VAL . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 197' ' ' LEU . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.856 HD13 HG11 ' A' ' 219' ' ' VAL . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.692 HG11 HD12 ' A' ' 195' ' ' LEU . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD12 ' A' ' 209' ' ' LEU . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 208' ' ' VAL . 6.9 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 176' ' ' LYS . 78.0 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 173' ' ' LEU . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.72 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.671 HG22 HG21 ' A' ' 244' ' ' ILE . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.695 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.59 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.671 HG21 HG22 ' A' ' 231' ' ' VAL . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.719 ' HG3' HG22 ' A' ' 216' ' ' THR . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TRP . . . . . 0.611 ' HB3' HD23 ' A' ' 242' ' ' LEU . 46.2 p90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' VAL . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 207' ' ' LEU . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 204' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.708 ' C ' HD12 ' A' ' 209' ' ' LEU . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.708 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 176' ' ' LYS . 62.2 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 173' ' ' LEU . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 244' ' ' ILE . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.628 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.628 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 177' ' ' TRP . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.491 HG12 HD23 ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.8 t -142.25 111.19 6.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.9 p -140.1 154.13 46.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.75 70.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.5 p -116.92 122.52 44.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.2 m -72.91 -50.45 23.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 43.02 71.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -94.94 -50.4 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.86 -177.66 3.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -48.36 144.1 6.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 216' ' ' THR . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.631 ' HB3' HD23 ' A' ' 242' ' ' LEU . 28.0 p90 -137.24 161.85 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -70.92 119.1 14.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 37.1 t -133.84 147.09 51.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -70.49 166.63 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 183' ' ' ASP . 7.5 mptt -53.9 166.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 6.9 pt-20 -35.09 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 181' ' ' LYS . 27.4 t70 -135.57 163.99 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.95 -13.73 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 14.0 t -91.36 129.48 37.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -71.88 -54.28 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.66 -58.85 0.56 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.77 30.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -156.7 177.4 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.871 HD12 HG21 ' A' ' 219' ' ' VAL . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.424 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 207' ' ' LEU . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 222' ' ' ALA . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.728 HD13 HG23 ' A' ' 219' ' ' VAL . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' ' 208' ' ' VAL . 8.3 mp -119.95 149.41 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -92.23 122.22 34.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 p -90.01 -36.06 15.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -40.76 -57.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -116.57 142.14 29.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.77 46.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.483 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 69.98 45.11 58.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.42 HG22 ' HD3' ' A' ' 176' ' ' LYS . 77.0 p -145.63 139.25 26.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 198' ' ' LEU . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.424 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 173' ' ' LEU . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.441 ' H ' HG13 ' A' ' 238' ' ' VAL . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 177' ' ' TRP . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 230' ' ' ALA . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.432 ' CD2' HD21 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -160.45 144.66 14.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 77.5 65.74 1.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -97.0 137.27 21.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.02 34.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.26 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -142.79 117.66 9.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -158.83 140.53 13.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.36 161.7 16.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.7 t -106.12 41.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.98 39.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.11 3.93 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.735 2.29 . . . . 0.0 112.357 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.9 p -79.36 165.64 22.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 p -169.48 176.16 5.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -80.81 105.76 12.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 p -166.61 145.2 5.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.822 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 138.22 75.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.6 p -87.43 170.07 11.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.1 m -158.09 134.23 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.03 154.98 18.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -87.95 150.66 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.85 -149.03 42.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -111.64 151.7 43.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.706 HD23 HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.996 ' HD2' HG22 ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.749 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 -163.92 143.58 8.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -55.68 161.04 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.95 165.11 31.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -79.03 -175.61 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -117.48 -43.62 2.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -116.85 -54.19 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.85 140.39 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.76 -50.6 69.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 60.7 m -42.48 130.71 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 24.58 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 118.29 -81.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.86 43.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 -153.16 157.91 41.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 219' ' ' VAL . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 219' ' ' VAL . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp -144.47 146.15 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -76.24 106.61 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 36.5 m -72.17 -62.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -47.3 -52.89 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -105.38 95.93 10.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.589 0.709 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 129.82 18.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 132.27 -28.63 3.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.996 HG22 ' HD2' ' A' ' 176' ' ' LYS . 9.4 p -114.4 169.46 9.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 173' ' ' LEU . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 198' ' ' LEU . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 219' ' ' VAL . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 244' ' ' ILE . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 227' ' ' ALA . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.839 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 177' ' ' TRP . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.839 HD11 ' OE2' ' A' ' 234' ' ' GLU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.91 153.49 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.88 50.07 4.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 18.9 tt0 -72.58 140.62 81.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.8 Cg_endo -69.77 172.7 12.18 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -91.12 150.14 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.79 -64.03 1.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.64 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.8 m -78.04 92.25 4.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -131.17 79.51 0.36 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 152.05 68.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.331 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.4 m -111.72 140.15 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.3 t -112.02 114.52 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 161' ' ' GLY . 66.7 m -36.33 127.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.5 m -164.29 177.23 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.29 -177.17 22.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 74.2 m -106.61 125.63 51.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.6 p -77.04 160.64 28.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.59 -134.03 3.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.35 120.28 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 158.26 165.1 15.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p -110.76 143.54 28.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 227' ' ' ALA . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.734 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.3 p90 -139.75 151.83 46.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -65.66 151.71 45.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 4.5 m -156.01 153.73 29.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -78.9 177.69 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -52.01 173.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.852 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.26 88.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' GLU . 9.3 m-20 -129.27 159.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' ASP . 10.1 mm-40 -37.44 -54.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 p -70.9 143.16 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 43.32 2.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.62 175.5 48.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -85.71 46.91 3.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 -149.7 163.92 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.461 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 219' ' ' VAL . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 222' ' ' ALA . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -126.96 134.28 50.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.8 t -65.21 102.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.9 t -70.28 -58.2 4.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.93 -55.88 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 8.8 mmmm -101.67 97.68 8.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.5 Cg_endo -69.74 130.95 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.83 -34.55 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p -107.44 145.5 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.622 ' N ' HG22 ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 222' ' ' ALA . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 244' ' ' ILE . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.455 ' H ' HG13 ' A' ' 238' ' ' VAL . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 177' ' ' TRP . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.592 HG21 HG22 ' A' ' 231' ' ' VAL . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.473 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.44 176.49 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.2 53.57 39.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -74.21 137.23 75.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.32 3.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 0.0 112.304 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.6 141.46 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.95 110.02 21.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -168.07 168.86 11.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -134.81 149.4 50.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 109.54 -158.08 14.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -28.45 25.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.386 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 46.53 46.65 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 56.3 m -133.17 163.16 29.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.1 t -120.28 95.08 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -116.38 142.1 47.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.76 -142.69 0.84 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.2 m -88.57 96.42 10.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.7 m -87.19 -51.78 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.36 157.88 9.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.36 143.13 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.1 160.51 10.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p -99.63 145.08 29.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 246' ' ' TRP . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.663 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 -149.59 144.01 25.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -49.96 152.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.9 p -156.69 145.85 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -78.77 179.73 7.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -89.8 75.34 7.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 181' ' ' LYS . 24.1 mt-10 36.7 48.23 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -95.13 -61.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -118.78 -45.6 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.6 p -150.18 -177.07 5.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -116.35 40.14 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.41 146.14 11.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -76.65 65.41 2.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.2 m-85 -162.32 169.33 20.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.489 ' CG ' HD23 ' A' ' 207' ' ' LEU . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 204' ' ' VAL . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 219' ' ' VAL . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 195' ' ' LEU . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 191' ' ' LYS . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.13 122.83 47.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -56.8 147.62 22.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.1 t -111.5 -47.54 3.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -38.98 -49.47 1.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -129.38 126.9 23.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 137.34 35.22 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.31 22.52 11.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p -140.36 140.64 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.601 ' N ' HG22 ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 227' ' ' ALA . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 244' ' ' ILE . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.716 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.716 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 177' ' ' TRP . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.697 HG21 HG22 ' A' ' 231' ' ' VAL . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.518 ' CE2' HD21 ' A' ' 173' ' ' LEU . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.84 173.12 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.1 26.96 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 33.4 tt0 -90.11 139.83 27.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.611 0.72 . . . . 0.0 110.901 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.75 176.79 6.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.359 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -66.97 130.57 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.94 -64.06 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -90.78 142.82 27.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.8 p -112.83 114.83 27.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -160.6 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 138.48 38.21 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.1 p -172.66 151.32 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 m 54.08 41.66 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.5 t -110.64 -46.61 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t 53.0 37.97 26.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.1 125.6 2.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 42.1 t -70.21 106.49 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 p -66.6 126.0 27.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 123.62 157.1 9.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -113.89 149.13 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 153.62 171.05 20.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p -71.19 142.08 86.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 221' ' ' PHE . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 198' ' ' LEU . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.778 ' HB3' HD23 ' A' ' 242' ' ' LEU . 38.6 p90 -152.58 141.65 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.82 98.62 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.8 p -82.21 -51.11 8.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.4 ' CG ' ' OG ' ' A' ' 185' ' ' SER . 3.4 mmtp -151.48 -179.07 7.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -101.1 87.5 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 63.42 35.89 11.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -134.11 176.2 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.03 114.33 28.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' A' ' 180' ' ' LYS . 10.7 p -167.09 158.95 12.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -85.19 -56.25 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 111.9 -130.31 9.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.92 53.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.497 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 -153.75 158.75 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 175' ' ' LEU . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.816 HD23 ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.556 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.8 mp -130.75 177.49 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 p -47.92 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.3 t -127.06 -32.01 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -126.85 -60.37 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -92.06 117.16 67.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.598 0.713 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 142.54 48.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.338 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 124.79 -13.95 7.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p -120.6 158.5 27.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 173' ' ' LEU . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 198' ' ' LEU . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 219' ' ' VAL . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.606 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 235' ' ' VAL . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.816 ' OE1' HD23 ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 233' ' ' ASN . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.45 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.778 HD23 ' HB3' ' A' ' 177' ' ' TRP . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 231' ' ' VAL . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.442 ' CG ' ' OE1' ' A' ' 250' ' ' GLN . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.98 140.79 29.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.08 49.74 1.85 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.442 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 11.2 tp60 -70.76 138.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.588 0.708 . . . . 0.0 110.879 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.76 162.56 41.6 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.86 117.09 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -126.61 151.34 48.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.03 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.1 t -97.09 135.43 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -100.55 146.11 17.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 258' ' ' SER . 54.2 Cg_endo -69.74 -13.71 35.11 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' PRO . 2.6 p -36.81 -73.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.8 t -100.98 141.6 33.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.1 p -115.39 167.76 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -74.09 159.77 32.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -160.89 35.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.5 p -153.14 113.74 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 t -106.79 158.11 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.43 -138.84 15.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -45.58 154.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.75 -157.41 30.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -93.02 140.92 23.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.552 HD11 ' HB1' ' A' ' 227' ' ' ALA . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 244' ' ' ILE . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.63 141.53 18.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -56.62 122.08 11.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 34.9 t -127.45 143.31 51.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.66 163.0 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.63 130.51 35.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.77 43.46 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.07 132.76 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -72.65 -53.9 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.2 t -49.61 -41.63 42.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 59.06 25.77 14.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 105.03 -98.99 1.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -173.82 41.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 242' ' ' LEU . 85.4 m-85 -132.64 167.37 20.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HZ3' HD23 ' A' ' 207' ' ' LEU . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.51 HD12 HG11 ' A' ' 204' ' ' VAL . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 219' ' ' VAL . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.562 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 195' ' ' LEU . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.526 HD23 ' HZ3' ' A' ' 191' ' ' LYS . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.757 ' C ' HD12 ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.757 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp -139.52 153.59 47.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.5 t -91.87 116.9 29.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.2 m -88.83 -39.23 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -52.05 -58.85 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -102.94 122.28 46.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 127.6 14.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 216' ' ' THR . . . 94.85 38.84 4.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.444 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 215' ' ' GLY . 3.7 p -155.64 145.77 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 173' ' ' LEU . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.562 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 244' ' ' ILE . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 235' ' ' VAL . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.725 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.725 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 189' ' ' TYR . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 231' ' ' VAL . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -159.45 146.04 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 55.12 5.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -92.37 136.3 25.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.924 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 142.98 49.52 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.688 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.31 86.63 7.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.91 134.3 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -127.32 114.08 17.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.0 t -112.44 104.36 12.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 86.28 76.48 1.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 102.27 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.706 2.271 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.8 t -153.45 139.27 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 65.0 m -141.7 173.0 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.463 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 161' ' ' GLY . 60.7 p 37.12 42.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.818 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -80.6 106.79 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -114.57 133.86 11.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.0 t -119.67 174.24 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 95.5 p -113.18 143.62 44.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -133.1 157.03 22.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.455 ' C ' ' CD ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -121.07 165.74 14.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.26 176.44 22.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -68.65 146.31 97.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.635 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.678 ' HB3' HD23 ' A' ' 242' ' ' LEU . 33.0 p90 -127.92 137.06 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -58.13 140.51 52.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 21.8 t -174.85 148.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -54.79 141.23 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -73.04 -50.95 20.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -80.44 44.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.06 149.85 43.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -86.62 -46.09 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.2 t -59.09 162.14 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -54.7 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 145.49 33.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 86.87 39.19 7.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.438 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 57.2 m-85 -160.99 135.56 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 175' ' ' LEU . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.465 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.14 136.41 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -77.94 129.87 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.0 t -90.49 -64.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -38.24 -55.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.27 106.98 20.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 116.68 4.68 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 103.44 28.7 5.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.86 150.27 39.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.571 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 219' ' ' VAL . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.465 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.41 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 227' ' ' ALA . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.421 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 231' ' ' VAL . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.498 ' CE2' HD21 ' A' ' 173' ' ' LEU . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -140.98 175.21 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 46.97 82.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.82 144.82 29.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 141.55 45.56 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -171.85 132.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.87 84.21 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.93 42.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.9 t -70.78 156.9 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 132.0 -95.85 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 114.0 3.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.2 t -72.9 164.43 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.0 t -107.01 -47.83 3.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.522 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.2 m 44.15 47.97 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.4 t -131.7 121.04 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.65 91.79 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.5 p -132.05 176.71 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -142.72 137.88 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.03 59.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -124.04 176.96 6.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.15 175.46 25.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p -56.04 143.43 62.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.947 HD12 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 -140.77 144.46 35.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -49.87 136.9 17.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.08 138.26 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.93 146.18 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -46.1 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.12 46.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.84 175.32 7.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -119.05 84.47 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 18.9 m -159.32 145.05 16.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -112.26 21.71 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.58 -60.88 2.43 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.34 60.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 99.3 m-85 -147.98 140.59 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.595 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 219' ' ' VAL . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' C ' HD12 ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.419 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.0 mp -127.13 142.33 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.0 t -76.12 122.76 24.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.4 m -88.57 -44.41 10.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.88 -42.93 89.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 34.0 mmtt -99.32 105.38 32.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.1 Cg_endo -69.8 128.74 16.42 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 89.11 32.04 11.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p -152.65 145.93 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 198' ' ' LEU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.947 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 227' ' ' ALA . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.595 ' CD ' HD22 ' A' ' 197' ' ' LEU . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.699 HG12 HD23 ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -154.03 177.24 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 48.56 57.21 8.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.408 ' CD ' ' HD2' ' A' ' 251' ' ' PRO . 12.4 tm0? -83.48 137.23 42.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.0 110.879 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.408 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 54.1 Cg_endo -69.69 107.5 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.679 2.253 . . . . 0.0 112.365 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -126.3 37.33 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -78.52 167.65 20.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -154.43 162.85 40.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.2 m -82.37 98.9 9.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.3 -165.11 33.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.454 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -48.99 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.647 2.231 . . . . 0.0 112.337 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.8 t -170.42 119.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.1 p -78.87 -22.13 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 p -122.54 126.58 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t 47.26 42.14 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.91 -76.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.5 m -69.12 106.01 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 30.1 p -94.88 -45.89 7.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -116.78 -175.78 17.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -108.18 129.29 55.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.15 31.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -59.31 144.06 84.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.587 HD12 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 216' ' ' THR . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -151.71 155.69 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -50.78 172.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.1 p -172.92 138.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -72.97 114.77 11.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.33 -52.26 10.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -49.6 -40.06 37.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.86 115.21 27.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -61.55 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 10.3 t -142.22 160.72 39.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -69.29 -52.36 28.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 135.05 -112.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' CD1' ' A' ' 189' ' ' TYR . . . -147.26 51.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.569 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.3 m-85 -162.07 161.2 28.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HG3' HD23 ' A' ' 207' ' ' LEU . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 197' ' ' LEU . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.73 ' CD1' HG21 ' A' ' 219' ' ' VAL . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 195' ' ' LEU . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.748 HD23 ' HG3' ' A' ' 191' ' ' LYS . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 209' ' ' LEU . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.2 mp -134.0 143.15 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -74.03 108.38 6.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 43.7 t -75.53 -66.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -43.68 -43.21 5.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 28.4 mmtt -119.51 93.46 47.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.606 0.717 . . . . 0.0 110.887 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.1 Cg_endo -69.69 123.04 9.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 146.97 -33.25 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 176' ' ' LYS . 20.9 p -113.5 164.0 14.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 198' ' ' LEU . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 223' ' ' THR . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 222' ' ' ALA . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.428 ' CD ' ' HG3' ' A' ' 251' ' ' PRO . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 19.0 m120 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 236' ' ' GLY . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.569 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 238' ' ' VAL . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.491 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -173.32 156.18 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.58 41.53 7.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -56.62 130.44 77.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.428 ' HG3' ' CD ' ' A' ' 228' ' ' GLU . 53.9 Cg_endo -69.78 2.38 3.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.378 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -77.35 59.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -161.29 144.85 12.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.31 120.73 40.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 59.0 m -90.78 -48.39 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.82 -170.26 26.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 93.89 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.5 m -101.57 -43.84 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 58.0 m -115.29 157.66 23.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 p -91.78 149.82 21.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 95.5 p -114.39 142.34 46.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.33 174.27 29.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.1 p -109.7 -64.39 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -169.29 163.01 10.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 168' ' ' GLN . . . 70.62 71.13 1.06 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.506 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 167' ' ' GLY . 11.2 pt20 -34.92 119.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -136.97 -175.92 14.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p -115.24 143.29 30.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.659 ' O ' HG13 ' A' ' 218' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 244' ' ' ILE . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.633 ' HD2' HG22 ' A' ' 216' ' ' THR . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.642 ' HB3' HD23 ' A' ' 242' ' ' LEU . 40.7 p90 -162.72 146.53 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -60.25 152.89 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.65 134.89 22.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.51 154.82 23.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -98.57 -41.0 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -66.58 -27.78 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.99 145.99 25.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.5 -11.95 44.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.9 p -72.89 162.18 29.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . 0.448 ' N ' ' HE2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -69.02 -48.42 63.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 146.81 -119.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -115.88 53.98 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.504 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.508 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 74.5 m-85 -162.87 121.48 2.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.513 HD12 HG11 ' A' ' 204' ' ' VAL . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 219' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 195' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 222' ' ' ALA . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.1 155.49 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.1 t -73.12 131.07 41.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.0 m -95.58 -60.84 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 1.1 ttmm -50.21 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 60.6 mmtt -98.86 101.39 12.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.5 Cg_endo -69.82 141.34 44.74 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.263 . . . . 0.0 112.316 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.87 -13.77 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.633 HG22 ' HD2' ' A' ' 176' ' ' LYS . 3.3 p -124.78 173.53 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 173' ' ' LEU . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 198' ' ' LEU . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.546 ' N ' HG22 ' A' ' 219' ' ' VAL . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.419 ' HE1' HG11 ' A' ' 219' ' ' VAL . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.513 ' HD2' HD11 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 225' ' ' LYS . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 227' ' ' ALA . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 177' ' ' TRP . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 175' ' ' LEU . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 247' ' ' LEU . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -174.09 171.22 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.88 38.91 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 35.5 tt0 -62.21 138.23 96.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 110.926 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.7 Cg_endo -69.75 110.56 2.58 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.721 2.281 . . . . 0.0 112.372 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -89.95 93.56 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.84 109.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -151.54 119.62 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -80.14 85.1 5.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.08 -93.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.447 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -11.95 31.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.67 2.247 . . . . 0.0 112.321 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t -73.42 84.57 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.7 t -43.57 109.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -165.48 128.2 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -79.54 -50.82 10.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 133.88 138.07 3.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.1 m -86.93 104.53 16.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -93.4 150.05 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -130.86 97.39 0.37 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -139.6 122.87 17.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 118.09 -156.74 15.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p -79.8 143.5 58.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.763 HD12 ' CE1' ' A' ' 221' ' ' PHE . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.514 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 -159.27 177.76 10.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -109.79 107.19 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.37 121.12 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -61.95 164.01 7.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -49.7 156.52 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.869 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -45.76 97.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 184' ' ' GLU . 31.7 t70 -134.11 166.9 21.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASP . 13.9 tt0 -35.92 -60.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.2 m -79.63 175.56 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -79.83 -64.82 1.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -157.72 42.5 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.09 11.94 47.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HD21 ' A' ' 242' ' ' LEU . 43.0 m-85 -142.23 130.23 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.446 HD13 ' OE2' ' A' ' 234' ' ' GLU . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.557 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 209' ' ' LEU . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp -128.89 140.45 51.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.7 p -38.73 145.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -121.75 -16.59 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 -47.88 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -133.13 123.32 17.83 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.543 0.687 . . . . 0.0 110.869 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.64 2.227 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.514 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p -120.06 168.15 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 220' ' ' GLU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.763 ' CE1' HD12 ' A' ' 173' ' ' LEU . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 260' ' ' GLY . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 255' ' ' SER . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 235' ' ' VAL . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 233' ' ' ASN . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.688 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.544 HG12 HD23 ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.496 ' CG ' ' OE1' ' A' ' 250' ' ' GLN . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -126.47 -11.54 6.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.448 ' O ' ' CE3' ' A' ' 246' ' ' TRP . . . -95.08 55.46 1.82 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.496 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 2.4 tp60 -80.39 129.07 70.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.581 0.705 . . . . 0.0 110.921 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.18 15.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -40.95 -50.59 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.3 -57.79 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 256' ' ' GLY . . . -159.06 145.6 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.422 ' O ' HG11 ' A' ' 224' ' ' VAL . 3.0 t -38.27 -31.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 254' ' ' ALA . . . 129.76 -161.09 22.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.2 m -101.37 137.91 39.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 4.6 t 40.05 45.73 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 223' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 p -81.62 114.87 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -127.22 123.0 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.95 148.51 17.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.6 t -101.87 -55.79 2.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.3 t -50.53 -54.65 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.24 -100.11 2.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -96.29 101.8 13.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 128.78 -174.96 18.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p -118.06 138.58 25.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 221' ' ' PHE . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.927 ' HD3' HG22 ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.552 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.1 p90 -149.43 140.94 23.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -62.97 134.9 56.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 27.3 p -117.41 132.64 56.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -53.2 169.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 182' ' ' GLU . 33.8 tptt -93.01 105.1 17.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' LYS . 15.8 mm-40 37.9 50.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 183' ' ' ASP . 27.6 t70 -88.61 41.93 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 41.47 40.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.3 p -172.47 167.64 5.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -96.25 -39.45 9.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.03 -166.38 32.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.94 29.75 10.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -137.69 165.16 27.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 204' ' ' VAL . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.543 HD22 ' HZ ' ' A' ' 221' ' ' PHE . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 195' ' ' LEU . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 209' ' ' LEU . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.9 mp -121.82 157.6 30.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 t -91.75 163.33 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.815 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 69.2 m -120.18 -55.52 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -53.7 -54.86 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 3.1 mmmm -91.04 108.53 28.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.2 Cg_endo -69.81 131.88 22.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.65 2.234 . . . . 0.0 112.324 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.448 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 87.64 26.86 28.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.927 HG22 ' HD3' ' A' ' 176' ' ' LYS . 71.7 p -136.63 150.87 48.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.614 ' N ' HG22 ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 244' ' ' ILE . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 16.8 m120 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.862 HG21 HG22 ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.538 ' CD1' ' OE1' ' A' ' 250' ' ' GLN . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 -161.28 108.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.54 55.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.538 ' OE1' ' CD1' ' A' ' 246' ' ' TRP . 22.0 tt0 -102.79 137.49 19.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.648 0.737 . . . . 0.0 110.865 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 144.55 53.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -119.13 -68.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.67 40.92 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.7 38.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.8 t -168.49 174.12 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.5 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 142.25 47.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.8 m -124.18 119.89 30.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 35.3 t -167.42 140.83 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.2 m -124.09 177.53 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.8 p -101.63 -45.67 5.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.35 -95.79 0.79 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.8 t -71.56 121.96 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.2 p -74.84 -51.59 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.85 -170.03 27.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -56.73 159.23 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.39 179.33 47.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p -103.15 152.27 38.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 221' ' ' PHE . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 194' ' ' LEU . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 -134.75 166.91 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -82.83 116.76 22.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 41.0 t -93.7 116.77 29.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -67.97 171.44 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -87.57 -47.8 8.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 2.7 pp20? -88.17 41.83 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -73.51 173.64 9.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -117.15 -55.0 2.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.0 t -113.51 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -134.1 -50.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.02 -53.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.465 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -170.69 37.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 82.8 m-85 -164.01 171.08 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.483 ' CG ' HD23 ' A' ' 207' ' ' LEU . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 175' ' ' LEU . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.407 HD12 HG11 ' A' ' 204' ' ' VAL . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 219' ' ' VAL . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.593 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 195' ' ' LEU . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.483 HD23 ' CG ' ' A' ' 191' ' ' LYS . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp -126.67 135.25 50.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.3 t -57.58 108.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.7 t -76.22 -49.13 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.428 ' N ' ' HD3' ' A' ' 212' ' ' LYS . 2.8 mppt? -62.91 -57.88 9.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -99.65 100.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 53.5 Cg_endo -69.82 129.55 17.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.628 2.219 . . . . 0.0 112.321 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 129.47 -36.17 2.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p -106.33 148.66 27.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 198' ' ' LEU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.593 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 201' ' ' TYR . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.568 HG22 HG21 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 233' ' ' ASN . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.568 HG21 HG22 ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -160.18 122.49 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 114.57 57.7 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.09 139.9 34.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.599 0.714 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 144.7 55.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -109.56 83.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -98.56 42.6 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -56.64 96.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.4 p -117.26 120.25 37.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -106.39 -176.13 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 1.71 4.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 66.7 m -79.39 157.15 27.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.2 m -77.33 164.38 25.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.517 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.8 t -161.38 149.76 15.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.0 t -96.74 -51.84 4.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.63 -100.03 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -145.05 171.04 15.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 m -124.17 148.9 46.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -159.65 55.13 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -42.01 142.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.46 163.26 10.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.89 147.15 35.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 227' ' ' ALA . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 244' ' ' ILE . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -135.31 141.79 45.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -53.14 141.99 21.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 8.1 t -158.14 144.35 17.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -77.11 159.6 29.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -81.11 -70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 183' ' ' ASP . 28.5 mm-40 -46.35 -44.27 16.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' GLU . 0.9 OUTLIER -37.23 -47.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 54.66 32.83 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.6 m -115.43 176.91 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -82.58 -46.67 13.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 119.45 -161.74 13.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.03 47.49 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.475 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.533 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 80.2 m-85 -148.15 127.59 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.481 ' CG ' HD23 ' A' ' 207' ' ' LEU . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.413 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 219' ' ' VAL . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.42 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 222' ' ' ALA . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 191' ' ' LYS . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp -127.44 146.39 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -79.4 136.79 37.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 80.8 p -100.92 -23.87 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.438 ' C ' ' HE3' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -74.17 -75.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 213' ' ' LYS . 0.1 OUTLIER -74.86 122.02 86.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.932 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 127.01 13.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.672 2.248 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 85.73 39.33 8.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p -145.22 145.99 31.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 198' ' ' LEU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 222' ' ' ALA . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.439 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.554 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.718 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.718 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.32 121.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 112.6 59.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 23.2 tt0 -99.34 139.36 20.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.3 Cg_endo -69.76 135.97 31.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 0.0 112.297 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -111.75 26.12 10.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.51 124.38 52.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.47 45.23 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -148.8 -175.83 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -126.81 -80.5 0.34 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.451 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -26.67 27.36 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.234 . . . . 0.0 112.341 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.2 m -63.69 148.3 49.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 80.7 p -62.14 157.76 18.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.4 t -133.64 174.42 10.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 t -73.87 90.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 69.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -42.31 -53.75 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.8 m -97.85 113.7 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.93 171.41 38.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.33 108.86 20.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.0 178.02 51.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p -50.94 142.9 16.33 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.857 HD12 ' CE1' ' A' ' 221' ' ' PHE . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 198' ' ' LEU . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 -144.6 153.9 42.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -59.78 110.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.6 p -102.7 146.57 28.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 -177.96 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -81.67 43.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.59 43.5 9.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.98 -49.95 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.79 -54.19 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.0 p -132.67 173.39 11.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -72.12 -48.01 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.7 31.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.28 35.27 84.02 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 242' ' ' LEU . 58.8 m-85 -158.72 152.48 23.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 219' ' ' VAL . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 39.1 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.582 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.471 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 207' ' ' LEU . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 222' ' ' ALA . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.425 ' HB2' HG11 ' A' ' 204' ' ' VAL . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.03 137.98 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -67.13 110.58 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.7 t -75.45 -69.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -47.17 -44.25 21.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mptt -104.53 92.75 5.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.1 Cg_endo -69.74 127.03 14.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.342 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 126.49 -34.4 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p -107.93 153.42 23.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.857 ' CE1' HD12 ' A' ' 173' ' ' LEU . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.471 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 244' ' ' ILE . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 229' ' ' LEU . 5.6 m120 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 231' ' ' VAL . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -160.44 146.63 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.92 44.4 6.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.17 130.22 50.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.559 0.695 . . . . 0.0 110.933 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 133.48 25.69 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 0.0 112.357 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -100.1 -43.96 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.77 156.14 23.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.52 127.58 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -131.51 -52.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.28 157.54 32.95 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -22.48 32.14 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 70.9 m -105.98 94.5 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.2 m -78.84 109.37 13.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.2 p 39.48 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 110.913 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.3 t -54.52 132.93 45.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 165' ' ' SER . . . 61.06 -115.05 7.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 164' ' ' GLY . 1.9 m 36.95 51.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.369 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.4 p -108.11 122.6 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.24 -58.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -53.78 156.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.33 -164.36 33.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p -45.57 144.6 2.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.787 HD12 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 198' ' ' LEU . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 242' ' ' LEU . 44.2 p90 -147.72 146.98 29.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -81.56 109.73 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.42 -74.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -156.15 165.87 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -84.69 -54.54 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -122.96 80.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -174.6 120.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -80.33 80.01 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.9 t -140.78 158.81 43.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -82.41 -52.15 7.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 115.87 -148.97 18.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.0 23.52 13.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.495 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 37.6 m-85 -128.42 139.16 52.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.501 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.663 HD13 HG11 ' A' ' 219' ' ' VAL . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.567 ' N ' HG12 ' A' ' 208' ' ' VAL . 7.0 mp -131.25 -177.38 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.8 p -53.4 179.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.7 t -123.85 -43.32 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -116.99 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -81.96 116.45 63.4 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.71 2.273 . . . . 0.0 112.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 129.21 -33.25 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p -101.97 159.59 15.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 198' ' ' LEU . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.787 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 223' ' ' THR . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 222' ' ' ALA . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.418 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 227' ' ' ALA . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -173.06 164.66 4.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 69.61 50.23 32.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.455 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 9.7 tt0 -77.37 142.86 67.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.934 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.77 119.83 6.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.351 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLN . . . . . 0.489 ' CD ' ' C ' ' A' ' 252' ' ' GLN . 1.7 pp0? -131.32 165.91 22.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.17 104.43 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -107.79 128.53 54.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.8 m -112.75 87.98 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -145.6 -88.88 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 1.08 4.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 m 41.58 45.22 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 27.0 t -116.18 -42.67 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -94.85 -49.86 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.823 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.6 p -102.67 114.8 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.22 -102.37 0.87 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.7 t -152.37 141.13 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.822 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 35.8 p -125.41 173.29 8.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.58 -137.09 13.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -135.18 158.74 43.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.08 155.83 25.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p -82.62 142.56 46.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.745 HD12 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.837 HD23 HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -137.4 153.08 50.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -62.62 147.18 50.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.2 p -159.54 166.02 31.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 182' ' ' GLU . 17.7 mttp -104.22 111.17 23.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -43.04 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 180' ' ' LYS . 11.6 pt-20 -127.4 -174.1 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 184' ' ' GLU . 0.6 OUTLIER 68.26 34.33 3.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 183' ' ' ASP . 28.5 tt0 34.5 41.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 43.7 t -97.3 104.96 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -67.79 -44.46 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.04 -50.98 0.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 126.41 47.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.6 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.7 m-85 -162.53 159.65 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.602 HD12 HG11 ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 222' ' ' ALA . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 208' ' ' VAL . 6.9 mp -124.0 139.55 53.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -82.95 94.99 7.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 62.5 p -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -55.97 -48.87 75.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -104.66 116.15 61.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 129.69 18.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 86.86 33.11 13.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p -150.24 145.51 26.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.602 HG22 ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.745 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.513 HG21 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 12.7 m120 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.79 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.686 ' H ' HG13 ' A' ' 238' ' ' VAL . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.6 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.837 HG12 HD23 ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.513 ' NE1' HG21 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -169.83 141.5 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.47 40.34 3.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.444 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 41.0 tt0 -78.12 138.57 60.64 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.454 ' HG3' ' CG ' ' A' ' 228' ' ' GLU . 53.6 Cg_endo -69.8 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -128.13 84.58 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -159.43 176.71 11.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 44.0 39.67 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 157.14 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 125.73 -171.06 17.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 97.69 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.352 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.8 p -121.78 177.44 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.9 p -144.92 148.22 33.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 83.8 p -81.84 85.78 6.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.2 t -38.87 -60.72 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.46 103.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -72.38 157.85 36.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.402 . . . . 0.0 110.813 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -88.04 145.39 26.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.4 118.99 4.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -144.4 140.6 29.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.904 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.77 178.8 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p -60.91 146.69 86.81 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.413 ' HZ2' HD23 ' A' ' 247' ' ' LEU . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 218' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 218' ' ' VAL . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 198' ' ' LEU . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 216' ' ' THR . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.5 p90 -143.8 145.54 32.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -52.58 162.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 18.8 p -158.7 151.96 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 182' ' ' GLU . 16.2 ttmm -52.99 166.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 182' ' ' GLU . 5.3 tmtm? -50.99 90.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 67.1 mm-40 34.22 54.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 23.5 p-10 -79.25 164.51 24.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.29 46.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.1 m -157.26 170.0 23.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -51.95 9.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 138.96 -118.48 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -113.63 40.39 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.501 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 -151.37 154.18 36.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.603 HD23 ' HZ1' ' A' ' 200' ' ' LYS . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 219' ' ' VAL . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.603 ' HZ1' HD23 ' A' ' 197' ' ' LEU . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.531 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 207' ' ' LEU . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 222' ' ' ALA . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 204' ' ' VAL . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.579 ' C ' HD12 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp -135.3 135.91 41.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -65.25 115.76 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 33.6 t -80.11 -54.32 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -53.25 -58.3 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -100.93 98.91 9.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.8 Cg_endo -69.78 131.45 21.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.14 -27.41 4.81 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 176' ' ' LYS . 61.8 p -110.64 150.46 28.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 173' ' ' LEU . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.531 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.565 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 246' ' ' TRP . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 231' ' ' VAL . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' TRP . . . . . 0.666 ' HE1' HG11 ' A' ' 231' ' ' VAL . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.413 HD23 ' HZ2' ' A' ' 172' ' ' LYS . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -174.14 157.05 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.72 66.08 1.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -95.57 152.82 39.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 121.05 7.75 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -107.53 157.91 17.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.86 82.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.33 114.55 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.0 t -72.67 -50.83 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.43 -157.36 15.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 121.87 8.55 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.721 2.281 . . . . 0.0 112.351 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 67.1 p -99.44 135.67 40.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 93.6 p -152.46 171.03 18.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 p -50.93 160.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p 41.04 42.1 1.46 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -83.15 138.38 17.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 47.7 t -51.63 148.93 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -126.58 133.8 50.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.15 -167.56 39.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -125.7 113.34 17.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.864 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.1 -173.51 28.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p -80.61 143.8 55.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.72 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HG3' HG22 ' A' ' 218' ' ' VAL . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 198' ' ' LEU . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 216' ' ' THR . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.493 ' CE2' ' O ' ' A' ' 215' ' ' GLY . 43.9 p90 -139.33 146.06 39.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 140.82 57.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.8 t -145.83 111.7 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -50.76 168.44 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -104.32 -45.39 4.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 181' ' ' LYS . 9.3 pt-20 -76.48 -37.05 57.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.06 95.42 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.5 93.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.1 m -169.28 164.39 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -71.01 -56.01 7.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.73 36.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.4 36.47 77.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.529 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.695 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 82.6 m-85 -157.31 162.79 39.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.451 HD11 ' CZ3' ' A' ' 177' ' ' TRP . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.692 HD12 HG11 ' A' ' 204' ' ' VAL . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 197' ' ' LEU . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.856 HD13 HG11 ' A' ' 219' ' ' VAL . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.692 HG11 HD12 ' A' ' 195' ' ' LEU . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD12 ' A' ' 209' ' ' LEU . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 208' ' ' VAL . 6.9 mp -129.15 137.3 51.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.7 t -60.62 123.72 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 m -87.35 -52.34 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -64.63 -55.49 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -101.18 98.75 9.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.582 0.706 . . . . 0.0 110.876 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.7 Cg_endo -69.76 142.6 48.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.318 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 115.82 -36.74 3.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.513 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 176' ' ' LYS . 78.0 p -101.76 146.58 27.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 173' ' ' LEU . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.72 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.671 HG22 HG21 ' A' ' 244' ' ' ILE . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.695 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.59 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.671 HG21 HG22 ' A' ' 231' ' ' VAL . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.21 176.75 9.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.43 58.14 16.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -71.13 134.79 85.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 252' ' ' GLN . 53.3 Cg_endo -69.76 2.7 3.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.33 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 251' ' ' PRO . 3.1 tp60 -34.47 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.25 176.25 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -135.87 -179.56 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.3 m -39.85 -54.86 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 65.05 161.19 0.59 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 0.53 5.52 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.348 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.9 m -69.98 169.18 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.4 t -69.09 147.42 51.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 -179.952 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.4 m -90.83 172.59 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 27.5 p -123.28 146.51 47.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.93 -117.94 0.83 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 80.1 p -56.4 104.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.9 m -49.33 176.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.835 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -121.32 -63.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.3 149.55 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.61 147.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p -115.04 144.14 31.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.719 ' HG3' HG22 ' A' ' 216' ' ' THR . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TRP . . . . . 0.611 ' HB3' HD23 ' A' ' 242' ' ' LEU . 46.2 p90 -146.53 137.89 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -51.15 101.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 44.1 t -96.8 117.74 31.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -53.85 -28.83 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 180' ' ' LYS . 30.9 ttpt 33.08 35.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 180' ' ' LYS . 34.4 mm-40 -133.98 -50.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.93 178.56 2.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.58 42.67 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 7.8 t -153.7 177.27 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -100.68 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.73 -177.76 43.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.47 40.9 2.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 -149.81 167.92 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' VAL . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 207' ' ' LEU . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 204' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.708 ' C ' HD12 ' A' ' 209' ' ' LEU . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.708 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp -137.88 134.91 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.0 t -55.57 138.14 47.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 38.3 p -100.54 -62.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -58.24 -53.01 63.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 213' ' ' LYS . 6.5 mptt -101.7 97.94 8.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.578 0.704 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.7 Cg_endo -69.75 141.94 46.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.361 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.44 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 120.5 -41.29 1.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.478 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 176' ' ' LYS . 62.2 p -97.65 151.02 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 173' ' ' LEU . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.419 ' CD ' ' HG3' ' A' ' 251' ' ' PRO . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 244' ' ' ILE . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.628 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.628 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 177' ' ' TRP . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.491 HG12 HD23 ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.88 112.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.51 65.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -107.24 133.08 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 110.931 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.419 ' HG3' ' CD ' ' A' ' 228' ' ' GLU . 54.1 Cg_endo -69.75 119.73 6.63 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.371 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -145.78 173.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -121.07 -48.56 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -62.92 84.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.7 m -86.69 172.77 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.57 166.48 29.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 174.75 9.03 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 20.0 m -79.94 150.45 30.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 3.0 t -60.63 -48.48 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 216' ' ' THR . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.631 ' HB3' HD23 ' A' ' 242' ' ' LEU . 28.0 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.871 HD12 HG21 ' A' ' 219' ' ' VAL . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.424 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 207' ' ' LEU . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 222' ' ' ALA . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.728 HD13 HG23 ' A' ' 219' ' ' VAL . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.42 HG22 ' HD3' ' A' ' 176' ' ' LYS . 77.0 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 198' ' ' LEU . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.424 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 173' ' ' LEU . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.441 ' H ' HG13 ' A' ' 238' ' ' VAL . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 177' ' ' TRP . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 230' ' ' ALA . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.432 ' CD2' HD21 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.706 HD23 HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.996 ' HD2' HG22 ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.749 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 219' ' ' VAL . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 219' ' ' VAL . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.996 HG22 ' HD2' ' A' ' 176' ' ' LYS . 9.4 p . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 173' ' ' LEU . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 198' ' ' LEU . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 219' ' ' VAL . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 244' ' ' ILE . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 227' ' ' ALA . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.839 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 177' ' ' TRP . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.839 HD11 ' OE2' ' A' ' 234' ' ' GLU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 227' ' ' ALA . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.734 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.3 p90 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.461 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 219' ' ' VAL . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 222' ' ' ALA . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.622 ' N ' HG22 ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 222' ' ' ALA . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 244' ' ' ILE . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.455 ' H ' HG13 ' A' ' 238' ' ' VAL . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 177' ' ' TRP . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.592 HG21 HG22 ' A' ' 231' ' ' VAL . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.473 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 246' ' ' TRP . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.663 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.2 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.489 ' CG ' HD23 ' A' ' 207' ' ' LEU . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 204' ' ' VAL . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 219' ' ' VAL . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 195' ' ' LEU . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 191' ' ' LYS . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.601 ' N ' HG22 ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 227' ' ' ALA . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 244' ' ' ILE . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.716 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.716 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 177' ' ' TRP . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.697 HG21 HG22 ' A' ' 231' ' ' VAL . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.518 ' CE2' HD21 ' A' ' 173' ' ' LEU . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 221' ' ' PHE . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 198' ' ' LEU . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.778 ' HB3' HD23 ' A' ' 242' ' ' LEU . 38.6 p90 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.497 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 175' ' ' LEU . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.816 HD23 ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.556 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.8 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 173' ' ' LEU . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 198' ' ' LEU . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 219' ' ' VAL . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.606 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 235' ' ' VAL . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.816 ' OE1' HD23 ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 233' ' ' ASN . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.45 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.778 HD23 ' HB3' ' A' ' 177' ' ' TRP . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 231' ' ' VAL . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.552 HD11 ' HB1' ' A' ' 227' ' ' ALA . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 244' ' ' ILE . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 242' ' ' LEU . 85.4 m-85 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HZ3' HD23 ' A' ' 207' ' ' LEU . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.51 HD12 HG11 ' A' ' 204' ' ' VAL . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 219' ' ' VAL . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.562 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 195' ' ' LEU . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.526 HD23 ' HZ3' ' A' ' 191' ' ' LYS . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.757 ' C ' HD12 ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.757 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 173' ' ' LEU . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.562 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 244' ' ' ILE . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 235' ' ' VAL . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.725 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.725 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 189' ' ' TYR . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 231' ' ' VAL . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.635 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.678 ' HB3' HD23 ' A' ' 242' ' ' LEU . 33.0 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.438 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 57.2 m-85 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 175' ' ' LEU . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.465 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.571 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 219' ' ' VAL . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.465 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.41 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 227' ' ' ALA . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.421 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 231' ' ' VAL . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.498 ' CE2' HD21 ' A' ' 173' ' ' LEU . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.947 HD12 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 99.3 m-85 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.595 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 219' ' ' VAL . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.419 ' C ' HD12 ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.419 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 198' ' ' LEU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.947 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 227' ' ' ALA . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.595 ' CD ' HD22 ' A' ' 197' ' ' LEU . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.699 HG12 HD23 ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.587 HD12 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 216' ' ' THR . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.569 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.3 m-85 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HG3' HD23 ' A' ' 207' ' ' LEU . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 197' ' ' LEU . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.73 ' CD1' HG21 ' A' ' 219' ' ' VAL . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 195' ' ' LEU . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.748 HD23 ' HG3' ' A' ' 191' ' ' LYS . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 209' ' ' LEU . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.2 mp . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 176' ' ' LYS . 20.9 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 198' ' ' LEU . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 223' ' ' THR . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 222' ' ' ALA . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 50.8 m-80 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 236' ' ' GLY . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.569 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 238' ' ' VAL . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.491 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.659 ' O ' HG13 ' A' ' 218' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 244' ' ' ILE . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.633 ' HD2' HG22 ' A' ' 216' ' ' THR . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.642 ' HB3' HD23 ' A' ' 242' ' ' LEU . 40.7 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.502 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 74.5 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.513 HD12 HG11 ' A' ' 204' ' ' VAL . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 219' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 195' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 222' ' ' ALA . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.633 HG22 ' HD2' ' A' ' 176' ' ' LYS . 3.3 p . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 173' ' ' LEU . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 198' ' ' LEU . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.546 ' N ' HG22 ' A' ' 219' ' ' VAL . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.419 ' HE1' HG11 ' A' ' 219' ' ' VAL . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.513 ' HD2' HD11 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 225' ' ' LYS . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 227' ' ' ALA . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 177' ' ' TRP . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 175' ' ' LEU . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 247' ' ' LEU . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 248' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.763 HD12 ' CE1' ' A' ' 221' ' ' PHE . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.514 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HD21 ' A' ' 242' ' ' LEU . 43.0 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.446 HD13 ' OE2' ' A' ' 234' ' ' GLU . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.557 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 209' ' ' LEU . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.514 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 220' ' ' GLU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.763 ' CE1' HD12 ' A' ' 173' ' ' LEU . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 235' ' ' VAL . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 233' ' ' ASN . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.688 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.544 HG12 HD23 ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 221' ' ' PHE . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.927 ' HD3' HG22 ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.552 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.1 p90 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 204' ' ' VAL . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.543 HD22 ' HZ ' ' A' ' 221' ' ' PHE . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 195' ' ' LEU . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 209' ' ' LEU . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.9 mp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.927 HG22 ' HD3' ' A' ' 176' ' ' LYS . 71.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.614 ' N ' HG22 ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 244' ' ' ILE . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 54.4 m-80 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.862 HG21 HG22 ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 221' ' ' PHE . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 194' ' ' LEU . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.483 ' CG ' HD23 ' A' ' 207' ' ' LEU . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 175' ' ' LEU . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.407 HD12 HG11 ' A' ' 204' ' ' VAL . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 219' ' ' VAL . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.593 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 195' ' ' LEU . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.483 HD23 ' CG ' ' A' ' 191' ' ' LYS . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 198' ' ' LEU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.593 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 201' ' ' TYR . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.568 HG22 HG21 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 233' ' ' ASN . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.568 HG21 HG22 ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 227' ' ' ALA . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 244' ' ' ILE . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.533 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 80.2 m-85 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.481 ' CG ' HD23 ' A' ' 207' ' ' LEU . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.413 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.41 ' HG ' ' NE2' ' A' ' 199' ' ' GLN . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 219' ' ' VAL . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.41 ' NE2' ' HG ' ' A' ' 195' ' ' LEU . 22.0 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.42 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 222' ' ' ALA . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 191' ' ' LYS . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 198' ' ' LEU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 222' ' ' ALA . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.554 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.718 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.718 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.857 HD12 ' CE1' ' A' ' 221' ' ' PHE . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 198' ' ' LEU . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 242' ' ' LEU . 58.8 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 219' ' ' VAL . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 9.6 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.582 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.471 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 207' ' ' LEU . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 222' ' ' ALA . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.425 ' HB2' HG11 ' A' ' 204' ' ' VAL . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.857 ' CE1' HD12 ' A' ' 173' ' ' LEU . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.471 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 244' ' ' ILE . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.539 HD21 HD22 ' A' ' 229' ' ' LEU . 9.2 m-80 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 231' ' ' VAL . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.787 HD12 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 198' ' ' LEU . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 242' ' ' LEU . 44.2 p90 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.495 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 37.6 m-85 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.501 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.663 HD13 HG11 ' A' ' 219' ' ' VAL . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.567 ' N ' HG12 ' A' ' 208' ' ' VAL . 7.0 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 198' ' ' LEU . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.787 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 223' ' ' THR . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 222' ' ' ALA . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.418 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 227' ' ' ALA . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p . . . . . 0 N--CA 1.457 -0.09 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.745 HD12 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.837 HD23 HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.6 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.7 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.602 HD12 HG11 ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 222' ' ' ALA . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 208' ' ' VAL . 6.9 mp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.602 HG22 ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.745 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.513 HG21 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 15.5 m-80 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.79 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.686 ' H ' HG13 ' A' ' 238' ' ' VAL . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.6 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.837 HG12 HD23 ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.513 ' NE1' HG21 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.413 ' HZ2' HD23 ' A' ' 247' ' ' LEU . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 218' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 218' ' ' VAL . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 198' ' ' LEU . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 216' ' ' THR . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.5 p90 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.501 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.603 HD23 ' HZ1' ' A' ' 200' ' ' LYS . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 219' ' ' VAL . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.603 ' HZ1' HD23 ' A' ' 197' ' ' LEU . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.531 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 207' ' ' LEU . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 222' ' ' ALA . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 204' ' ' VAL . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.579 ' C ' HD12 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 176' ' ' LYS . 61.8 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 173' ' ' LEU . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.531 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.565 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 246' ' ' TRP . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 231' ' ' VAL . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . 0.666 ' HE1' HG11 ' A' ' 231' ' ' VAL . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.413 HD23 ' HZ2' ' A' ' 172' ' ' LYS . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.72 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HG3' HG22 ' A' ' 218' ' ' VAL . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 198' ' ' LEU . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 216' ' ' THR . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.451 ' CZ3' HD11 ' A' ' 194' ' ' LEU . 43.9 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.695 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 82.6 m-85 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.451 HD11 ' CZ3' ' A' ' 177' ' ' TRP . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.692 HD12 HG11 ' A' ' 204' ' ' VAL . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 197' ' ' LEU . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.856 HD13 HG11 ' A' ' 219' ' ' VAL . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.692 HG11 HD12 ' A' ' 195' ' ' LEU . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD12 ' A' ' 209' ' ' LEU . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 208' ' ' VAL . 6.9 mp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 176' ' ' LYS . 78.0 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 173' ' ' LEU . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.72 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.671 HG22 HG21 ' A' ' 244' ' ' ILE . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.695 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.59 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.671 HG21 HG22 ' A' ' 231' ' ' VAL . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.719 ' HG3' HG22 ' A' ' 216' ' ' THR . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TRP . . . . . 0.611 ' HB3' HD23 ' A' ' 242' ' ' LEU . 46.2 p90 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' VAL . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 207' ' ' LEU . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 204' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.708 ' C ' HD12 ' A' ' 209' ' ' LEU . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.708 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 176' ' ' LYS . 62.2 p . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 173' ' ' LEU . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 244' ' ' ILE . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.628 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.628 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 177' ' ' TRP . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.491 HG12 HD23 ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.8 t -142.25 111.19 6.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.886 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.9 p -140.1 154.13 46.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.861 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.75 70.04 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 77.5 p -116.92 122.52 44.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 38.2 m -72.91 -50.45 23.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.83 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 43.02 71.53 0.4 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.464 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -94.94 -50.4 5.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.892 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.86 -177.66 3.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.477 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 32.6 p -48.36 144.1 6.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.617 0.722 . . . . 0.0 111.152 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 84.08 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.641 2.227 . . . . 0.0 112.346 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -76.67 143.03 40.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.927 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 221' ' ' PHE . 87.6 mt -121.64 153.37 38.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -108.93 122.33 47.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.505 HD23 HG12 ' A' ' 244' ' ' ILE . 24.5 mt -102.56 112.97 25.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.42 ' HD3' HG22 ' A' ' 216' ' ' THR . 16.6 ttpt -124.8 135.39 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.846 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.631 ' HB3' HD23 ' A' ' 242' ' ' LEU . 28.0 p90 -137.24 161.85 35.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.5 mmtt -70.92 119.1 14.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 37.1 t -133.84 147.09 51.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.896 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -70.49 166.63 20.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.912 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 183' ' ' ASP . 7.5 mptt -53.9 166.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 6.9 pt-20 -35.09 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 181' ' ' LYS . 27.4 t70 -135.57 163.99 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.95 -13.73 60.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 14.0 t -91.36 129.48 37.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -71.88 -54.28 10.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 141.66 -58.85 0.56 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.522 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.77 30.95 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.5 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -156.7 177.4 11.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.896 0.379 . . . . 0.0 110.918 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.429 ' O ' ' C ' ' A' ' 191' ' ' LYS . 5.2 t -173.12 150.55 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.867 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 190' ' ' SER . 57.6 tttt -35.87 -44.28 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.37 -67.81 0.41 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.839 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.1 t -38.51 -54.12 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.14 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 28.0 mt -62.7 -39.67 94.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.74 -48.95 79.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.936 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 5.4 ptm180 -67.72 -31.16 70.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 30.9 mt -63.77 -39.32 93.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.871 HD12 HG21 ' A' ' 219' ' ' VAL . 34.6 mt -85.34 -45.79 11.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.919 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 198' ' ' LEU . 44.1 mt-30 -34.64 -55.93 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 8.1 ptpt -45.6 -47.46 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.452 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 96.8 m-85 -72.66 -54.04 10.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.934 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.424 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -152.11 156.63 26.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.473 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -65.58 126.88 29.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.93 0.395 . . . . 0.0 110.892 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 207' ' ' LEU . 79.8 t -90.07 90.34 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.112 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 222' ' ' ALA . 23.8 mt -52.32 -52.51 52.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.927 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -140.92 137.24 33.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.728 HD13 HG23 ' A' ' 219' ' ' VAL . 58.4 tp -132.28 98.83 4.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.91 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 209' ' ' LEU . 88.5 t -102.97 157.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' ' 208' ' ' VAL . 8.3 mp -119.95 149.41 42.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.6 m -92.23 122.22 34.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.1 p -90.01 -36.06 15.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -40.76 -57.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -116.57 142.14 29.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.582 0.706 . . . . 0.0 110.889 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 141.77 46.14 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.483 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 69.98 45.11 58.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.42 HG22 ' HD3' ' A' ' 176' ' ' LYS . 77.0 p -145.63 139.25 26.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 111.111 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -160.77 173.89 14.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.157 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.5 t -141.94 123.75 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.871 HG21 HD12 ' A' ' 198' ' ' LEU . 3.4 p -102.92 152.21 5.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -119.85 114.58 22.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.843 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.581 ' CE1' HD12 ' A' ' 173' ' ' LEU . 46.3 m-85 -92.4 170.36 9.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.882 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -105.78 -23.63 12.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.124 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 20.0 p -132.08 161.44 33.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.131 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 92.1 t -78.17 -39.77 25.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.085 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -51.57 -60.64 2.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.424 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -51.45 -54.26 28.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.132 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -44.94 -59.14 2.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.085 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.29 -56.67 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 69.4 mt -56.64 -29.39 62.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.545 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -80.69 -11.56 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.109 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 173' ' ' LEU . 46.2 t -105.41 -14.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -106.88 -60.7 1.64 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -67.03 -74.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 3.0 tp10 -55.05 112.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 242' ' ' LEU . 10.4 m -117.77 -0.22 8.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 101.71 -106.81 3.08 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.528 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 77.5 mt -135.12 138.33 43.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.852 0.358 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.441 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.2 p -42.81 -52.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.115 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.441 ' H ' HG13 ' A' ' 238' ' ' VAL . 18.6 t70 -60.7 -41.35 95.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -130.07 88.51 48.21 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 110.879 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.9 Cg_endo -69.76 93.36 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.702 2.268 . . . . 0.0 112.322 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.631 HD23 ' HB3' ' A' ' 177' ' ' TRP . 31.3 mt -37.71 152.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -107.56 84.7 2.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.545 HD13 ' O ' ' A' ' 230' ' ' ALA . 7.0 mt -87.58 107.44 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 51.5 m -114.57 155.44 26.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.432 ' CD2' HD21 ' A' ' 173' ' ' LEU . 72.7 m95 -86.61 97.82 10.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.929 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -58.03 -46.2 85.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -160.45 144.66 14.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 77.5 65.74 1.88 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.464 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -97.0 137.27 21.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.644 0.735 . . . . 0.0 110.882 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 137.02 34.48 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.691 2.26 . . . . 0.0 112.334 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -142.79 117.66 9.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -158.83 140.53 13.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -113.36 161.7 16.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.071 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 16.7 t -106.12 41.59 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -163.62 176.98 39.66 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.527 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 115.11 3.93 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.735 2.29 . . . . 0.0 112.357 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 46.9 p -79.36 165.64 22.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 48.4 p -169.48 176.16 5.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 95.3 p -80.81 105.76 12.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.871 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.5 p -166.61 145.2 5.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.822 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 138.22 75.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.472 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.6 p -87.43 170.07 11.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.1 m -158.09 134.23 9.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.847 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.03 154.98 18.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -87.95 150.66 23.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.849 0.357 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.85 -149.03 42.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.501 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -111.64 151.7 43.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.631 0.729 . . . . 0.0 111.11 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 85.63 0.62 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.234 . . . . 0.0 112.331 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.3 mtmt -79.08 141.16 37.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.713 HD12 ' CE1' ' A' ' 221' ' ' PHE . 57.7 mt -116.92 158.37 24.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.4 tttp -111.03 115.57 29.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.706 HD23 HG12 ' A' ' 244' ' ' ILE . 30.8 mt -92.38 117.9 30.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.996 ' HD2' HG22 ' A' ' 216' ' ' THR . 13.0 tptp -121.42 144.17 48.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.749 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 -163.92 143.58 8.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.906 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.5 pttt -55.68 161.04 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 19.1 p -147.95 165.11 31.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 30.5 mmtt -79.03 -175.61 4.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -117.48 -43.62 2.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.899 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -116.85 -54.19 2.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -40.85 140.39 0.73 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.76 -50.6 69.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 60.7 m -42.48 130.71 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.06 24.58 4.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 118.29 -81.66 0.32 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.86 43.62 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.478 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.47 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 73.0 m-85 -153.16 157.91 41.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.885 0.374 . . . . 0.0 110.908 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 191' ' ' LYS . 87.7 p -149.0 149.97 32.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 190' ' ' SER . 63.2 tttt -36.31 -52.1 0.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.876 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -58.26 -62.28 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 37.9 t -41.73 -67.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 94.9 mt -44.13 -54.48 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -47.16 -36.36 8.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.888 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -74.94 -49.84 18.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 24.4 mt -49.7 -29.2 7.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 219' ' ' VAL . 14.0 mt -96.51 -48.69 5.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 200' ' ' LYS . 38.5 mt-30 -36.27 -65.55 0.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.895 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 199' ' ' GLN . 1.6 ptmt -34.74 -40.13 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.5 m-85 -78.97 -68.06 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.924 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -123.94 -174.57 14.18 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.52 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -99.62 88.64 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.858 0.361 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.74 104.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.147 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 56.0 mt -66.86 -53.11 35.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 -132.37 158.67 41.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 219' ' ' VAL . 20.8 tp -143.52 113.18 7.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.729 ' C ' HD12 ' A' ' 209' ' ' LEU . 96.7 t -110.26 161.16 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.729 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp -144.47 146.15 32.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.4 t -76.24 106.61 7.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 36.5 m -72.17 -62.75 1.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.88 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -47.3 -52.89 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp -105.38 95.93 10.74 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.589 0.709 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 129.82 18.32 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.683 2.256 . . . . 0.0 112.349 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 132.27 -28.63 3.44 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.996 HG22 ' HD2' ' A' ' 176' ' ' LYS . 9.4 p -114.4 169.46 9.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -174.46 174.87 2.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 173' ' ' LEU . 48.8 t -142.03 131.34 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.142 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 198' ' ' LEU . 11.7 p -111.37 154.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.438 ' N ' HG22 ' A' ' 219' ' ' VAL . 18.9 tt0 -119.82 113.65 20.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.713 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.2 m-85 -87.63 176.84 7.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -106.63 -25.21 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 22.5 p -137.79 158.62 43.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.141 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 225' ' ' LYS . 87.1 t -69.9 -59.27 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 224' ' ' VAL . 17.1 tptm -34.46 -63.71 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.76 -52.83 17.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.658 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -47.79 -51.66 21.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.118 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -59.02 -46.9 87.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.43 -37.58 78.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.452 ' O ' HD12 ' A' ' 244' ' ' ILE . . . -71.72 -26.78 62.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.132 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 227' ' ' ALA . 81.3 t -83.55 -18.0 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.133 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.99 -71.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 31.8 m-80 -50.77 -73.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.836 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.839 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.1 OUTLIER -59.46 116.39 3.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.4 m -116.35 -3.08 10.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.145 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.99 -134.15 11.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.495 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 29.0 mt -116.96 141.21 48.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 0.0 110.9 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.6 p -43.64 -46.1 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.089 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -64.61 -43.18 94.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.412 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 41.4 t-20 -134.63 89.38 26.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 93.11 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.677 2.251 . . . . 0.0 112.361 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 177' ' ' TRP . 30.8 mt -38.1 153.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -122.32 94.85 4.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.839 HD11 ' OE2' ' A' ' 234' ' ' GLU . 34.1 mt -87.91 98.47 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.3 m -97.78 139.3 33.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.83 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -75.57 101.17 4.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.9 tp -60.25 -41.84 94.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.921 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.91 153.49 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.878 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.88 50.07 4.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.489 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 18.9 tt0 -72.58 140.62 81.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.601 0.715 . . . . 0.0 110.954 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.8 Cg_endo -69.77 172.7 12.18 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.339 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -91.12 150.14 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -75.79 -64.03 1.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -89.13 89.64 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.109 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 11.8 m -78.04 92.25 4.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -131.17 79.51 0.36 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 152.05 68.9 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.681 2.254 . . . . 0.0 112.331 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 3.4 m -111.72 140.15 46.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.3 t -112.02 114.52 27.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.495 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.426 ' C ' ' O ' ' A' ' 161' ' ' GLY . 66.7 m -36.33 127.54 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 0.0 110.858 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.5 m -164.29 177.23 8.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.841 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -148.29 -177.17 22.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 74.2 m -106.61 125.63 51.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.6 p -77.04 160.64 28.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.85 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 168.59 -134.03 3.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.52 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -50.35 120.28 4.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 158.26 165.1 15.01 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.2 p -110.76 143.54 28.45 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.598 0.714 . . . . 0.0 111.183 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 80.03 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.718 2.279 . . . . 0.0 112.303 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -61.98 144.7 54.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.632 HD11 ' HB1' ' A' ' 227' ' ' ALA . 78.1 mt -130.9 140.31 50.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -103.15 126.94 50.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.851 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.487 ' CD2' HG12 ' A' ' 244' ' ' ILE . 25.0 mt -103.58 127.45 50.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.939 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -132.05 126.64 34.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.734 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.3 p90 -139.75 151.83 46.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -65.66 151.71 45.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 4.5 m -156.01 153.73 29.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -78.9 177.69 8.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -52.01 173.29 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.852 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -60.26 88.64 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' A' ' 184' ' ' GLU . 9.3 m-20 -129.27 159.79 35.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 183' ' ' ASP . 10.1 mm-40 -37.44 -54.06 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.859 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 p -70.9 143.16 51.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 43.32 2.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.92 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 87.62 175.5 48.42 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.496 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -85.71 46.91 3.71 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.513 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 64.7 m-85 -149.7 163.92 36.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.37 . . . . 0.0 110.92 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 191' ' ' LYS . 21.0 p -165.34 158.59 16.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 190' ' ' SER . 58.1 tttt -36.7 -47.69 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 195' ' ' LEU . 15.0 m-20 -67.02 -68.23 0.39 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.876 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 192' ' ' ASP . 91.5 t -34.62 -49.67 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.82 -39.79 83.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 192' ' ' ASP . 13.6 tp -59.06 -38.25 78.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.902 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 7.7 ptm180 -77.83 -34.02 52.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.461 ' N ' ' HG3' ' A' ' 196' ' ' ARG . 42.2 mt -66.16 -28.64 68.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 219' ' ' VAL . 12.5 mt -99.47 -48.3 4.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 23.7 mm-40 -36.26 -62.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.972 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.0 ptmt -37.31 -44.16 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.891 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.7 m-85 -83.18 -63.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.967 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.03 142.18 14.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -68.02 83.78 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.917 0.389 . . . . 0.0 110.915 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 198' ' ' LEU . 91.0 t -43.49 113.47 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 222' ' ' ALA . 46.2 mt -86.96 -55.88 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.953 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -125.17 113.41 17.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.884 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 40.4 tp -112.93 103.23 11.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 61.7 t -103.11 143.31 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.125 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -126.96 134.28 50.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.952 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 15.8 t -65.21 102.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 21.9 t -70.28 -58.2 4.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -53.93 -55.88 22.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 8.8 mmmm -101.67 97.68 8.27 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.555 0.693 . . . . 0.0 110.893 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.5 Cg_endo -69.74 130.95 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.83 -34.55 2.96 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 63.9 p -107.44 145.5 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.78 0.324 . . . . 0.0 111.141 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.3 169.54 21.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.069 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 75.4 t -140.63 124.33 17.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -109.68 164.24 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.622 ' N ' HG22 ' A' ' 219' ' ' VAL . 27.7 tt0 -136.04 113.92 11.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.532 ' CE1' HD12 ' A' ' 173' ' ' LEU . 15.4 m-85 -84.03 170.57 13.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.883 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.521 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -96.85 -9.42 28.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.115 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 222' ' ' ALA . 17.5 p -155.99 179.41 9.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.439 ' O ' ' C ' ' A' ' 225' ' ' LYS . 89.3 t -87.28 -60.57 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 224' ' ' VAL . 10.5 tptm -34.83 -66.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.28 -52.4 16.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.066 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.632 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -53.35 -60.18 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.63 -41.7 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.438 ' O ' ' N ' ' A' ' 233' ' ' ASN . 23.8 mt -71.9 -54.73 9.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 221' ' ' PHE . . . -49.33 -29.68 6.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 244' ' ' ILE . 58.0 t -78.73 -33.82 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.167 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.62 -66.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.962 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.438 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.7 m-80 -41.68 -62.76 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.45 ' C ' ' OE1' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -79.17 124.34 28.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.884 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.88 -4.24 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.67 -122.56 7.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.472 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -133.37 140.21 47.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.874 0.369 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.455 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.4 p -41.45 -50.98 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.103 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.455 ' H ' HG13 ' A' ' 238' ' ' VAL . 14.0 t70 -59.94 -44.46 94.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -130.29 87.89 49.41 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.64 0.733 . . . . 0.0 110.895 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 93.18 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.363 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 177' ' ' TRP . 23.8 mt -40.38 147.68 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.904 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.9 85.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.87 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.592 HG21 HG22 ' A' ' 231' ' ' VAL . 15.5 mt -81.2 102.01 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.153 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 88.8 p -107.34 135.1 49.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.473 ' CE2' HD21 ' A' ' 173' ' ' LEU . 59.6 m95 -74.7 104.73 5.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.4 tp -63.24 -55.52 24.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.903 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.44 176.49 10.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.2 53.57 39.72 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.502 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -74.21 137.23 75.4 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.597 0.713 . . . . 0.0 110.938 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 112.32 3.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.708 2.272 . . . . 0.0 112.304 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.6 141.46 58.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.95 110.02 21.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -168.07 168.86 11.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 1.7 t -134.81 149.4 50.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 109.54 -158.08 14.74 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 -28.45 25.11 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.386 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.9 t 46.53 46.65 14.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 56.3 m -133.17 163.16 29.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.1 t -120.28 95.08 4.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 10.8 t -116.38 142.1 47.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -74.76 -142.69 0.84 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.556 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.2 m -88.57 96.42 10.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.875 0.369 . . . . 0.0 110.875 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.7 m -87.19 -51.78 5.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 162.36 157.88 9.26 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.486 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -91.36 143.13 26.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.868 0.366 . . . . 0.0 110.911 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.1 160.51 10.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 p -99.63 145.08 29.5 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.573 0.701 . . . . 0.0 111.119 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 81.05 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.681 2.254 . . . . 0.0 112.342 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -75.07 138.85 42.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD21 ' CE2' ' A' ' 246' ' ' TRP . 52.4 mt -114.2 144.79 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.5 tttp -101.9 118.12 36.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.48 ' CD2' HG12 ' A' ' 244' ' ' ILE . 21.8 mt -101.39 142.62 32.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -144.18 140.57 29.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.663 ' HB3' HD23 ' A' ' 242' ' ' LEU . 48.5 p90 -149.59 144.01 25.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.945 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -49.96 152.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.9 p -156.69 145.85 20.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -78.77 179.73 7.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.921 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -89.8 75.34 7.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.918 179.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 181' ' ' LYS . 24.1 mt-10 36.7 48.23 0.62 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -95.13 -61.33 1.5 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.844 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -118.78 -45.6 2.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 88.6 p -150.18 -177.07 5.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -116.35 40.14 2.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 109.41 146.14 11.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.486 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.5 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -76.65 65.41 2.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.484 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.614 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.2 m-85 -162.32 169.33 20.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 191' ' ' LYS . 28.7 t -158.16 145.33 17.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.489 ' CG ' HD23 ' A' ' 207' ' ' LEU . 26.3 tttm -34.67 -48.06 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.927 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -61.76 -63.09 1.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 94.2 t -41.03 -62.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 50.8 mt -52.83 -45.35 67.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 204' ' ' VAL . 14.7 tp -51.97 -35.04 44.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.886 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 43.3 mtm-85 -77.31 -46.03 24.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.867 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.45 -28.67 45.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 219' ' ' VAL . 11.5 mt -98.4 -45.96 5.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.464 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 9.1 mm-40 -35.53 -64.57 0.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.588 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -36.3 -51.17 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.588 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 85.3 m-85 -73.93 -63.59 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -124.59 143.66 14.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.53 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -71.29 83.58 0.76 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.873 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.486 HG11 HD12 ' A' ' 195' ' ' LEU . 71.6 t -43.39 110.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.112 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.08 -45.72 17.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.902 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -141.79 136.3 30.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.489 HD23 ' CG ' ' A' ' 191' ' ' LYS . 42.9 tp -129.34 114.86 16.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.919 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.8 t -114.57 151.28 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.13 122.83 47.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.2 m -56.8 147.62 22.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.1 t -111.5 -47.54 3.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mttm -38.98 -49.47 1.7 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -129.38 126.9 23.05 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.872 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 137.34 35.22 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.31 22.52 11.52 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 11.0 p -140.36 140.64 35.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -152.77 139.8 19.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 37.8 t -108.19 123.93 64.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.151 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.601 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.5 p -101.57 164.33 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.14 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.601 ' N ' HG22 ' A' ' 219' ' ' VAL . 39.6 tt0 -132.17 113.77 13.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -85.58 176.39 8.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.906 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -105.33 -11.26 16.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.101 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 23.6 p -153.94 164.44 38.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.147 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 227' ' ' ALA . 59.4 t -71.39 -62.19 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 224' ' ' VAL . 28.1 tttp -36.74 -71.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -37.91 -46.99 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.4 -56.69 18.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.078 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.72 -52.44 48.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 87.4 mt -50.33 -53.27 30.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.899 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -52.28 -63.53 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.09 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.697 HG22 HG21 ' A' ' 244' ' ' ILE . 37.0 t -43.9 -27.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.141 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -91.69 -75.13 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 64.7 m-80 -47.35 -70.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.88 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.535 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -58.31 122.7 13.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.17 -29.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 121.27 -126.85 6.71 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.614 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.6 mt -119.75 130.63 55.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.919 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.716 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.08 -61.56 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.716 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.9 m-20 -54.93 -44.26 74.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 237' ' ' LEU . 74.8 m-20 -130.38 91.52 38.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.582 0.706 . . . . 0.0 110.907 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.7 Cg_endo -69.79 95.69 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.331 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 177' ' ' TRP . 33.1 mt -34.2 147.77 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -111.55 98.36 7.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.878 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.697 HG21 HG22 ' A' ' 231' ' ' VAL . 19.6 mt -91.59 117.66 35.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 16.5 m -125.96 126.0 43.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.518 ' CE2' HD21 ' A' ' 173' ' ' LEU . 66.2 m95 -63.28 103.05 0.45 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 9.5 tp -60.34 -37.71 81.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -172.84 173.12 3.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.846 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.79 56.1 26.96 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.482 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 33.4 tt0 -90.11 139.83 27.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.611 0.72 . . . . 0.0 110.901 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.75 176.79 6.3 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.648 2.232 . . . . 0.0 112.359 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -66.97 130.57 43.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -76.94 -64.06 1.22 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -90.78 142.82 27.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.107 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 95.8 p -112.83 114.83 27.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -160.6 -92.7 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.485 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.67 138.48 38.21 Favored 'Trans proline' 0 N--CA 1.465 -0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 54.1 p -172.66 151.32 2.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.1 m 54.08 41.66 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.855 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.5 t -110.64 -46.61 3.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.7 t 53.0 37.97 26.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.1 125.6 2.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.481 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 42.1 t -70.21 106.49 3.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.86 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 p -66.6 126.0 27.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.462 ' O ' ' NE2' ' A' ' 168' ' ' GLN . . . 123.62 157.1 9.71 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.476 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.462 ' NE2' ' O ' ' A' ' 167' ' ' GLY . 1.7 mp0 -113.89 149.13 35.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.835 0.35 . . . . 0.0 110.913 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 153.62 171.05 20.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.0 p -71.19 142.08 86.87 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.599 0.714 . . . . 0.0 111.147 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 79.93 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.664 2.243 . . . . 0.0 112.363 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -73.61 122.98 23.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.606 HD12 ' CE1' ' A' ' 221' ' ' PHE . 30.0 mt -104.37 164.05 12.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.952 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.5 ttmm -115.97 127.13 54.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 198' ' ' LEU . 40.9 mt -106.28 113.18 26.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -123.51 142.59 50.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.778 ' HB3' HD23 ' A' ' 242' ' ' LEU . 38.6 p90 -152.58 141.65 21.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.924 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -64.82 98.62 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.8 p -82.21 -51.11 8.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.89 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.4 ' CG ' ' OG ' ' A' ' 185' ' ' SER . 3.4 mmtp -151.48 -179.07 7.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.931 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -101.1 87.5 3.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 63.42 35.89 11.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -134.11 176.2 8.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -103.03 114.33 28.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.4 ' OG ' ' CG ' ' A' ' 180' ' ' LYS . 10.7 p -167.09 158.95 12.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -85.19 -56.25 3.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.898 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 111.9 -130.31 9.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.503 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -121.92 53.61 0.71 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.507 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.497 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 44.6 m-85 -153.75 158.75 41.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.893 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 t -148.9 156.92 42.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.56 -49.21 2.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 195' ' ' LEU . 3.1 m-20 -62.05 -68.04 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 192' ' ' ASP . 86.9 t -35.04 -47.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.456 HD22 HD13 ' A' ' 175' ' ' LEU . 54.4 mt -69.68 -42.25 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.499 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 17.4 tp -59.96 -37.51 79.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.912 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.425 ' CG ' ' O ' ' A' ' 193' ' ' VAL . 11.2 ptp180 -76.4 -38.92 54.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 20.5 mt -61.65 -32.72 72.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.816 HD23 ' OE1' ' A' ' 234' ' ' GLU . 14.8 mt -93.29 -54.79 3.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.499 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 17.6 mm-40 -34.89 -55.22 0.58 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.921 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.556 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.9 ptmt -39.81 -49.87 2.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 233' ' ' ASN . 96.8 m-85 -75.1 -64.7 1.0 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.938 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.45 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.91 145.38 15.92 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -65.73 99.86 0.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.879 0.371 . . . . 0.0 110.895 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 88.1 t -57.51 134.21 22.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.118 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 59.9 mt -101.33 -43.26 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -148.91 119.09 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 44.6 tp -111.02 104.04 12.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.652 ' C ' HD12 ' A' ' 209' ' ' LEU . 62.3 t -101.6 164.08 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.652 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.8 mp -130.75 177.49 7.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.6 p -47.92 174.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 32.3 t -127.06 -32.01 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -126.85 -60.37 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 33.6 mmtt -92.06 117.16 67.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.598 0.713 . . . . 0.0 110.879 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 142.54 48.21 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.7 2.267 . . . . 0.0 112.338 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 124.79 -13.95 7.62 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.477 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 40.7 p -120.6 158.5 27.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.777 0.322 . . . . 0.0 111.127 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.65 174.5 11.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 173' ' ' LEU . 77.4 t -145.64 127.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG21 HD13 ' A' ' 198' ' ' LEU . 12.3 p -108.45 162.33 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.533 ' N ' HG22 ' A' ' 219' ' ' VAL . 41.5 tt0 -131.15 105.26 7.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.606 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.9 m-85 -78.26 167.63 21.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.856 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.42 -16.33 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.139 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 11.0 p -143.78 170.27 16.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.165 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 49.8 t -86.28 -46.99 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.47 -56.36 7.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.45 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -57.63 -42.38 83.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.123 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.653 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -55.73 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -63.52 -48.9 75.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.53 -44.58 89.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.45 80.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.072 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.0 t -63.9 -21.97 29.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -91.81 -72.87 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 235' ' ' VAL . 68.2 m-80 -54.87 -74.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.816 ' OE1' HD23 ' A' ' 198' ' ' LEU . 7.2 tt0 -43.97 109.88 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 233' ' ' ASN . 17.0 m -110.05 -16.39 9.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.118 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.12 -135.41 12.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.52 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.449 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 72.0 mt -115.62 137.94 51.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 0.0 110.951 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.45 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -42.0 -52.5 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.111 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.45 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.4 p-10 -60.75 -42.36 97.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -133.21 87.75 37.93 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.596 0.712 . . . . 0.0 110.841 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 95.02 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.778 HD23 ' HB3' ' A' ' 177' ' ' TRP . 24.2 mt -38.54 158.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -124.82 95.7 4.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.926 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.519 ' CG2' HG22 ' A' ' 231' ' ' VAL . 6.8 mt -91.37 115.95 31.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.124 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 2.1 t -119.2 158.34 26.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.442 ' CG ' ' OE1' ' A' ' 250' ' ' GLN . 80.3 m95 -91.46 92.62 8.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.928 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 3.2 tp -55.95 -69.26 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -143.98 140.79 29.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.892 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.08 49.74 1.85 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.442 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 11.2 tp60 -70.76 138.16 85.57 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.588 0.708 . . . . 0.0 110.879 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.421 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.76 162.56 41.6 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.68 2.253 . . . . 0.0 112.342 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.86 117.09 18.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.94 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -126.61 151.34 48.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.03 34.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.119 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 13.1 t -97.09 135.43 39.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -100.55 146.11 17.46 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.46 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 258' ' ' SER . 54.2 Cg_endo -69.74 -13.71 35.11 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.702 2.268 . . . . 0.0 112.334 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' PRO . 2.6 p -36.81 -73.98 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 1.8 t -100.98 141.6 33.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.503 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 72.1 p -115.39 167.76 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 15.1 m -74.09 159.77 32.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.877 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 85.04 -160.89 35.56 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.517 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 59.5 p -153.14 113.74 4.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.902 0.382 . . . . 0.0 110.85 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.7 t -106.79 158.11 17.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.842 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 110.43 -138.84 15.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.502 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -45.58 154.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -97.75 -157.41 30.32 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.6 p -93.02 140.92 23.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.581 0.705 . . . . 0.0 111.114 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 81.48 0.81 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.675 2.25 . . . . 0.0 112.332 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -66.14 149.6 50.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.898 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.552 HD11 ' HB1' ' A' ' 227' ' ' ALA . 83.8 mt -132.96 162.03 32.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tttp -116.12 136.11 53.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 244' ' ' ILE . 33.7 mt -119.41 114.29 22.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.29 144.87 43.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -155.63 141.53 18.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -56.62 122.08 11.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 34.9 t -127.45 143.31 51.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.84 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -87.66 163.0 16.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.63 130.51 35.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 52.77 43.46 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -111.07 132.76 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.864 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -72.65 -53.9 10.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 28.2 t -49.61 -41.63 42.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 64.1 mttt 59.06 25.77 14.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 105.03 -98.99 1.55 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.451 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -173.82 41.23 0.14 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 242' ' ' LEU . 85.4 m-85 -132.64 167.37 20.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.931 0.396 . . . . 0.0 110.939 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -172.97 156.38 3.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.526 ' HZ3' HD23 ' A' ' 207' ' ' LEU . 18.7 tptp -34.24 -61.53 0.37 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.44 ' O ' ' C ' ' A' ' 193' ' ' VAL . 3.2 t70 -53.41 -69.56 0.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 192' ' ' ASP . 67.9 t -34.64 -65.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 73.0 mt -52.94 -57.09 11.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.903 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.51 HD12 HG11 ' A' ' 204' ' ' VAL . 14.8 tp -41.15 -38.77 1.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -71.47 -57.7 4.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.851 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 46.0 mt -43.94 -27.38 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 219' ' ' VAL . 14.9 mt -94.17 -57.04 2.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 200' ' ' LYS . 11.2 mt-30 -34.39 -60.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 199' ' ' GLN . 14.0 mtmm -34.4 -48.25 0.34 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.572 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 49.9 m-85 -81.99 -63.56 1.36 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.898 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.562 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -134.43 142.47 13.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -58.49 126.2 26.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.904 0.383 . . . . 0.0 110.866 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 195' ' ' LEU . 76.3 t -83.63 107.34 15.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.141 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 38.8 mt -74.43 -59.7 2.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.911 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -131.44 113.44 13.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.526 HD23 ' HZ3' ' A' ' 191' ' ' LYS . 44.5 tp -106.32 100.14 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.967 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.757 ' C ' HD12 ' A' ' 209' ' ' LEU . 78.0 t -98.46 164.65 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.757 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp -139.52 153.59 47.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.5 t -91.87 116.9 29.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.2 m -88.83 -39.23 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.414 ' HE3' ' N ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -52.05 -58.85 5.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.912 179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -102.94 122.28 46.18 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.646 0.736 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 127.6 14.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.421 ' O ' HG23 ' A' ' 216' ' ' THR . . . 94.85 38.84 4.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.444 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 215' ' ' GLY . 3.7 p -155.64 145.77 21.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.03 179.05 7.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 173' ' ' LEU . 24.5 t -150.21 134.7 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 HD13 ' A' ' 198' ' ' LEU . 9.7 p -116.01 166.74 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.099 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.3 tt0 -131.89 110.57 10.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.868 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -81.88 173.29 12.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.851 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -98.11 -26.94 14.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.096 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 30.7 p -137.76 173.9 11.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.135 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.444 ' O ' ' C ' ' A' ' 225' ' ' LYS . 75.1 t -81.25 -61.37 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 224' ' ' VAL . 19.6 tptp -34.95 -69.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.562 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -39.47 -56.75 1.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.133 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.552 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -50.13 -64.53 0.78 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 227' ' ' ALA . 3.8 mm-40 -36.68 -48.28 0.7 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 21.2 mt -66.65 -48.53 69.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.955 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -56.4 -19.11 13.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.067 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.548 HG22 HG21 ' A' ' 244' ' ' ILE . 91.1 t -94.34 -30.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.122 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -90.05 -69.32 0.73 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 235' ' ' VAL . 35.6 m-80 -54.27 -74.52 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 0.2 OUTLIER -56.3 115.21 2.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 242' ' ' LEU . 31.5 m -109.23 -18.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.084 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 117.8 -119.18 4.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.484 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 240' ' ' ASN . 59.5 mt -121.34 133.35 55.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.825 0.345 . . . . 0.0 110.916 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.725 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.03 -62.13 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.162 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.725 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.8 m-20 -51.85 -45.74 64.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 237' ' ' LEU . 51.7 t30 -131.1 92.06 34.32 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.602 0.715 . . . . 0.0 110.901 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.453 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.73 94.9 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.707 2.271 . . . . 0.0 112.378 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 189' ' ' TYR . 40.1 mt -34.18 148.25 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.932 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.477 ' HE3' ' N ' ' A' ' 244' ' ' ILE . 0.1 OUTLIER -109.78 96.3 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.548 HG21 HG22 ' A' ' 231' ' ' VAL . 8.7 mt -91.95 115.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 79.6 p -123.86 140.21 53.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.872 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -71.18 94.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.91 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 12.9 tp -65.46 -39.84 92.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -159.45 146.04 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 55.12 5.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -92.37 136.3 25.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.924 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 142.98 49.52 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.688 2.259 . . . . 0.0 112.333 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.546 HE22 ' HB2' ' A' ' 254' ' ' ALA . 1.4 tm0? -84.31 86.63 7.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.88 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.91 134.3 34.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.862 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.546 ' HB2' HE22 ' A' ' 252' ' ' GLN . . . -127.32 114.08 17.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 6.0 t -112.44 104.36 12.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 86.28 76.48 1.24 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.504 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 102.27 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.706 2.271 . . . . 0.0 112.366 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.8 t -153.45 139.27 18.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 65.0 m -141.7 173.0 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.463 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 162' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.479 -0.249 . . . . 0.0 112.479 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 161' ' ' GLY . 60.7 p 37.12 42.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.818 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.5 m -80.6 106.79 12.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -114.57 133.86 11.33 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 4.0 t -119.67 174.24 6.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 0.0 110.847 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 95.5 p -113.18 143.62 44.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -133.1 157.03 22.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.504 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.455 ' C ' ' CD ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -121.07 165.74 14.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.917 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.26 176.44 22.69 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 17.4 p -68.65 146.31 97.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.584 0.707 . . . . 0.0 111.167 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 80.26 0.9 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.663 2.242 . . . . 0.0 112.321 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -66.23 143.65 57.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.932 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.635 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.6 mt -122.59 151.93 40.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -107.7 122.83 47.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 244' ' ' ILE . 19.6 mt -102.71 117.66 35.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 42.8 tttt -126.64 124.94 41.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.678 ' HB3' HD23 ' A' ' 242' ' ' LEU . 33.0 p90 -127.92 137.06 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.859 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -58.13 140.51 52.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 21.8 t -174.85 148.81 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.916 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -54.79 141.23 33.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.919 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -73.04 -50.95 20.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.936 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 0.5 OUTLIER -80.44 44.37 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -123.06 149.85 43.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.857 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -86.62 -46.09 10.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 22.2 t -59.09 162.14 4.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.28 -54.7 7.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.868 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 145.49 33.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 86.87 39.19 7.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.508 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.438 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 57.2 m-85 -160.99 135.56 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 191' ' ' LYS . 37.4 m -123.52 148.8 45.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 190' ' ' SER . 71.2 tttt -36.52 -42.76 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -64.93 -63.43 1.11 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.849 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 95.4 t -41.02 -67.18 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.416 ' CD2' HD11 ' A' ' 242' ' ' LEU . 70.8 mt -45.06 -53.64 7.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 13.7 tp -49.11 -33.45 11.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.912 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 42.3 mtt180 -77.42 -47.92 18.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 36.6 mt -55.02 -25.91 33.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.423 HD11 HD11 ' A' ' 175' ' ' LEU . 24.6 mt -100.76 -42.33 6.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.946 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.492 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 8.2 mm-40 -42.74 -59.28 2.0 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.561 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 5.4 ptpp? -42.05 -30.38 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.561 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 99.0 m-85 -91.22 -63.4 1.27 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.465 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -133.17 134.07 7.33 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.513 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -55.16 94.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.489 HG11 HD12 ' A' ' 195' ' ' LEU . 71.4 t -62.61 101.05 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.135 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 25.6 mt -63.58 -52.27 61.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -135.02 148.64 49.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 52.5 tp -140.89 110.71 6.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 88.2 t -110.48 149.42 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.14 136.41 54.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -77.94 129.87 35.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.0 t -90.49 -64.15 1.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -38.24 -55.29 1.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.877 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -92.27 106.98 20.06 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.602 0.715 . . . . 0.0 110.888 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 116.68 4.68 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.245 . . . . 0.0 112.304 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 103.44 28.7 5.94 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.48 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.86 150.27 39.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -162.11 173.5 14.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 71.2 t -144.35 112.36 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.119 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.571 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.0 p -95.43 165.35 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.571 ' N ' HG22 ' A' ' 219' ' ' VAL . 21.4 tt0 -130.55 111.96 12.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 173' ' ' LEU . 14.9 m-85 -85.2 170.43 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -95.98 -24.12 16.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 43.7 p -142.19 171.91 13.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 225' ' ' LYS . 67.3 t -81.18 -60.51 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 224' ' ' VAL . 20.0 tptt -35.03 -59.01 0.51 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.465 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -55.7 -50.46 70.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.774 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -52.9 -53.59 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -50.22 -44.2 53.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 48.9 mt -67.07 -58.78 4.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.41 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -47.18 -22.94 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 227' ' ' ALA . 61.8 t -86.24 -31.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.087 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -100.31 -66.4 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -42.66 -65.26 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -69.08 136.88 52.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 -39.92 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.103 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 129.74 -128.56 5.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 64.8 mt -123.38 137.53 54.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.421 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -41.81 -50.69 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.161 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.421 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.9 t70 -62.92 -42.57 99.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -132.74 86.14 45.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 0.0 110.869 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.5 Cg_endo -69.76 93.56 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.3 mt -35.93 153.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -124.12 85.7 2.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.94 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 231' ' ' VAL . 16.1 mt -78.2 130.53 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.103 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 12.7 p -137.14 132.14 33.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.498 ' CE2' HD21 ' A' ' 173' ' ' LEU . 63.5 m95 -67.37 105.5 1.8 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.894 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.6 tp -69.94 -56.06 8.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -140.98 175.21 9.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 46.97 82.44 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.517 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -104.82 144.82 29.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.934 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 141.55 45.56 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.346 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -171.85 132.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.87 84.21 2.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.93 42.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.04 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.9 t -70.78 156.9 38.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.855 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 132.0 -95.85 0.31 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 114.0 3.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.688 2.259 . . . . 0.0 112.321 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.2 t -72.9 164.43 26.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 7.0 t -107.01 -47.83 3.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.798 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.522 -179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.2 m 44.15 47.97 7.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.939 0.399 . . . . 0.0 110.878 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 33.4 t -131.7 121.04 23.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.9 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -178.65 91.79 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.47 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 86.5 p -132.05 176.71 8.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.871 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 2.8 t -142.72 137.88 30.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.839 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -144.03 59.62 0.52 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -124.04 176.96 6.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.88 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.15 175.46 25.46 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.48 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.3 p -56.04 143.43 62.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.593 0.711 . . . . 0.0 111.134 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 80.16 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.68 2.253 . . . . 0.0 112.336 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -70.77 123.37 21.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.947 HD12 ' CE1' ' A' ' 221' ' ' PHE . 41.5 mt -98.43 155.86 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -108.12 124.89 50.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.699 HD23 HG12 ' A' ' 244' ' ' ILE . 68.2 mt -102.3 111.37 23.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 25.9 tttm -117.12 133.77 55.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 42.7 p90 -140.77 144.46 35.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.964 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -49.87 136.9 17.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.914 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 2.5 t -151.08 138.26 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.853 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.93 146.18 25.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.77 -46.1 7.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.882 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -87.12 46.95 1.43 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -166.84 175.32 7.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -119.05 84.47 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 18.9 m -159.32 145.05 16.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -112.26 21.71 15.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.936 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 74.58 -60.88 2.43 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.464 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 149.34 60.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.526 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.735 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 99.3 m-85 -147.98 140.59 24.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.922 0.391 . . . . 0.0 110.941 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -139.27 158.11 44.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -42.19 -46.94 4.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.0 OUTLIER -65.21 -68.7 0.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.82 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 192' ' ' ASP . 37.5 t -35.61 -56.08 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.125 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 80.1 mt -59.33 -50.73 72.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 35.1 tp -47.52 -32.98 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -78.45 -46.39 19.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.851 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.595 HD22 ' CD ' ' A' ' 234' ' ' GLU . 20.5 mt -51.62 -30.73 22.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 219' ' ' VAL . 5.7 mt -97.74 -49.76 4.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 13.4 mm-40 -34.59 -57.43 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.92 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 19.6 ptmt -42.19 -54.12 3.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 79.3 m-85 -72.1 -67.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -121.9 151.92 16.89 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.463 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -76.83 96.64 4.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.27 120.58 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 42.3 mt -86.71 -52.03 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.944 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -141.07 114.93 9.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 46.7 tp -101.14 116.65 33.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.419 ' C ' HD12 ' A' ' 209' ' ' LEU . 54.5 t -117.25 152.62 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.151 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.419 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.0 mp -127.13 142.33 51.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.951 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 3.0 t -76.12 122.76 24.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.4 m -88.57 -44.41 10.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -65.88 -42.93 89.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 34.0 mmtt -99.32 105.38 32.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.64 0.733 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.1 Cg_endo -69.8 128.74 16.42 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.687 2.258 . . . . 0.0 112.338 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 89.11 32.04 11.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.499 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 22.4 p -152.65 145.93 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -155.05 -179.75 8.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.041 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 45.9 t -147.63 127.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.124 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 1.023 HG21 HD13 ' A' ' 198' ' ' LEU . 8.1 p -109.61 143.29 20.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.102 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -107.45 114.04 27.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.876 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.947 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -87.91 168.69 12.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -93.61 -14.63 26.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.063 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 46.0 p -155.26 174.87 14.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.179 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 225' ' ' LYS . 84.6 t -84.95 -51.89 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.101 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 224' ' ' VAL . 51.3 tptt -36.09 -55.98 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -61.34 -48.84 79.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.098 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.73 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.18 -43.08 52.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.24 -47.52 70.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.2 -37.85 81.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.947 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -64.33 -47.88 77.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 227' ' ' ALA . 42.5 t -60.91 -30.92 48.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -90.02 -69.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.886 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.463 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 56.9 m-80 -50.26 -73.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.595 ' CD ' HD22 ' A' ' 197' ' ' LEU . 5.1 tp10 -57.57 118.1 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 26.9 m -110.51 -15.64 9.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.132 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 104.95 -134.37 12.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.502 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.4 mt -113.56 135.71 53.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.848 0.356 . . . . 0.0 110.951 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -39.54 -62.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 11.3 m-20 -50.83 -43.25 59.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 237' ' ' LEU . 42.6 m-20 -133.3 93.7 21.61 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.436 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.75 93.35 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 0.0 112.362 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.735 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 18.2 mt -35.4 143.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 13.5 tptt -112.44 90.66 3.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.699 HG12 HD23 ' A' ' 175' ' ' LEU . 56.6 mt -83.88 97.77 5.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 36.5 m -98.4 136.9 37.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -69.82 95.06 0.87 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.3 tp -52.97 -52.37 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.967 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -154.03 177.24 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 48.56 57.21 8.59 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.475 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.408 ' CD ' ' HD2' ' A' ' 251' ' ' PRO . 12.4 tm0? -83.48 137.23 42.02 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.576 0.703 . . . . 0.0 110.879 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.408 ' HD2' ' CD ' ' A' ' 250' ' ' GLN . 54.1 Cg_endo -69.69 107.5 1.86 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.679 2.253 . . . . 0.0 112.365 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -126.3 37.33 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -78.52 167.65 20.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -154.43 162.85 40.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 15.2 m -82.37 98.9 9.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 179.3 -165.11 33.69 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.454 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -48.99 0.61 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.647 2.231 . . . . 0.0 112.337 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 22.8 t -170.42 119.51 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 37.1 p -78.87 -22.13 46.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.806 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.477 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.469 -0.252 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.9 p -122.54 126.58 48.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.35 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t 47.26 42.14 13.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.852 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.91 -76.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.509 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 73.5 m -69.12 106.01 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 30.1 p -94.88 -45.89 7.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.888 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -116.78 -175.78 17.66 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.463 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -108.18 129.29 55.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.824 0.345 . . . . 0.0 110.932 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.15 31.19 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.3 p -59.31 144.06 84.25 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.562 0.696 . . . . 0.0 111.139 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 89.55 0.53 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.685 2.257 . . . . 0.0 112.321 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -80.93 128.36 33.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.587 HD12 ' CE1' ' A' ' 221' ' ' PHE . 51.8 mt -105.53 159.63 15.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -111.56 124.09 51.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 35.9 mt -105.79 108.4 19.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.921 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.428 ' HG3' HG22 ' A' ' 216' ' ' THR . 67.4 tttt -115.98 143.51 45.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -151.71 155.69 38.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.4 mttp -50.78 172.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.914 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 3.1 p -172.92 138.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -72.97 114.77 11.49 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -76.33 -52.26 10.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -49.6 -40.06 37.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.843 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -113.86 115.21 27.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -61.55 97.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 10.3 t -142.22 160.72 39.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 39.3 mttt -69.29 -52.36 28.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 135.05 -112.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' O ' ' CD1' ' A' ' 189' ' ' TYR . . . -147.26 51.86 0.56 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.472 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.569 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 96.3 m-85 -162.07 161.2 28.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.879 0.371 . . . . 0.0 110.964 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 10.6 t -146.5 143.49 28.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HG3' HD23 ' A' ' 207' ' ' LEU . 63.8 tttt -34.38 -38.57 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.889 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.98 -66.4 0.6 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 81.9 t -38.86 -53.99 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.7 mt -62.85 -43.56 98.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 204' ' ' VAL . 48.6 tp -54.39 -48.47 71.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -65.16 -41.68 94.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 197' ' ' LEU . 20.2 mt -51.96 -42.9 63.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.923 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.73 ' CD1' HG21 ' A' ' 219' ' ' VAL . 19.9 mt -83.16 -43.87 15.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.447 ' O ' ' C ' ' A' ' 200' ' ' LYS . 8.7 mt-30 -34.3 -68.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.585 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 2.5 ptpp? -34.43 -40.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 86.4 m-85 -85.45 -65.29 1.03 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -126.57 150.82 17.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -76.4 91.88 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.904 0.383 . . . . 0.0 110.927 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 195' ' ' LEU . 68.0 t -47.56 113.33 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.114 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 40.8 mt -85.3 -45.88 11.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.878 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.69 118.08 10.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.748 HD23 ' HG3' ' A' ' 191' ' ' LYS . 18.1 tp -115.07 104.11 11.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.921 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.625 ' C ' HD12 ' A' ' 209' ' ' LEU . 59.1 t -100.87 154.22 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.117 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.2 mp -134.0 143.15 47.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.8 m -74.03 108.38 6.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 43.7 t -75.53 -66.9 0.72 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -43.68 -43.21 5.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 28.4 mmtt -119.51 93.46 47.36 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.606 0.717 . . . . 0.0 110.887 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.1 Cg_endo -69.69 123.04 9.74 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 146.97 -33.25 1.38 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.49 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.428 HG22 ' HG3' ' A' ' 176' ' ' LYS . 20.9 p -113.5 164.0 14.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.759 0.314 . . . . 0.0 111.166 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -163.66 171.41 15.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.076 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.04 120.28 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.166 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.73 HG21 ' CD1' ' A' ' 198' ' ' LEU . 7.6 p -101.24 153.9 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.09 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.75 116.32 23.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.587 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.8 m-85 -89.3 171.66 9.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 223' ' ' THR . . . -96.84 -9.79 27.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.139 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 222' ' ' ALA . 33.8 p -156.45 179.22 9.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.127 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 225' ' ' LYS . 96.9 t -87.07 -58.75 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 224' ' ' VAL . 13.4 tptm -35.69 -65.18 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.919 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -47.13 -48.39 23.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.078 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -58.19 -59.1 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.428 ' CD ' ' HG3' ' A' ' 251' ' ' PRO . 3.6 mm-40 -47.15 -37.83 10.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.874 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 233' ' ' ASN . 84.9 mt -71.77 -57.42 4.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.95 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -48.44 -49.64 34.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.102 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.576 HG22 HD13 ' A' ' 173' ' ' LEU . 45.8 t -59.03 -25.55 30.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -101.9 -73.08 0.66 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 229' ' ' LEU . 50.8 m-80 -39.13 -64.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.576 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 14.3 tp10 -66.65 145.92 55.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 236' ' ' GLY . 27.4 m -124.6 -41.74 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 130.12 -119.21 2.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.569 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 84.0 mt -121.18 129.02 53.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.714 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.4 p -36.62 -62.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.714 ' H ' HG13 ' A' ' 238' ' ' VAL . 3.7 m-20 -54.71 -44.02 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 237' ' ' LEU . 37.4 m-20 -129.79 93.01 35.61 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.567 0.699 . . . . 0.0 110.85 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.68 97.91 0.65 Allowed 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.709 2.272 . . . . 0.0 112.361 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.491 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 21.3 mt -37.93 147.7 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.8 95.53 5.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.905 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.467 HG22 HG13 ' A' ' 231' ' ' VAL . 33.6 mt -91.16 106.48 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.082 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -117.32 143.75 45.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -74.04 106.18 5.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.924 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 5.8 tp -65.88 -39.97 91.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.918 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -173.32 156.18 3.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.58 41.53 7.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.484 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -56.62 130.44 77.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.873 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.428 ' HG3' ' CD ' ' A' ' 228' ' ' GLU . 53.9 Cg_endo -69.78 2.38 3.59 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.653 2.236 . . . . 0.0 112.378 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.35 59.03 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -161.29 144.85 12.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -115.31 120.73 40.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 59.0 m -90.78 -48.39 7.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.82 -170.26 26.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 93.89 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.643 2.229 . . . . 0.0 112.352 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 8.5 m -101.57 -43.84 5.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 58.0 m -115.29 157.66 23.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.824 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.499 -179.953 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.0 p -91.78 149.82 21.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.866 0.365 . . . . 0.0 110.902 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 95.5 p -114.39 142.34 46.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 160.33 174.27 29.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.498 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.1 p -109.7 -64.39 1.26 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.852 0.358 . . . . 0.0 110.879 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -169.29 163.01 10.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.837 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 168' ' ' GLN . . . 70.62 71.13 1.06 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.506 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 167' ' ' GLY . 11.2 pt20 -34.92 119.4 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.822 0.344 . . . . 0.0 110.932 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -136.97 -175.92 14.07 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.0 p -115.24 143.29 30.04 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.557 0.694 . . . . 0.0 111.181 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 81.75 0.78 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -74.23 120.6 20.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.898 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.659 ' O ' HG13 ' A' ' 218' ' ' VAL . 50.3 mt -98.14 158.58 15.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -112.2 126.48 55.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.415 HD23 HG12 ' A' ' 244' ' ' ILE . 43.6 mt -102.98 117.62 34.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.633 ' HD2' HG22 ' A' ' 216' ' ' THR . 11.9 tptm -117.45 145.77 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.863 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.642 ' HB3' HD23 ' A' ' 242' ' ' LEU . 40.7 p90 -162.72 146.53 11.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.932 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -60.25 152.89 23.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.65 134.89 22.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.946 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.51 154.82 23.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 60.0 mmtt -98.57 -41.0 7.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -66.58 -27.78 67.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -97.99 145.99 25.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.5 -11.95 44.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 54.9 p -72.89 162.18 29.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . 0.448 ' N ' ' HE2' ' A' ' 186' ' ' LYS . 0.2 OUTLIER -69.02 -48.42 63.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.932 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 146.81 -119.01 1.09 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.508 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -115.88 53.98 0.6 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.504 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.508 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 74.5 m-85 -162.87 121.48 2.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.875 0.369 . . . . 0.0 110.917 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 191' ' ' LYS . 3.1 m -112.73 144.94 41.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 190' ' ' SER . 70.9 tttt -34.13 -41.39 0.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -69.03 -62.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 98.5 t -37.7 -55.72 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.0 mt -59.14 -55.18 38.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.927 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.513 HD12 HG11 ' A' ' 204' ' ' VAL . 15.2 tp -44.55 -35.83 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 51.0 mtt180 -71.92 -61.66 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 26.4 mt -38.31 -39.33 0.43 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.558 HD13 HG21 ' A' ' 219' ' ' VAL . 8.4 mt -86.07 -52.33 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.428 ' C ' ' O ' ' A' ' 198' ' ' LEU . 8.0 mm-40 -35.8 -36.18 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -59.17 -56.35 23.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.91 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.574 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 45.7 m-85 -68.55 -68.15 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -116.57 166.65 12.4 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -85.44 85.95 7.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.915 0.388 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 195' ' ' LEU . 48.8 t -46.48 114.75 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.15 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 222' ' ' ALA . 59.1 mt -84.69 -53.98 5.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.948 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -135.81 122.34 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.901 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.38 97.29 5.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 74.8 t -101.6 145.03 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 8.2 mp -118.1 155.49 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 41.1 t -73.12 131.07 41.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 8.0 m -95.58 -60.84 1.57 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 214' ' ' PRO . 1.1 ttmm -50.21 -65.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 60.6 mmtt -98.86 101.39 12.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.5 Cg_endo -69.82 141.34 44.74 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.694 2.263 . . . . 0.0 112.316 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.87 -13.77 9.79 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.437 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.633 HG22 ' HD2' ' A' ' 176' ' ' LYS . 3.3 p -124.78 173.53 8.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.798 0.332 . . . . 0.0 111.139 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -175.04 -179.53 1.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 173' ' ' LEU . 94.0 t -151.27 134.71 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.558 HG21 HD13 ' A' ' 198' ' ' LEU . 10.8 p -112.25 163.58 9.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.546 ' N ' HG22 ' A' ' 219' ' ' VAL . 24.3 tt0 -129.32 113.31 14.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.419 ' HE1' HG11 ' A' ' 219' ' ' VAL . 3.8 m-85 -90.32 169.77 10.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.32 -20.71 16.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.096 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 13.9 p -140.23 161.11 38.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 86.3 t -75.97 -48.62 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.513 ' HD2' HD11 ' A' ' 229' ' ' LEU . 0.0 OUTLIER -42.99 -65.33 0.49 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -43.81 -58.66 2.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.101 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.662 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -42.91 -54.78 4.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.099 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -48.98 -51.92 27.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.513 HD11 ' HD2' ' A' ' 225' ' ' LYS . 71.3 mt -61.3 -44.29 97.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -63.09 -26.53 68.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.075 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 227' ' ' ALA . 58.7 t -86.34 -22.28 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.096 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -98.51 -69.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -54.19 -73.6 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 22.5 tt0 -59.99 119.43 7.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 29.0 m -112.24 -32.75 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 130.04 -123.4 4.01 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.527 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 240' ' ' ASN . 82.9 mt -118.96 132.45 56.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.724 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.5 p -37.07 -62.04 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.724 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.2 m-20 -53.01 -45.14 67.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 237' ' ' LEU . 62.9 t30 -130.32 91.05 39.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.708 . . . . 0.0 110.921 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.3 Cg_endo -69.73 92.36 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.673 2.249 . . . . 0.0 112.367 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.642 HD23 ' HB3' ' A' ' 177' ' ' TRP . 35.7 mt -35.91 153.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -114.33 105.49 13.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.88 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 175' ' ' LEU . 11.7 mt -100.84 92.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 3.8 m -96.8 155.43 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.803 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -89.43 108.89 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.576 ' O ' HD12 ' A' ' 247' ' ' LEU . 6.2 tp -65.22 -41.15 94.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.484 ' N ' ' OE1' ' A' ' 248' ' ' GLU . 0.0 OUTLIER -174.09 171.22 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.88 38.91 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.426 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 35.5 tt0 -62.21 138.23 96.02 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 110.926 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.7 Cg_endo -69.75 110.56 2.58 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.721 2.281 . . . . 0.0 112.372 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -89.95 93.56 9.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -47.84 109.43 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -151.54 119.62 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.085 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -80.14 85.1 5.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -65.08 -93.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.447 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 -11.95 31.94 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.67 2.247 . . . . 0.0 112.321 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.4 t -73.42 84.57 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 2.7 t -43.57 109.19 0.13 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.491 179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.4 p -165.48 128.2 2.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.878 0.37 . . . . 0.0 110.865 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -79.54 -50.82 10.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.897 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 133.88 138.07 3.93 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 27.1 m -86.93 104.53 16.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.0 m -93.4 150.05 20.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.842 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -130.86 97.39 0.37 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -139.6 122.87 17.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.902 0.382 . . . . 0.0 110.935 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 118.09 -156.74 15.51 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.46 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 p -79.8 143.5 58.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.612 0.72 . . . . 0.0 111.095 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 80.67 0.87 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.636 2.224 . . . . 0.0 112.332 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.5 mtpt -72.11 150.51 43.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.763 HD12 ' CE1' ' A' ' 221' ' ' PHE . 37.1 mt -132.86 153.98 50.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.927 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -108.4 111.82 23.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.932 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.544 HD23 HG12 ' A' ' 244' ' ' ILE . 44.3 mt -88.02 114.3 24.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.952 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.514 ' CD ' HG22 ' A' ' 216' ' ' THR . 21.0 tptp -118.08 145.65 44.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 49.0 p90 -159.27 177.76 10.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -109.79 107.19 17.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.872 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.37 121.12 10.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -61.95 164.01 7.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.924 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -49.7 156.52 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.869 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -45.76 97.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 184' ' ' GLU . 31.7 t70 -134.11 166.9 21.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 183' ' ' ASP . 13.9 tt0 -35.92 -60.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.863 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 15.2 m -79.63 175.56 10.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.88 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -79.83 -64.82 1.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -157.72 42.5 0.51 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.09 11.94 47.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.667 ' CD2' HD21 ' A' ' 242' ' ' LEU . 43.0 m-85 -142.23 130.23 21.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.944 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.0 p -132.73 162.66 30.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -42.66 -57.47 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 193' ' ' VAL . 4.3 m-20 -55.74 -67.73 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 192' ' ' ASP . 23.2 t -36.74 -67.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.102 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.8 mt -46.69 -52.26 14.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 16.6 tp -48.97 -30.31 5.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -77.72 -50.33 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.903 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.446 HD13 ' OE2' ' A' ' 234' ' ' GLU . 29.1 mt -51.58 -30.93 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 21.9 mt -92.91 -46.28 7.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -45.07 -43.27 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.878 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.557 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 17.0 ptpt -52.13 -35.64 48.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.852 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.4 m-85 -89.69 -63.92 1.21 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.908 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.514 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -127.15 155.05 19.69 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -75.38 92.02 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.901 0.382 . . . . 0.0 110.898 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.0 118.98 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 72.9 mt -77.3 -56.84 4.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.887 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -128.6 145.76 51.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 22.1 tp -132.23 102.1 5.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.417 ' C ' HD12 ' A' ' 209' ' ' LEU . 84.7 t -97.37 145.59 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.417 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.1 mp -128.89 140.45 51.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.7 p -38.73 145.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.84 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 4.9 p -121.75 -16.59 7.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.68 -47.88 6.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.886 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -133.13 123.32 17.83 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.543 0.687 . . . . 0.0 110.869 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 121.53 8.21 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.64 2.227 . . . . 0.0 112.373 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 150.01 -22.75 1.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.502 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.514 HG22 ' CD ' ' A' ' 176' ' ' LYS . 11.5 p -120.06 168.15 11.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.751 0.31 . . . . 0.0 111.205 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -173.12 170.94 4.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 173' ' ' LEU . 58.6 t -142.89 128.46 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.585 HG22 ' N ' ' A' ' 220' ' ' GLU . 9.9 p -109.57 167.07 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.585 ' N ' HG22 ' A' ' 219' ' ' VAL . 36.0 tt0 -133.41 109.3 9.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.897 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.763 ' CE1' HD12 ' A' ' 173' ' ' LEU . 39.7 m-85 -81.25 173.94 12.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -109.32 -3.71 16.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.612 HG22 ' C ' ' A' ' 260' ' ' GLY . 3.0 p -154.15 155.98 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.422 HG11 ' O ' ' A' ' 255' ' ' SER . 92.2 t -73.94 -47.98 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 8.5 tttp -49.13 -63.23 1.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.916 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -49.02 -49.08 42.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -53.14 -49.96 65.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -60.13 -40.55 90.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 23.2 mt -69.44 -27.43 65.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -77.09 -41.15 43.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.153 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 227' ' ' ALA . 47.3 t -69.69 -25.03 27.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -90.42 -75.07 0.47 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.955 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.672 ' O ' HG13 ' A' ' 235' ' ' VAL . 40.6 m-80 -53.42 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.564 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 2.0 tm-20 -53.08 116.69 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 233' ' ' ASN . 20.8 m -125.72 5.45 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 99.95 -110.78 4.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' A' ' 238' ' ' VAL . 13.9 mt -142.51 138.81 31.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.688 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.8 p -37.74 -60.35 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.17 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.688 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.2 OUTLIER -52.37 -45.91 65.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -128.41 86.97 56.42 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.659 0.742 . . . . 0.0 110.856 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 97.07 0.62 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.706 2.271 . . . . 0.0 112.333 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.667 HD21 ' CD2' ' A' ' 189' ' ' TYR . 28.3 mt -42.09 164.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.921 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -125.46 83.18 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.544 HG12 HD23 ' A' ' 175' ' ' LEU . 11.6 mt -83.23 115.41 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.5 m -133.14 136.12 45.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.496 ' CG ' ' OE1' ' A' ' 250' ' ' GLN . 92.0 m95 -59.08 159.82 6.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.901 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 31.0 tp -122.4 -75.02 0.6 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -126.47 -11.54 6.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.448 ' O ' ' CE3' ' A' ' 246' ' ' TRP . . . -95.08 55.46 1.82 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.509 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.496 ' OE1' ' CG ' ' A' ' 246' ' ' TRP . 2.4 tp60 -80.39 129.07 70.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.581 0.705 . . . . 0.0 110.921 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -5.18 15.57 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.676 2.251 . . . . 0.0 112.389 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 9.6 tp60 -40.95 -50.59 3.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.922 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -47.3 -57.79 4.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.85 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 256' ' ' GLY . . . -159.06 145.6 16.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.422 ' O ' HG11 ' A' ' 224' ' ' VAL . 3.0 t -38.27 -31.58 0.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 254' ' ' ALA . . . 129.76 -161.09 22.91 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.484 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 173.34 11.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.262 . . . . 0.0 112.352 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 14.2 m -101.37 137.91 39.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.84 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 4.6 t 40.05 45.73 1.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.612 ' C ' HG22 ' A' ' 223' ' ' THR . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.441 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 28.9 p -81.62 114.87 20.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.863 0.363 . . . . 0.0 110.843 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.9 t -127.22 123.0 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.811 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.95 148.51 17.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.505 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 40.6 t -101.87 -55.79 2.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.872 0.368 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.3 t -50.53 -54.65 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 100.24 -100.11 2.13 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.494 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -96.29 101.8 13.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.844 0.354 . . . . 0.0 110.889 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 128.78 -174.96 18.92 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 29.3 p -118.06 138.58 25.63 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.554 0.693 . . . . 0.0 111.148 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 82.11 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.683 2.255 . . . . 0.0 112.376 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -71.01 130.57 41.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 221' ' ' PHE . 72.7 mt -109.61 151.35 26.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.955 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -104.49 115.35 30.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.934 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 95.0 mt -90.64 108.79 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.927 ' HD3' HG22 ' A' ' 216' ' ' THR . 0.0 OUTLIER -117.27 134.76 54.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.552 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.1 p90 -149.43 140.94 23.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -62.97 134.9 56.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 27.3 p -117.41 132.64 56.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 19.9 mtmt -53.2 169.62 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.902 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 182' ' ' GLU . 33.8 tptt -93.01 105.1 17.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' LYS . 15.8 mm-40 37.9 50.43 1.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.874 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.415 ' CG ' ' O ' ' A' ' 183' ' ' ASP . 27.6 t70 -88.61 41.93 1.05 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 41.47 40.75 1.38 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 84.3 p -172.47 167.64 5.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.884 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -96.25 -39.45 9.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 155.03 -166.38 32.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.479 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -96.94 29.75 10.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.49 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -137.69 165.16 27.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.897 0.38 . . . . 0.0 110.954 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.7 t -162.65 152.23 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.81 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 190' ' ' SER . 32.0 tttt -37.69 -50.97 1.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -63.09 -62.85 1.43 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 82.7 t -40.2 -63.53 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 40.5 mt -51.16 -45.03 61.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.42 HD12 HG11 ' A' ' 204' ' ' VAL . 13.3 tp -51.83 -44.02 63.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.2 mtt180 -71.5 -29.07 64.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 197' ' ' LEU . 17.7 mt -67.91 -32.07 72.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.543 HD22 ' HZ ' ' A' ' 221' ' ' PHE . 24.3 mt -94.71 -37.62 11.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 201' ' ' TYR . 44.6 mt-30 -44.43 -63.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.58 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 6.4 ptpp? -38.62 -27.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.58 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 95.9 m-85 -93.92 -66.06 0.95 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.959 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -129.92 157.31 21.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.52 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -74.71 92.14 2.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.882 0.372 . . . . 0.0 110.86 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.42 HG11 HD12 ' A' ' 195' ' ' LEU . 74.4 t -53.31 122.51 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.1 -51.39 6.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.887 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.93 140.47 32.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.916 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 21.6 tp -131.63 100.65 5.19 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.431 ' C ' HD12 ' A' ' 209' ' ' LEU . 65.7 t -100.08 148.89 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.431 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.9 mp -121.82 157.6 30.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 7.7 t -91.75 163.33 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.815 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 69.2 m -120.18 -55.52 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 29.8 mtmt -53.7 -54.86 31.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 3.1 mmmm -91.04 108.53 28.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.6 0.714 . . . . 0.0 110.877 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.2 Cg_endo -69.81 131.88 22.1 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.65 2.234 . . . . 0.0 112.324 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.448 ' HA2' ' NE1' ' A' ' 177' ' ' TRP . . . 87.64 26.86 28.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.927 HG22 ' HD3' ' A' ' 176' ' ' LYS . 71.7 p -136.63 150.87 48.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.342 . . . . 0.0 111.142 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -172.59 168.22 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.076 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 19.1 t -133.44 141.06 45.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.094 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.614 HG22 ' N ' ' A' ' 220' ' ' GLU . 12.3 p -119.2 165.8 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.614 ' N ' HG22 ' A' ' 219' ' ' VAL . 31.3 tt0 -130.84 123.91 30.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.573 ' CE1' HD12 ' A' ' 173' ' ' LEU . 36.4 m-85 -99.63 164.22 12.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -90.71 -24.95 20.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.123 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 24.7 p -139.14 169.65 17.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 30.9 t -82.53 -52.15 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -41.37 -60.78 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -49.18 -53.02 23.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.153 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.496 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -50.85 -55.73 15.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.106 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -50.73 -40.66 55.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.871 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 233' ' ' ASN . 85.3 mt -67.87 -47.44 68.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.928 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -57.12 -43.07 81.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.092 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 244' ' ' ILE . 26.0 t -70.38 -29.0 37.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -92.08 -71.43 0.64 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.947 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' O ' ' A' ' 229' ' ' LEU . 54.4 m-80 -49.64 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.569 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 4.9 tp10 -66.8 128.89 38.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.864 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 32.4 m -121.76 2.02 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.01 -117.56 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.47 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 51.4 mt -132.85 136.09 46.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.854 0.359 . . . . 0.0 110.907 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.1 p -41.29 -50.81 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.117 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.22 -43.94 98.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.837 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 12.9 t-20 -129.46 92.65 37.68 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.619 0.723 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.6 Cg_endo -69.78 94.27 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.691 2.261 . . . . 0.0 112.352 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' TRP . 22.8 mt -39.88 160.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -125.94 81.28 1.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.862 HG21 HG22 ' A' ' 231' ' ' VAL . 22.9 mt -76.49 97.09 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 20.0 m -102.25 132.88 47.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.538 ' CD1' ' OE1' ' A' ' 250' ' ' GLN . 81.0 m95 -68.08 102.71 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.402 ' O ' ' CG ' ' A' ' 248' ' ' GLU . 16.2 tp -56.92 -59.06 5.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.954 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . 0.402 ' CG ' ' O ' ' A' ' 247' ' ' LEU . 33.3 mt-10 -161.28 108.05 1.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.54 55.23 0.16 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.538 ' OE1' ' CD1' ' A' ' 246' ' ' TRP . 22.0 tt0 -102.79 137.49 19.33 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.648 0.737 . . . . 0.0 110.865 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.84 144.55 53.97 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 66.0 mm-40 -119.13 -68.02 0.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.944 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.67 40.92 1.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 40.7 38.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.094 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.8 t -168.49 174.12 7.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -129.5 -164.5 11.45 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.5 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 142.25 47.47 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.707 2.272 . . . . 0.0 112.347 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 52.8 m -124.18 119.89 30.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 35.3 t -167.42 140.83 3.5 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.841 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.55 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 58.2 m -124.09 177.53 5.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.851 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 90.8 p -101.63 -45.67 5.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.834 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.35 -95.79 0.79 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.8 t -71.56 121.96 19.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.88 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 78.2 p -74.84 -51.59 13.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.874 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 145.85 -170.03 27.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -56.73 159.23 4.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.85 0.357 . . . . 0.0 110.909 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -176.39 179.33 47.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.482 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.6 p -103.15 152.27 38.59 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.578 0.704 . . . . 0.0 111.147 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 81.33 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.647 2.231 . . . . 0.0 112.354 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -71.33 153.41 42.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 221' ' ' PHE . 49.6 mt -132.09 149.53 52.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -109.12 120.63 43.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 194' ' ' LEU . 36.7 mt -97.25 124.21 41.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.954 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -124.97 131.62 53.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.478 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 49.0 p90 -134.75 166.91 21.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -82.83 116.76 22.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 41.0 t -93.7 116.77 29.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 180' ' ' LYS . 0.3 OUTLIER -67.97 171.44 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -87.57 -47.8 8.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' CD ' ' O ' ' A' ' 182' ' ' GLU . 2.7 pp20? -88.17 41.83 1.03 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.862 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -73.51 173.64 9.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.854 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -117.15 -55.0 2.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.0 t -113.51 -55.94 2.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.837 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -134.1 -50.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.909 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 154.02 -53.25 0.45 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.465 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.537 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . -170.69 37.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' A' ' 188' ' ' GLY . 82.8 m-85 -164.01 171.08 15.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.897 0.379 . . . . 0.0 110.938 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 191' ' ' LYS . 24.1 p -162.16 142.87 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.483 ' CG ' HD23 ' A' ' 207' ' ' LEU . 29.8 ttpt -34.42 -45.32 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -56.5 -63.7 1.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 62.5 t -48.79 -56.41 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 175' ' ' LEU . 71.1 mt -54.53 -43.93 72.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.407 HD12 HG11 ' A' ' 204' ' ' VAL . 13.9 tp -54.42 -39.08 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -72.38 -55.44 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.0 mt -45.3 -35.99 3.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.91 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 219' ' ' VAL . 11.6 mt -87.96 -55.43 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 200' ' ' LYS . 16.1 mm-40 -33.92 -61.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.546 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.6 ptmt -34.57 -50.94 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 57.3 m-85 -79.08 -65.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.593 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -119.08 137.73 12.94 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.488 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -65.19 84.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 110.898 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.407 HG11 HD12 ' A' ' 195' ' ' LEU . 96.2 t -42.36 117.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 65.9 mt -93.18 -49.46 5.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.933 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -134.95 110.35 9.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.483 HD23 ' CG ' ' A' ' 191' ' ' LYS . 48.5 tp -108.15 115.05 29.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.915 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 87.9 t -117.36 146.38 21.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.104 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 6.8 mp -126.67 135.25 50.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 17.3 t -57.58 108.08 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.7 t -76.22 -49.13 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.428 ' N ' ' HD3' ' A' ' 212' ' ' LYS . 2.8 mppt? -62.91 -57.88 9.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.849 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -99.65 100.38 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 212' ' ' LYS . 53.5 Cg_endo -69.82 129.55 17.72 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.628 2.219 . . . . 0.0 112.321 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 129.47 -36.17 2.43 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.511 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 51.0 p -106.33 148.66 27.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.784 0.326 . . . . 0.0 111.134 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.25 178.95 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 80.2 t -152.27 116.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 198' ' ' LEU . 7.2 p -103.53 160.71 4.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.115 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.559 ' N ' HG22 ' A' ' 219' ' ' VAL . 26.2 tt0 -126.89 116.37 20.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 6.3 m-85 -88.39 165.09 15.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.871 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -89.43 -30.27 18.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 69.6 p -136.12 171.11 14.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 94.3 t -78.4 -53.72 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 25.8 tttt -43.5 -65.35 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.845 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.593 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -42.93 -51.3 5.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.557 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -56.0 -51.39 67.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -54.73 -47.07 74.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.864 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.6 -41.25 98.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 201' ' ' TYR . . . -63.65 -62.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.119 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.568 HG22 HG21 ' A' ' 244' ' ' ILE . 93.4 t -45.27 -39.01 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.55 -67.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.512 ' O ' HG13 ' A' ' 235' ' ' VAL . 7.8 m-80 -52.96 -71.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.444 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 40.8 tt0 -44.29 120.01 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 233' ' ' ASN . 16.5 m -115.25 -34.88 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.184 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.51 -125.99 6.83 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.9 mt -121.6 140.05 52.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.818 0.342 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -47.51 -37.85 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -72.85 -39.97 66.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.411 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 65.8 m-20 -134.82 95.33 15.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.639 0.733 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 240' ' ' ASN . 53.8 Cg_endo -69.76 91.23 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.678 2.252 . . . . 0.0 112.352 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.478 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 17.3 mt -37.8 142.22 0.16 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.939 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -109.51 100.06 9.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.568 HG21 HG22 ' A' ' 231' ' ' VAL . 18.3 mt -93.65 104.41 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.159 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 48.0 p -109.52 132.76 53.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -66.78 98.59 0.55 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 38.2 tp -52.9 -58.49 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -160.18 122.49 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 114.57 57.7 0.37 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.504 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -86.09 139.9 34.68 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.599 0.714 . . . . 0.0 110.897 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 144.7 55.04 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.668 2.245 . . . . 0.0 112.333 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -109.56 83.69 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -98.56 42.6 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -56.64 96.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 83.4 p -117.26 120.25 37.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -106.39 -176.13 23.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.512 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 1.71 4.16 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.68 2.253 . . . . 0.0 112.345 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 66.7 m -79.39 157.15 27.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 21.2 m -77.33 164.38 25.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.517 -179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.8 t -161.38 149.76 15.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 0.0 110.887 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 3.0 t -96.74 -51.84 4.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.865 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.63 -100.03 1.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -145.05 171.04 15.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.903 0.382 . . . . 0.0 110.83 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 m -124.17 148.9 46.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.839 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -159.65 55.13 0.35 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -42.01 142.63 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.882 0.372 . . . . 0.0 110.923 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.46 163.26 10.8 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.453 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.89 147.15 35.28 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.55 0.691 . . . . 0.0 111.16 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 81.28 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.721 2.281 . . . . 0.0 112.357 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -76.31 140.95 41.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 ' HB1' ' A' ' 227' ' ' ALA . 24.4 mt -117.02 150.85 37.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.911 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -105.56 123.69 48.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.428 HD23 HG12 ' A' ' 244' ' ' ILE . 48.0 mt -99.06 106.77 19.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 40.5 tttm -114.87 129.38 56.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.918 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 38.2 p90 -135.31 141.79 45.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -53.14 141.99 21.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.922 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 8.1 t -158.14 144.35 17.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 25.6 mmtp -77.11 159.6 29.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -81.11 -70.51 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 183' ' ' ASP . 28.5 mm-40 -46.35 -44.27 16.77 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 182' ' ' GLU . 0.9 OUTLIER -37.23 -47.93 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.832 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 54.66 32.83 18.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.908 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.6 m -115.43 176.91 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -82.58 -46.67 13.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.911 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 119.45 -161.74 13.96 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.486 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -93.03 47.49 2.45 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.475 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.533 ' CZ ' HD21 ' A' ' 242' ' ' LEU . 80.2 m-85 -148.15 127.59 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 0.0 110.89 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 191' ' ' LYS . 26.2 t -121.96 144.56 48.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.872 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.481 ' CG ' HD23 ' A' ' 207' ' ' LEU . 36.5 tttt -34.18 -52.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.935 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.04 -58.12 9.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.413 ' HA ' ' NH1' ' A' ' 196' ' ' ARG . 85.0 t -44.11 -58.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.146 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.4 mt -59.63 -41.76 91.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.41 ' HG ' ' NE2' ' A' ' 199' ' ' GLN . 14.7 tp -55.77 -45.75 78.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.887 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.413 ' NH1' ' HA ' ' A' ' 193' ' ' VAL . 6.9 ptp85 -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 19.5 mt -72.13 -31.8 66.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.594 HD13 HG21 ' A' ' 219' ' ' VAL . 10.3 mt -96.91 -44.61 6.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.41 ' NE2' ' HG ' ' A' ' 195' ' ' LEU . 22.0 mt-30 -38.12 -54.67 1.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 18.1 ptmt -45.53 -40.76 8.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.57 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 89.4 m-85 -85.05 -63.07 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.96 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.42 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -126.73 146.63 16.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -70.81 92.06 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.893 0.377 . . . . 0.0 110.847 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 73.2 t -52.6 120.49 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 222' ' ' ALA . 84.1 mt -87.98 -49.42 7.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.93 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -142.68 124.49 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 191' ' ' LYS . 39.5 tp -111.69 108.65 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 209' ' ' LEU . 50.1 t -110.92 153.23 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.133 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 208' ' ' VAL . 8.3 mp -127.44 146.39 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 2.9 m -79.4 136.79 37.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 80.8 p -100.92 -23.87 14.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.872 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.438 ' C ' ' HE3' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -74.17 -75.55 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.466 ' HE3' ' N ' ' A' ' 213' ' ' LYS . 0.1 OUTLIER -74.86 122.02 86.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.582 0.706 . . . . 0.0 110.932 179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 127.01 13.98 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.672 2.248 . . . . 0.0 112.345 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 85.73 39.33 8.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.469 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 77.9 p -145.22 145.99 31.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.809 0.337 . . . . 0.0 111.14 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -159.31 170.53 21.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.097 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.43 122.77 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.594 HG21 HD13 ' A' ' 198' ' ' LEU . 6.7 p -102.1 162.41 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.586 ' N ' HG22 ' A' ' 219' ' ' VAL . 42.9 tt0 -128.71 115.87 18.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 227' ' ' ALA . 3.1 m-85 -90.27 176.26 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -108.78 -1.42 19.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.073 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 222' ' ' ALA . 2.1 p -157.49 168.7 26.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.164 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.7 t -82.85 -58.43 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -38.37 -67.39 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.933 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.42 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -40.23 -59.68 1.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.113 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.67 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -45.17 -63.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.091 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.439 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 20.1 mm-40 -42.98 -42.03 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.874 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 233' ' ' ASN . 63.3 mt -68.57 -49.58 58.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -55.39 -45.27 76.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.125 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 244' ' ' ILE . 43.5 t -61.68 -27.01 41.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.154 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -99.26 -72.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 201' ' ' TYR . 6.0 m-80 -42.28 -67.27 0.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.554 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.4 OUTLIER -69.36 119.99 14.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 242' ' ' LEU . 19.4 m -111.61 -11.07 11.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.91 -117.42 5.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.516 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' O ' ' C ' ' A' ' 240' ' ' ASN . 71.3 mt -121.67 131.4 54.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.718 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.1 p -35.55 -65.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.144 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.718 ' H ' HG13 ' A' ' 238' ' ' VAL . 0.4 OUTLIER -50.75 -45.55 58.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.448 ' C ' ' O ' ' A' ' 237' ' ' LEU . 30.4 t30 -124.86 88.54 53.75 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.592 0.71 . . . . 0.0 110.901 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.3 Cg_endo -69.8 97.18 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.647 2.231 . . . . 0.0 112.315 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.533 HD21 ' CZ ' ' A' ' 189' ' ' TYR . 17.2 mt -37.34 139.52 0.25 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.84 84.0 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.834 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.607 HG21 HG22 ' A' ' 231' ' ' VAL . 17.3 mt -78.53 110.71 14.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 49.8 m -118.64 134.97 54.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -67.95 109.02 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 10.0 tp -63.73 -44.65 92.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -173.32 121.29 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.893 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 112.6 59.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.488 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.47 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 23.2 tt0 -99.34 139.36 20.87 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.578 0.704 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.3 Cg_endo -69.76 135.97 31.8 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.66 2.24 . . . . 0.0 112.297 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -111.75 26.12 10.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.51 124.38 52.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.47 45.23 2.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.0 t -148.8 -175.83 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -126.81 -80.5 0.34 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.451 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -26.67 27.36 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.652 2.234 . . . . 0.0 112.341 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 1.2 m -63.69 148.3 49.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 80.7 p -62.14 157.76 18.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.472 -179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.474 -0.251 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.4 t -133.64 174.42 10.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.91 0.386 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 29.5 t -73.87 90.53 1.92 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.847 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -149.81 69.16 0.33 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.464 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -42.31 -53.75 4.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.852 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 64.8 m -97.85 113.7 25.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -68.93 171.41 38.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.463 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.33 108.86 20.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.845 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.0 178.02 51.24 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 33.3 p -50.94 142.9 16.33 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 85.37 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.742 2.294 . . . . 0.0 112.334 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -77.3 140.19 39.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.857 HD12 ' CE1' ' A' ' 221' ' ' PHE . 18.1 mt -117.82 157.28 26.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -110.0 118.85 37.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.54 HD11 HD11 ' A' ' 198' ' ' LEU . 30.5 mt -90.9 126.36 36.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.89 135.28 47.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.485 ' HB3' ' CD2' ' A' ' 242' ' ' LEU . 48.7 p90 -144.6 153.9 42.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.92 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -59.78 110.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 26.6 p -102.7 146.57 28.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 -177.96 3.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -81.67 43.61 0.76 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.59 43.5 9.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -77.98 -49.95 13.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -122.79 -54.19 1.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 90.0 p -132.67 173.39 11.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.879 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -72.12 -48.01 46.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 173.7 31.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.523 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 59.28 35.27 84.02 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.481 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.455 ' CE2' HD21 ' A' ' 242' ' ' LEU . 58.8 m-85 -158.72 152.48 23.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.885 0.374 . . . . 0.0 110.923 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 t -146.98 173.15 12.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -52.42 -58.22 7.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.922 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.73 -66.15 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.903 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 58.7 t -38.94 -67.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 87.1 mt -49.94 -46.94 52.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.946 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 14.2 tp -50.36 -38.27 41.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 38.3 mtt180 -75.05 -57.12 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 29.8 mt -43.11 -29.55 0.37 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.921 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.012 HD13 HG21 ' A' ' 219' ' ' VAL . 12.1 mt -97.13 -56.4 2.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 198' ' ' LEU . 9.6 mt-30 -33.93 -62.56 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.874 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.582 ' HG3' ' CD2' ' A' ' 201' ' ' TYR . 15.9 ptmt -33.96 -47.99 0.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.868 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 200' ' ' LYS . 88.5 m-85 -78.64 -66.22 0.89 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.471 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -120.73 136.37 11.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.423 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -61.28 84.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.381 . . . . 0.0 110.865 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.425 HG11 ' HB2' ' A' ' 207' ' ' LEU . 97.7 t -43.55 110.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 222' ' ' ALA . 84.4 mt -78.04 -49.08 14.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.931 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -142.66 117.63 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.425 ' HB2' HG11 ' A' ' 204' ' ' VAL . 60.1 tp -111.75 105.73 14.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.968 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 93.5 t -104.22 143.56 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.163 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 7.2 mp -122.03 137.98 54.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.932 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -67.13 110.58 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 13.7 t -75.45 -69.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -47.17 -44.25 21.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 2.0 mptt -104.53 92.75 5.18 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.62 0.724 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 54.1 Cg_endo -69.74 127.03 14.03 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.693 2.262 . . . . 0.0 112.342 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 126.49 -34.4 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.558 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 44.0 p -107.93 153.42 23.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 0.0 111.172 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -158.0 177.79 10.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.052 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 51.9 t -143.06 130.32 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.139 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 1.012 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -115.49 139.9 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.101 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -106.84 124.24 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.857 ' CE1' HD12 ' A' ' 173' ' ' LEU . 18.4 m-85 -95.08 168.28 10.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -92.01 -31.44 15.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.092 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 77.4 p -140.47 174.17 10.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.16 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 225' ' ' LYS . 93.1 t -78.92 -59.42 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.175 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 224' ' ' VAL . 33.0 tptt -37.0 -56.5 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.938 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.471 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -57.13 -53.74 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.104 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 221' ' ' PHE . . . -51.2 -58.59 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.075 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -43.58 -57.45 3.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.872 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.539 HD22 HD21 ' A' ' 233' ' ' ASN . 61.1 mt -53.69 -54.01 43.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -47.94 -30.63 4.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.132 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 244' ' ' ILE . 84.0 t -77.39 -38.11 26.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.55 -63.1 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.539 HD21 HD22 ' A' ' 229' ' ' LEU . 9.2 m-80 -42.93 -68.5 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.926 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.3 OUTLIER -67.63 136.02 53.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.924 179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.58 -37.41 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.117 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 125.23 -126.36 5.93 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.493 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 34.0 mt -123.16 138.06 54.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.929 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -45.53 -39.94 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.126 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.11 -41.72 70.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.404 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 30.2 m-20 -134.14 94.93 17.32 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.624 0.726 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.7 90.28 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.672 2.248 . . . . 0.0 112.376 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 177' ' ' TRP . 15.7 mt -36.2 139.24 0.17 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -111.09 108.08 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 231' ' ' VAL . 54.3 mt -100.29 130.42 49.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.8 m -129.53 138.0 51.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -73.11 95.2 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 16.0 tp -55.86 -51.76 66.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -160.44 146.63 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.905 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 84.92 44.4 6.37 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.514 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.17 130.22 50.79 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.559 0.695 . . . . 0.0 110.933 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 133.48 25.69 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.705 2.27 . . . . 0.0 112.357 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -100.1 -43.96 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.77 156.14 23.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.885 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -132.52 127.58 35.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -131.51 -52.73 1.01 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 94.28 157.54 32.95 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.433 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -22.48 32.14 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.714 2.276 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 70.9 m -105.98 94.5 5.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 43.2 m -78.84 109.37 13.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.843 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.486 -179.97 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.2 p 39.48 45.14 1.24 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 110.913 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 42.3 t -54.52 132.93 45.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.839 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 165' ' ' SER . . . 61.06 -115.05 7.32 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.506 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 164' ' ' GLY . 1.9 m 36.95 51.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.369 . . . . 0.0 110.817 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 23.4 p -108.11 122.6 47.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.875 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -146.24 -58.28 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.499 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -53.78 156.93 2.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.812 0.339 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 159.33 -164.36 33.88 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p -45.57 144.6 2.44 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.565 0.697 . . . . 0.0 111.12 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 83.35 0.69 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.36 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -77.32 136.61 38.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.787 HD12 ' CE1' ' A' ' 221' ' ' PHE . 36.5 mt -114.28 155.24 26.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.918 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -106.52 127.43 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 198' ' ' LEU . 69.7 mt -104.1 119.92 39.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.864 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -128.07 139.7 52.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.932 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 242' ' ' LEU . 44.2 p90 -147.72 146.98 29.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.1 mtmm -81.56 109.73 16.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 43.9 t -99.42 -74.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -156.15 165.87 35.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.902 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -84.69 -54.54 4.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -122.96 80.26 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -174.6 120.07 0.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.88 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -80.33 80.01 6.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.9 t -140.78 158.81 43.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -82.41 -52.15 7.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 115.87 -148.97 18.9 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -88.0 23.52 13.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.467 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.495 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 37.6 m-85 -128.42 139.16 52.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.921 0.391 . . . . 0.0 110.925 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 1.5 t -134.24 145.29 49.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 27.9 tttt -34.97 -42.41 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -66.03 -64.82 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 59.1 t -38.3 -61.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.501 ' CD2' HD11 ' A' ' 242' ' ' LEU . 80.9 mt -52.49 -44.94 65.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.403 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 21.8 tp -55.81 -40.92 73.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.98 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.62 58.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.875 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.92 -31.92 61.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.663 HD13 HG11 ' A' ' 219' ' ' VAL . 15.9 mt -99.31 -24.83 14.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.403 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 7.3 mm-40 -57.05 -59.31 5.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -43.04 -24.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.523 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 99.2 m-85 -93.94 -66.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.418 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -124.73 158.43 19.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.54 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -78.26 81.14 4.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 96.2 t -42.01 121.18 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.152 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 73.5 mt -90.09 -32.99 16.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.972 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -157.02 131.66 8.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.882 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 25.8 tp -120.53 105.45 10.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 209' ' ' LEU . 60.3 t -103.13 162.12 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.567 ' N ' HG12 ' A' ' 208' ' ' VAL . 7.0 mp -131.25 -177.38 4.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.94 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.8 p -53.4 179.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.835 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 9.7 t -123.85 -43.32 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.862 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 22.6 mmtm -116.99 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -81.96 116.45 63.4 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.618 0.723 . . . . 0.0 110.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 144.62 54.83 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.71 2.273 . . . . 0.0 112.349 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.535 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 129.21 -33.25 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.508 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 39.7 p -101.97 159.59 15.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.81 0.338 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 209' ' ' LEU . . . -163.84 176.18 9.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.084 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 55.4 t -149.01 126.58 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.663 HG11 HD13 ' A' ' 198' ' ' LEU . 9.5 p -108.24 166.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.572 ' N ' HG22 ' A' ' 219' ' ' VAL . 46.9 tt0 -132.32 124.25 28.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.787 ' CE1' HD12 ' A' ' 173' ' ' LEU . 45.5 m-85 -95.93 172.7 7.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 223' ' ' THR . . . -101.72 -9.88 20.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 222' ' ' ALA . 10.8 p -157.26 158.44 36.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.146 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.61 -43.08 83.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.49 -68.11 0.22 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.912 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.418 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.93 -46.7 16.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.701 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.19 -54.98 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.13 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -52.06 -35.81 48.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 28.4 mt -77.1 -38.44 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.902 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.53 ' O ' HD13 ' A' ' 244' ' ' ILE . . . -70.45 -19.73 62.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.077 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 227' ' ' ALA . 46.6 t -91.56 -23.48 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -101.5 -65.41 0.98 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -53.18 -75.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.864 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -55.21 120.05 6.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.42 -25.08 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.16 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 116.76 -125.01 6.38 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.46 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.45 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 77.4 mt -123.19 135.26 54.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.825 0.345 . . . . 0.0 110.911 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.495 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.0 OUTLIER -41.32 -54.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.167 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 238' ' ' VAL . 4.9 m-20 -61.25 -41.17 96.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.837 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -132.75 86.73 43.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.605 0.717 . . . . 0.0 110.928 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.6 Cg_endo -69.76 92.86 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.713 2.276 . . . . 0.0 112.357 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.5 mt -38.05 157.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -122.94 99.17 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 230' ' ' ALA . 28.3 mt -90.73 100.66 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.148 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 27.9 p -102.12 142.46 33.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -78.41 100.31 6.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.7 tp -60.68 -41.42 95.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -173.06 164.66 4.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 69.61 50.23 32.35 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.483 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.455 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 9.7 tt0 -77.37 142.86 67.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.63 0.728 . . . . 0.0 110.934 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.455 ' HD2' ' CG ' ' A' ' 250' ' ' GLN . 53.9 Cg_endo -69.77 119.83 6.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.69 2.26 . . . . 0.0 112.351 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.489 ' CD ' ' C ' ' A' ' 252' ' ' GLN . 1.7 pp0? -131.32 165.91 22.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.17 104.43 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -107.79 128.53 54.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 2.8 m -112.75 87.98 2.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.828 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -145.6 -88.88 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.486 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 1.08 4.79 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.351 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 4.6 m 41.58 45.22 2.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.848 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 27.0 t -116.18 -42.67 3.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.464 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -94.85 -49.86 5.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.875 0.369 . . . . 0.0 110.823 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 59.6 p -102.67 114.8 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 120.22 -102.37 0.87 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.458 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.7 t -152.37 141.13 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.822 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 35.8 p -125.41 173.29 8.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 108.58 -137.09 13.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -135.18 158.74 43.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.859 0.361 . . . . 0.0 110.888 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.08 155.83 25.95 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 12.1 p -82.62 142.56 46.07 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 81.07 0.83 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.724 2.283 . . . . 0.0 112.333 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -71.95 136.88 46.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.862 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.745 HD12 ' CE1' ' A' ' 221' ' ' PHE . 32.1 mt -118.4 165.11 14.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.7 ttmt -121.62 116.02 23.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.897 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.837 HD23 HG12 ' A' ' 244' ' ' ILE . 21.2 mt -86.84 114.7 23.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -125.14 129.62 50.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -137.4 153.08 50.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.911 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -62.62 147.18 50.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 30.2 p -159.54 166.02 31.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' A' ' 182' ' ' GLU . 17.7 mttp -104.22 111.17 23.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -43.04 -22.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 180' ' ' LYS . 11.6 pt-20 -127.4 -174.1 3.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 184' ' ' GLU . 0.6 OUTLIER 68.26 34.33 3.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 183' ' ' ASP . 28.5 tt0 34.5 41.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 43.7 t -97.3 104.96 17.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.856 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -67.79 -44.46 77.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.938 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 151.04 -50.98 0.53 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.523 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' ' CG ' ' A' ' 189' ' ' TYR . . . 126.41 47.55 0.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.545 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.6 ' CE2' HD21 ' A' ' 242' ' ' LEU . 96.7 m-85 -162.53 159.65 25.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.932 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 191' ' ' LYS . 62.7 m -140.77 145.49 36.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 190' ' ' SER . 49.2 tttt -35.14 -47.4 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.887 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 193' ' ' VAL . 1.7 m-20 -62.43 -69.05 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 192' ' ' ASP . 83.0 t -36.61 -66.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.067 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 74.1 mt -47.42 -52.38 17.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.906 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.602 HD12 HG11 ' A' ' 204' ' ' VAL . 15.7 tp -48.4 -45.82 36.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.8 mtm105 -66.73 -49.75 65.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 28.3 mt -47.64 -32.45 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 199' ' ' GLN . 22.9 mt -92.2 -40.04 11.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.934 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 201' ' ' TYR . 14.4 mt-30 -37.41 -71.4 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.921 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 199' ' ' GLN . 7.0 pttt -34.31 -32.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 199' ' ' GLN . 93.5 m-85 -88.47 -66.87 0.87 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.903 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.504 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -128.44 149.88 18.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.509 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -72.41 79.58 1.03 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.911 0.386 . . . . 0.0 110.925 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.602 HG11 HD12 ' A' ' 195' ' ' LEU . 89.6 t -41.47 106.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.138 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 222' ' ' ALA . 87.7 mt -71.19 -50.18 35.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -140.9 138.57 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.429 ' CD1' ' HB ' ' A' ' 219' ' ' VAL . 53.3 tp -127.88 106.48 9.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.923 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 209' ' ' LEU . 57.9 t -107.64 156.36 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.108 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' ' 208' ' ' VAL . 6.9 mp -124.0 139.55 53.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -82.95 94.99 7.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.847 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 62.5 p -66.94 -38.78 86.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -55.97 -48.87 75.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.887 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -104.66 116.15 61.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.623 0.725 . . . . 0.0 110.874 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 129.69 18.05 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.336 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 86.86 33.11 13.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . . . . . . . . . 4.1 p -150.24 145.51 26.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.14 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -153.88 169.86 22.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 54.3 t -138.2 124.03 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.602 HG22 ' N ' ' A' ' 220' ' ' GLU . 6.4 p -109.34 163.04 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.602 ' N ' HG22 ' A' ' 219' ' ' VAL . 17.0 tt0 -130.46 121.1 25.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.745 ' CE1' HD12 ' A' ' 173' ' ' LEU . 38.5 m-85 -93.27 173.32 7.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.878 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -99.03 -24.8 14.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.111 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 42.1 p -140.21 173.65 11.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.167 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 91.8 t -81.42 -48.63 18.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.114 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -44.23 -66.08 0.43 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -45.43 -52.03 10.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.102 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -50.11 -62.43 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.454 ' CG ' ' HG3' ' A' ' 251' ' ' PRO . 36.8 mt-10 -43.66 -48.68 7.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 233' ' ' ASN . 30.6 mt -61.14 -45.23 95.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -59.96 -31.1 69.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.095 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.513 HG21 ' NE1' ' A' ' 246' ' ' TRP . 95.7 t -78.89 -19.94 12.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -109.07 -68.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.954 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.449 ' CB ' ' CE1' ' A' ' 201' ' ' TYR . 15.5 m-80 -45.92 -70.43 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.79 ' OE2' HD11 ' A' ' 244' ' ' ILE . 0.0 OUTLIER -62.67 124.0 19.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.39 -27.27 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 114.07 -119.78 4.86 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.457 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 27.3 mt -130.19 137.17 49.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.896 0.379 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.686 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.1 p -40.46 -59.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.686 ' H ' HG13 ' A' ' 238' ' ' VAL . 13.4 t0 -52.32 -43.76 64.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.822 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 17.1 m-20 -131.92 94.0 25.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.671 0.748 . . . . 0.0 110.881 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.72 92.29 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.695 2.264 . . . . 0.0 112.385 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.6 HD21 ' CE2' ' A' ' 189' ' ' TYR . 16.0 mt -34.0 143.01 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 tmtt? -119.59 85.64 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.835 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.837 HG12 HD23 ' A' ' 175' ' ' LEU . 55.2 mt -80.58 111.9 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 18.2 m -107.83 145.52 33.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.875 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.513 ' NE1' HG21 ' A' ' 231' ' ' VAL . 72.6 m95 -83.89 105.92 15.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.928 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 13.7 tp -64.88 -47.84 76.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.904 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -169.83 141.5 2.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 97.47 40.34 3.7 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.444 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 41.0 tt0 -78.12 138.57 60.64 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.608 0.718 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.454 ' HG3' ' CG ' ' A' ' 228' ' ' GLU . 53.6 Cg_endo -69.8 118.28 5.59 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -128.13 84.58 2.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -159.43 176.71 11.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 44.0 39.67 2.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.053 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.0 t -94.14 157.14 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 125.73 -171.06 17.59 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.506 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 97.69 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.695 2.263 . . . . 0.0 112.352 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 85.8 p -121.78 177.44 5.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 61.9 p -144.92 148.22 33.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.996 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 83.8 p -81.84 85.78 6.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 9.2 t -38.87 -60.72 0.81 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 164.46 103.93 0.18 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.49 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.4 t -72.38 157.85 36.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.402 . . . . 0.0 110.813 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 t -88.04 145.39 26.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.871 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -83.4 118.99 4.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.533 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -144.4 140.6 29.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.871 0.367 . . . . 0.0 110.904 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 54.77 178.8 0.17 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.8 p -60.91 146.69 86.81 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.633 0.73 . . . . 0.0 111.13 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 81.6 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.652 2.234 . . . . 0.0 112.35 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.413 ' HZ2' HD23 ' A' ' 247' ' ' LEU . 5.8 mtmp? -63.82 142.51 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.928 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 218' ' ' VAL . 47.5 mt -126.34 151.78 47.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 218' ' ' VAL . 36.7 tttt -114.95 125.25 53.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.53 HD11 HD11 ' A' ' 198' ' ' LEU . 29.1 mt -103.01 124.65 48.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.963 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.497 ' HG2' HG22 ' A' ' 216' ' ' THR . 6.5 tmtm? -129.08 133.62 47.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 242' ' ' LEU . 49.5 p90 -143.8 145.54 32.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.926 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -52.58 162.37 0.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 18.8 p -158.7 151.96 22.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 182' ' ' GLU . 16.2 ttmm -52.99 166.24 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.439 ' O ' ' C ' ' A' ' 182' ' ' GLU . 5.3 tmtm? -50.99 90.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 181' ' ' LYS . 67.1 mm-40 34.22 54.74 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.913 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.429 ' CG ' ' HB3' ' A' ' 180' ' ' LYS . 23.5 p-10 -79.25 164.51 24.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.899 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -85.29 46.27 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.1 m -157.26 170.0 23.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.36 -51.95 9.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 138.96 -118.48 1.56 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.493 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -113.63 40.39 2.52 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.482 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.501 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 54.8 m-85 -151.37 154.18 36.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.918 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 18.2 p -137.0 168.45 19.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -54.96 -44.3 74.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.03 -54.18 34.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 55.9 t -47.9 -43.72 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 98.2 mt -74.42 -43.11 57.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.475 ' O ' ' CG ' ' A' ' 199' ' ' GLN . 18.6 tp -57.53 -39.19 76.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 40.1 ptt85 -77.9 -43.85 28.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.603 HD23 ' HZ1' ' A' ' 200' ' ' LYS . 31.5 mt -56.85 -27.65 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.694 HD13 HG21 ' A' ' 219' ' ' VAL . 13.0 mt -99.83 -43.12 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.859 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.475 ' CG ' ' O ' ' A' ' 195' ' ' LEU . 6.9 mm-40 -46.64 -61.21 1.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.889 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.603 ' HZ1' HD23 ' A' ' 197' ' ' LEU . 7.1 ptpp? -36.49 -30.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.922 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 234' ' ' GLU . 97.8 m-85 -92.06 -60.23 1.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.531 ' HA3' ' HB1' ' A' ' 226' ' ' ALA . . . -142.09 147.48 18.99 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.478 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.66 125.63 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 110.878 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 207' ' ' LEU . 43.7 t -85.4 97.42 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.119 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 222' ' ' ALA . 19.0 mt -59.25 -58.73 7.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.22 123.82 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 204' ' ' VAL . 48.9 tp -117.03 109.56 17.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.579 ' C ' HD12 ' A' ' 209' ' ' LEU . 86.6 t -107.26 152.02 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.579 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.7 mp -135.3 135.91 41.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.947 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.2 t -65.25 115.76 5.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.816 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 33.6 t -80.11 -54.32 5.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 3.3 ttmm -53.25 -58.3 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -100.93 98.91 9.27 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.589 0.709 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.8 Cg_endo -69.78 131.45 21.22 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.68 2.253 . . . . 0.0 112.346 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 127.14 -27.41 4.81 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 176' ' ' LYS . 61.8 p -110.64 150.46 28.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.794 0.33 . . . . 0.0 111.127 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.79 175.87 13.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.101 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 173' ' ' LEU . 93.9 t -146.15 131.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.694 HG21 HD13 ' A' ' 198' ' ' LEU . 7.7 p -114.5 143.3 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.133 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -112.1 108.47 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -82.21 177.46 8.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.893 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 205' ' ' LEU . . . -99.86 -32.51 10.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 29.7 p -137.48 164.65 28.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.16 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.404 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.6 t -72.2 -53.43 19.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.122 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 224' ' ' VAL . 0.6 OUTLIER -37.99 -59.91 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.531 ' HB1' ' HA3' ' A' ' 202' ' ' GLY . . . -54.18 -45.89 72.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.068 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.565 ' O ' HG23 ' A' ' 231' ' ' VAL . . . -54.33 -56.55 17.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.091 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -49.8 -45.57 50.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 98.1 mt -64.19 -47.04 81.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.918 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' A' ' 244' ' ' ILE . . . -64.75 -28.32 69.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.666 HG11 ' HE1' ' A' ' 246' ' ' TRP . 96.3 t -82.58 -17.66 11.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.161 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.8 -69.25 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -45.69 -68.9 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 20.3 tt0 -57.0 132.26 52.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.906 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.406 HG23 ' N ' ' A' ' 236' ' ' GLY . 26.9 m -119.3 -40.31 2.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.108 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.406 ' N ' HG23 ' A' ' 235' ' ' VAL . . . 123.91 -123.58 5.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.497 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 40.2 mt -122.97 138.06 54.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.837 0.351 . . . . 0.0 110.932 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 1.5 p -43.96 -44.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.102 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -67.09 -42.52 84.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -134.11 92.28 22.02 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.635 0.731 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 242' ' ' LEU . 54.0 Cg_endo -69.73 92.65 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.695 2.264 . . . . 0.0 112.34 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 177' ' ' TRP . 21.7 mt -34.75 140.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.437 ' C ' ' HD3' ' A' ' 243' ' ' LYS . 0.8 OUTLIER -112.59 91.33 3.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.549 HG21 HG22 ' A' ' 231' ' ' VAL . 19.7 mt -77.84 106.02 7.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 34.6 m -103.82 125.48 50.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . 0.666 ' HE1' HG11 ' A' ' 231' ' ' VAL . 56.9 m95 -67.81 104.57 1.71 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.413 HD23 ' HZ2' ' A' ' 172' ' ' LYS . 9.7 tp -59.3 -43.74 92.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -174.14 157.05 2.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.72 66.08 1.88 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.519 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -95.57 152.82 39.45 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 121.05 7.75 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.696 2.264 . . . . 0.0 112.382 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -107.53 157.91 17.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.932 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.86 82.94 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.818 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.33 114.55 3.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 23.0 t -72.67 -50.83 22.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.835 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.43 -157.36 15.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.541 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 121.87 8.55 Favored 'Trans proline' 0 N--CA 1.466 -0.142 0 C-N-CA 122.721 2.281 . . . . 0.0 112.351 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 67.1 p -99.44 135.67 40.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 93.6 p -152.46 171.03 18.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.474 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.8 p -50.93 160.45 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.922 0.391 . . . . 0.0 110.81 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p 41.04 42.1 1.46 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -83.15 138.38 17.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.486 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 47.7 t -51.63 148.93 4.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.88 0.371 . . . . 0.0 110.878 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -126.58 133.8 50.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 67.15 -167.56 39.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.443 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -125.7 113.34 17.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.836 0.35 . . . . 0.0 110.864 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.1 -173.51 28.71 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.0 p -80.61 143.8 55.47 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.546 0.689 . . . . 0.0 111.164 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 80.47 0.88 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 0.0 112.35 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -69.89 133.81 47.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.72 HD12 ' CE1' ' A' ' 221' ' ' PHE . 35.8 mt -112.67 160.98 17.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.412 ' HG3' HG22 ' A' ' 218' ' ' VAL . 23.8 tttm -112.85 130.87 55.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 198' ' ' LEU . 31.4 mt -107.79 117.69 34.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.706 ' HG3' HG22 ' A' ' 216' ' ' THR . 24.9 ttmt -124.74 130.47 52.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.89 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.493 ' CE2' ' O ' ' A' ' 215' ' ' GLY . 43.9 p90 -139.33 146.06 39.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.76 140.82 57.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 53.8 t -145.83 111.7 5.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -50.76 168.44 0.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HG3' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -104.32 -45.39 4.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 181' ' ' LYS . 9.3 pt-20 -76.48 -37.05 57.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -75.06 95.42 3.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -60.5 93.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.829 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 2.1 m -169.28 164.39 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.857 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -71.01 -56.01 7.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.73 36.19 0.17 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 69.4 36.47 77.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.529 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.695 ' CZ ' HD12 ' A' ' 237' ' ' LEU . 82.6 m-85 -157.31 162.79 39.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.904 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 t -160.11 165.7 31.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.917 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -51.04 -44.24 61.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.35 -57.62 7.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 92.7 t -47.09 -64.81 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.451 HD11 ' CZ3' ' A' ' 177' ' ' TRP . 96.2 mt -49.3 -41.95 39.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.692 HD12 HG11 ' A' ' 204' ' ' VAL . 12.7 tp -56.92 -37.03 70.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -75.81 -47.77 24.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 197' ' ' LEU . 19.6 mt -51.38 -32.75 27.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.856 HD13 HG11 ' A' ' 219' ' ' VAL . 26.2 mt -95.01 -49.28 5.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.456 ' C ' ' O ' ' A' ' 198' ' ' LEU . 25.7 mt-30 -34.05 -65.8 0.18 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.581 ' HD2' ' CE2' ' A' ' 201' ' ' TYR . 16.8 ptpt -34.18 -42.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.581 ' CE2' ' HD2' ' A' ' 200' ' ' LYS . 92.6 m-85 -81.8 -61.26 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . 0.475 ' CA ' ' HB1' ' A' ' 226' ' ' ALA . . . -128.58 139.4 10.99 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.51 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -64.33 92.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.907 0.384 . . . . 0.0 110.922 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.692 HG11 HD12 ' A' ' 195' ' ' LEU . 76.7 t -50.59 114.43 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.609 HD11 ' HA ' ' A' ' 222' ' ' ALA . 47.7 mt -85.41 -51.93 6.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -134.84 115.33 13.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.873 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.474 HD13 HG23 ' A' ' 219' ' ' VAL . 63.7 tp -111.58 104.26 12.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.946 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.403 ' C ' HD12 ' A' ' 209' ' ' LEU . 91.4 t -101.52 148.45 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.149 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.403 HD12 ' C ' ' A' ' 208' ' ' VAL . 6.9 mp -129.15 137.3 51.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.961 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 30.7 t -60.62 123.72 18.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 2.8 m -87.35 -52.34 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -64.63 -55.49 19.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -101.18 98.75 9.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.582 0.706 . . . . 0.0 110.876 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.7 Cg_endo -69.76 142.6 48.36 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.318 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.493 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 115.82 -36.74 3.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.513 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.706 HG22 ' HG3' ' A' ' 176' ' ' LYS . 78.0 p -101.76 146.58 27.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -150.41 177.61 9.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.113 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 173' ' ' LEU . 68.8 t -149.66 121.5 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.127 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.856 HG11 HD13 ' A' ' 198' ' ' LEU . 5.4 p -105.79 150.63 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.167 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -116.07 111.15 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.72 ' CE1' HD12 ' A' ' 173' ' ' LEU . 21.4 m-85 -80.53 170.7 16.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.609 ' HA ' HD11 ' A' ' 205' ' ' LEU . . . -94.59 -24.08 17.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 27.8 p -145.62 169.79 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.089 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 59.6 t -76.35 -56.01 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -41.3 -61.54 1.01 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.475 ' HB1' ' CA ' ' A' ' 202' ' ' GLY . . . -49.43 -52.28 29.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.1 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.514 ' HB1' HD11 ' A' ' 173' ' ' LEU . . . -54.9 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 227' ' ' ALA . 2.6 mm-40 -37.37 -54.05 1.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' A' ' 233' ' ' ASN . 61.9 mt -56.72 -59.12 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -45.47 -34.34 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.671 HG22 HG21 ' A' ' 244' ' ' ILE . 63.2 t -73.41 -43.16 56.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -87.42 -62.72 1.43 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 229' ' ' LEU . 2.4 m-80 -44.21 -69.47 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 201' ' ' TYR . 8.3 tp10 -66.2 136.78 56.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 22.8 m -115.55 -33.73 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 124.15 -128.36 6.8 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.455 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.695 HD12 ' CZ ' ' A' ' 189' ' ' TYR . 51.2 mt -123.96 135.1 53.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 239' ' ' ASP . 1.9 p -39.85 -55.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.104 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.59 ' H ' HG13 ' A' ' 238' ' ' VAL . 1.4 p-10 -55.83 -45.15 78.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.417 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 27.6 m-20 -133.37 97.13 16.44 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.616 0.722 . . . . 0.0 110.875 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.73 91.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.697 2.265 . . . . 0.0 112.338 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 241' ' ' PRO . 20.3 mt -34.82 144.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.925 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -117.12 97.98 6.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.671 HG21 HG22 ' A' ' 231' ' ' VAL . 37.1 mt -91.9 111.31 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 25.1 m -113.19 137.87 50.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -72.15 95.39 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.66 -60.25 3.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.21 176.75 9.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.43 58.14 16.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.13 134.79 85.09 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.615 0.721 . . . . 0.0 110.897 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.441 ' O ' ' C ' ' A' ' 252' ' ' GLN . 53.3 Cg_endo -69.76 2.7 3.3 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.632 2.221 . . . . 0.0 112.33 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 251' ' ' PRO . 3.1 tp60 -34.47 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.25 176.25 8.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -135.87 -179.56 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.09 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 50.3 m -39.85 -54.86 2.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 65.05 161.19 0.59 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.495 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 0.53 5.52 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.348 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 16.9 m -69.98 169.18 13.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 16.4 t -69.09 147.42 51.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.865 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.511 -179.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.4 m -90.83 172.59 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 110.874 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 27.5 p -123.28 146.51 47.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.84 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 153.93 -117.94 0.83 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.471 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 80.1 p -56.4 104.5 0.15 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.867 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 1.9 m -49.33 176.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.835 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -121.32 -63.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.3 149.55 51.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.806 0.336 . . . . 0.0 110.88 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 68.61 147.68 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.492 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.6 p -115.04 144.14 31.51 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 0.0 111.123 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 88.42 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.641 2.228 . . . . 0.0 112.36 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -71.53 152.62 42.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 221' ' ' PHE . 88.8 mt -132.15 149.6 52.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -105.31 117.7 34.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 244' ' ' ILE . 15.6 mt -99.17 120.8 40.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.928 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.719 ' HG3' HG22 ' A' ' 216' ' ' THR . 42.4 tttm -128.71 138.32 52.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TRP . . . . . 0.611 ' HB3' HD23 ' A' ' 242' ' ' LEU . 46.2 p90 -146.53 137.89 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -51.15 101.1 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' CYS . . . . . . . . . . . . . 44.1 t -96.8 117.74 31.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -53.85 -28.83 38.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.468 ' C ' ' O ' ' A' ' 180' ' ' LYS . 30.9 ttpt 33.08 35.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.878 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 180' ' ' LYS . 34.4 mm-40 -133.98 -50.19 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -68.93 178.56 2.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -85.58 42.67 0.97 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.922 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 7.8 t -153.7 177.27 11.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -100.68 -61.43 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 169.73 -177.76 43.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -80.47 40.9 2.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.473 ' CZ ' ' HG ' ' A' ' 242' ' ' LEU . 58.6 m-85 -149.81 167.92 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.89 0.376 . . . . 0.0 110.891 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.4 t -167.3 163.99 15.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.847 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -46.68 -45.79 19.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -66.54 -56.51 10.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 97.9 t -49.91 -39.65 15.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 64.7 mt -77.94 -38.83 44.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 17.0 tp -61.45 -42.85 99.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 197' ' ' LEU . 13.9 ptm180 -71.59 -49.01 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.417 ' HB3' ' CD ' ' A' ' 234' ' ' GLU . 32.0 mt -47.89 -45.74 30.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 219' ' ' VAL . 10.7 mt -80.42 -50.78 9.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 198' ' ' LEU . 11.9 mm-40 -34.59 -56.81 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.896 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -39.1 -50.39 1.85 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' CE1' ' HB2' ' A' ' 234' ' ' GLU . 23.4 m-85 -80.73 -64.53 1.17 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -120.75 140.41 14.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -69.22 88.95 0.45 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.873 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.503 HG11 ' HB2' ' A' ' 207' ' ' LEU . 78.0 t -44.63 109.96 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 77.0 mt -86.93 -49.85 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -131.44 106.97 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.906 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . 0.503 ' HB2' HG11 ' A' ' 204' ' ' VAL . 67.5 tp -107.94 109.59 21.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.708 ' C ' HD12 ' A' ' 209' ' ' LEU . 58.0 t -107.05 151.51 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.708 HD12 ' C ' ' A' ' 208' ' ' VAL . 7.6 mp -137.88 134.91 35.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.0 t -55.57 138.14 47.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 38.3 p -100.54 -62.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.819 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -58.24 -53.01 63.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 213' ' ' LYS . 6.5 mptt -101.7 97.94 8.78 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.578 0.704 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 213' ' ' LYS . 53.7 Cg_endo -69.75 141.94 46.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.681 2.254 . . . . 0.0 112.361 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.44 ' O ' ' CE2' ' A' ' 177' ' ' TRP . . . 120.5 -41.29 1.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.478 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' THR . . . . . 0.719 HG22 ' HG3' ' A' ' 176' ' ' LYS . 62.2 p -97.65 151.02 20.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.771 0.32 . . . . 0.0 111.154 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -157.76 168.91 25.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 173' ' ' LEU . 98.5 t -143.44 122.41 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 220' ' ' GLU . 11.8 p -107.47 166.9 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.175 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.604 ' N ' HG22 ' A' ' 219' ' ' VAL . 38.4 tt0 -132.74 115.54 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 173' ' ' LEU . 9.2 m-85 -80.87 172.67 13.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.876 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -94.98 -29.01 14.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.11 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 71.5 p -141.56 159.28 42.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.145 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' A' ' 225' ' ' LYS . 90.4 t -67.09 -59.47 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.101 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' VAL . 40.0 tptt -37.48 -55.08 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -55.24 -50.54 69.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.057 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.53 -61.79 2.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.078 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.419 ' CD ' ' HG3' ' A' ' 251' ' ' PRO . 43.5 mt-10 -43.32 -50.01 6.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 55.8 mt -61.83 -44.99 95.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.891 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -60.23 -39.92 88.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . 0.483 HG22 HG21 ' A' ' 244' ' ' ILE . 63.0 t -67.23 -32.31 57.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -88.67 -72.45 0.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -49.26 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.846 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.582 ' HB2' ' CE1' ' A' ' 201' ' ' TYR . 36.1 tt0 -64.3 114.93 4.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.91 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 21.8 m -122.1 7.51 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.115 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.73 -119.93 6.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.451 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.439 ' N ' ' OH ' ' A' ' 189' ' ' TYR . 19.3 mt -128.91 138.3 51.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.89 0.376 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.628 HG13 ' H ' ' A' ' 239' ' ' ASP . 2.5 p -39.42 -56.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.628 ' H ' HG13 ' A' ' 238' ' ' VAL . 2.8 t0 -54.28 -45.94 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.92 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 241' ' ' PRO . 56.7 t30 -130.89 91.08 37.79 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.665 0.745 . . . . 0.0 110.903 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 242' ' ' LEU . 53.8 Cg_endo -69.8 95.59 0.56 Allowed 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.333 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 177' ' ' TRP . 29.6 mt -35.64 152.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.952 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 85.27 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.928 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.491 HG12 HD23 ' A' ' 175' ' ' LEU . 41.0 mt -85.04 105.38 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' SER . . . . . . . . . . . . . 17.0 m -115.18 137.31 52.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.817 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.58 102.62 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 21.6 tp -64.39 -50.11 68.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -163.88 112.63 1.2 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 125.51 65.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.499 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -107.24 133.08 20.48 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.531 0.681 . . . . 0.0 110.931 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.419 ' HG3' ' CD ' ' A' ' 228' ' ' GLU . 54.1 Cg_endo -69.75 119.73 6.63 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.371 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -145.78 173.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.924 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -121.07 -48.56 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -62.92 84.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.06 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.7 m -86.69 172.77 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 99.57 166.48 29.66 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 174.75 9.03 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.718 2.279 . . . . 0.0 112.382 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' SER . . . . . . . . . . . . . 20.0 m -79.94 150.45 30.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' SER . . . . . . . . . . . . . 3.0 t -60.63 -48.48 81.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.484 179.975 . . . . . . . . 0 0 . 1 stop_ save_